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Abstract  
Chronic kidney disease of undetermined aetiology (CKDu) is mainly responsible 
for the deaths of young males in agricultural lowland regions of Central 
America. The aim of this thesis was to advance the understanding of the causes 
of CKDu by conducting several different epidemiological research studies.  
 
The systematic review identified a number of cross-sectional studies and 
occupational cohort studies with limited follow-up periods, but the findings were 
inconclusive regarding the causes of CKDu.  
 
The cohort study described in this PhD thesis is the first community-based 
cohort study in the region to evaluate the natural history of disease in 
apparently healthy people aged 18-30 years. It collected information about a 
wide range of exposure conditions with a questionnaire, biological samples, and 
water samples. There was an unparalleled, asymptomatic and very rapid 
decline in renal function among 10% of males and 3.5% of females who had 
normal renal function at baseline. Meanwhile, the group displaying established 
renal dysfunction (mean estimated glomerular filtration rate, eGFR: 58 
mL/min/1.73 m2) at baseline showed a slower subsequent decline in kidney 
function (3.6 mL/min/1.73 m2/year). A rapid decrease in eGFR was associated 
with outdoor work, agricultural work, and a lack of shade during work breaks. 
 
The nested case-control study measured eGFR, and urinary neutrophil 
gelatinase-associated lipocalin (uNGAL) at baseline. After adjusting for eGFR, 
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uNGAL did not improve prediction a rapid decline in kidney function among 
individuals who initially presented a normal eGFR. 
 
This is the first study to show that in northwest Nicaragua, 10% of the male and 
3.5% of the female population aged 18-30 years showed a very strong decline 
in kidney function. Larger community-based and occupational longitudinal 
studies with more detailed analyses of exposure data are needed to identify the 
cause(s) of CKDu.  
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Chapter 1. General background 
 
1.1 Chronic kidney disease 
Chronic kidney disease (CKD) is an abnormality in kidney function or structure 
that is present for three or more months.[1] Kidney function is usually measured 
by calculating the estimated glomerular filtration rate (eGFR) from biomarkers 
(usually serum creatinine) measured in the blood.[2] A moderate to severe 
kidney function impairment (stage 3-5 CKD) is defined as an eGFR of <60 
mL/min/1.73 m2 for at least 3 months.[1] In countries such as the US and the UK, 
the main known risk factors for CKD are ageing, diabetes, hypertension, obesity 
and glomerulonephritis.[1]  
 
1.1.1 Estimated glomerular filtration rate (eGFR) 
Several methods have been used for measuring glomerular filtration rate (GFR). 
For example, Inulin, Iohexol or Iothalamate clearance have been frequently 
used for measurements of GFR and both methods perform very well. However, 
these methods are difficult to implement in field research or clinical practice 
because they are invasive, challenging to implement in field and carry risks 
some minor adverse effects, etc. 
Currently, different equations have been developed to estimate the glomerular 
filtration rate based on serum creatinine. The most widely used equations are 
Cockcroft-Gault,[3] the Modification of Diet in Renal Disease (MDRD)[4-6] and 
recently the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 
equation.[7] However, creatinine-based estimates appear to be affected by 
different sources of variation such as diet, body mass index (BMI), ethnicity, 
medications use, etc.[8]  
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Therefore, the international guidelines (Kidney Disease Improving Global 
Outcomes (KDIGO)) in 2012 has recommended the use of an additional 
marker-based method for eGFR calculation which include cystatin C. Also, 
equations use a combination of cystatin C and creatinine which offer an 
improved precision and accuracy if compared to creatinine-based estimates 
alone using CKD-EPI, particularly at higher kidney function (eGFR: >60 
mL/min/1.73m2).[1, 2, 7] However, this equation has not been validated for Latin-
American population yet.  
Table 1: Chronic kidney disease epidemiology collaboration (CKD-EPI) 
equation for estimating the GFR based on creatinine, cystatin c and 
creatinine and cystatin c[2, 7] 
Formula 
and Sex 
Serum 
creatinine 
levels 
(mg/dL) 
Serum 
Cystatin 
C levels 
(mg/liter) 
Formula for estimating GFR 
CKD-EPI formula for Scr 
Male ≤0.9  eGFR: 141 x (Scr/0.9)
-0.411 x 0.993Age [x 1.159 if black] 
>0.9  eGFR: 141 x (Scr/0.9)-1.209 x 0.993Age [x 1.159 if black] 
Female ≤0.7  eGFR: 144 x (Scr/0.7)
-0.329 x 0.993Age [x 1.159 if black] 
>0.7  eGFR: 141 x (Scr/0.9)-1.209 x 0.993Age [x 1.159 if black] 
CKD-EPI formula for Scys 
Male or 
female  ≤0.8 
eGFR: 133 x (Scys/0.8)-0.499 x 0.996Age [x 0.932 if black] 
Male or 
female  >0.8 
eGFR: 133 x (Scys/0.8)-1.328 x 0.996Age [x 0.932 if black] 
CKD-EPI formula for Scr and Scys 
Male 
≤0.9 
≤0.8 
eGFR: 135 x (Scr/0.9)-0.207 x (Scys/0.8)-0.375 x 0.995Age [x 
1.08 if black]  
>0.8 
eGFR: 135 x (Scr/0.9)-0.207 x (Scys/0.8)-0.711 x 0.995Age [x 
1.08 if black]  
>0.9 
≤0.8 
eGFR: 135 x (Scr/0.9)-0.601 x (Scys/0.8)-0.375 x 0.995Age [x 
1.08 if black]  
>0.8 
eGFR: 135 x (Scr/0.9)-0.601 x (Scys/0.8)-0.711 x 0.995Age [x 
1.08 if black]  
Female 
≤0.9 
≤0.8 
eGFR: 130 x (Scr/0.7)-0.248 x (Scys/0.8)-0.375 x 0.995Age [x 
1.08 if black]  
>0.8 
eGFR: 130 x (Scr/0.7)-0.248 x (Scys/0.8)-0.711 x 0.995Age [x 
1.08 if black]  
>0.9 
≤0.8 
eGFR: 130 x (Scr/0.7)-0.601 x (Scys/0.8)-0.375 x 0.995Age [x 
1.08 if black]  
>0.8 eGFR: 130 x (Scr/0.7)
-0.601 x (Scys/0.8)-0.711 x 0.995Age [x 
1.08 if black]  
Abbreviations: eGFR: estimated glomerular filtration rate; CKD-EPI: chronic kidney disease epidemiology 
collaboration equation; Scr: serum creatinine, Scys: serum cystatin c. 
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1.1.2 Classification of CKD 
Central America has adopted the classification of CKD developed by the United 
States National Kidney Foundation as part of KDIGO 2012 criteria.[1] CKD is 
diagnosed by using both blood and urine markers. It can also be diagnosed 
using imaging or biopsy, but these methods are generally not accessible to 
much of the population in low- and middle-income countries (LMICs) in 
Mesoamerica. An eGFR is calculated using age, sex and biomarkers from the 
blood (serum creatinine or cystatin c). Additionally, the amount of protein loss in 
the urine (usually albumin) is usually quantified as the albumin/creatinine ratio. 
Two measurements recorded at least three months apart are required to 
confirm chronicity. Based on the two measurements, CKD is diagnosed and 
classified into five stages (see Table 1), including the mild stages (1-2) and 
moderate to severe stages (3-5).[1] 
 
Table 2: KDIGO 2012 classification of CKD prognosis by eGFR categories 
and albuminuria levels[1] 
    Albuminuria categories 
    A1 A2 A3 
 
Stages 
of CKD 
eGFR 
categories  
Clinical 
interpretation 
<30 mg/g 
(normal to 
mildly 
increased) 
30-300 mg/g 
(Moderately 
increased) 
>300 mg/g 
(Severely 
increased) 
eG
FR
 c
at
eg
or
ie
s 
(m
L/
m
in
/1
.7
3  
m
2 )
 
G1 >90 Normal    
G2 60 – 89 Mildly decreased    
G3a 45 – 59 
Mildly to moderately 
decreased 
   
G3b 30 – 44 
Moderately to 
severely decreased 
   
G4 15 – 29 Severely decreased    
G5 <15 Kidney failure    
Abbreviations: eGFR: estimated glomerular filtration rate; CKD: chronic kidney disease. 
Green: low risk; yellow: moderately increased risk; orange: high risk; and red: very high risk. 
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CKD is often defined solely on the basis of an eGFR<60 mL/min/1.73m2. 
However, based on the results from a consortium of international studies 
performed primarily in developed nations (the CKD Prognosis Consortium), 
proteinuric kidney disease can exhibit the same risks of poor outcomes 
(cardiovascular diseases, death and complete renal failure), even if the eGFR is 
initially not low.[9, 10]  
 
1.2 Acute kidney injury 
Acute kidney injury (AKI) is defined as a sudden kidney impairment due to an 
increase in serum creatinine (Scr) levels of ≥0.3 mg/dL within 48 hours; an 
increase in Scr levels to ≥1.5 times the baseline value, which is known or 
presumed to have occurred within the previous 7 days; or a poor urine volume 
of 0.05 mL/kg/h for 6 hours (See Table 2).[11]  
Table 3: Criteria for the diagnosis and classification of AKI[11]  
Stage Serum creatinine level Urine output 
1 
1.5 – 1.9 times the baseline value 
or 
≥0.3 mg/dL (≥26.5 µmol/L) increase within 48 
hours 
<0.5 mL/kg/h for 6-12 hours 
2 2.0 – 2.9 times the baseline value <0.5 mL/kg/h for ≥12 hours 
3 
3.0 times the baseline value 
or  
an increase in serum creatinine levels to ≥4.9 
mg/dL (≥353.6 µmol/L) 
or 
initiation of renal replacement therapy 
or 
in patients <18 years, a decrease in eGFR to 
<35 mL/min/1.73 m2 
<0.3 mL/kg/h for ≥24 hours 
or  
anuria for ≥12 hours 
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1.3 Chronic kidney disease of unknown aetiology 
Chronic kidney disease of unknown aetiology (CKDu), also known as 
Mesoamerican nephropathy (MeN) when it occurs in Latin America, has 
emerged over the last two decades and represents a major public health 
problem in rural communities in Mesoamerica.[12-18] This form of CKD is not 
associated with conventional CKD risk factors, such as diabetes, hypertension, 
glomerulonephritis and obesity.[15, 18-21] According to epidemiological studies, 
this disease mainly affects (but is not restricted to) young agricultural workers 
who live on the Pacific coast and typically work in occupations requiring high 
intensity physical activity in hot environments. Clinical and laboratory studies 
have shown asymptomatic increases in serum creatinine levels and normal 
blood pressure, no or only low-grade proteinuria, hyponatremia, hypokalaemia, 
and hyperuricaemia,[15, 18, 21-27] and both tubulointerstitial and glomerular 
damage upon biopsy.[28, 29]  
1.3.1 Prevalence of CKDu  
The prevalence of CKDu (as estimated by a SINGLE measure of eGFR<60 
mL/min/1.73 m2) is highly variable, depending on the geographic area. It 
predominantly affects rural populations, with a prevalence ranging from 13.4% 
to 26%, compared to much lower levels in urban populations (0.0% to 9.1%), 
where the highest reported prevalence is approximately half the rural 
estimates.[15, 18-21, 30] Prevalence appears to be lower at higher altitudes (1.2 to 
7.5%) than at sea level (0% to 18.5%).[15, 18, 31] 
Differences in prevalence with age, sex and certain occupations have also been 
observed. Relatively young age groups, e.g., individuals aged 18-40 years, 
appear to be particularly affected, with a prevalence rate ranging from 8.1% to 
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38.5%. Males are more frequently affected, with the highest estimates ranging 
from 13.8% to 42%, compared to females with a range of 5.8% to 22%; the 
average male:female ratio is 2:1.[15, 18-21, 30, 32] Most affected individuals have 
been rural sugarcane workers, with the highest prevalence (13% to 44% for 
males),[15, 18, 20, 21, 24] followed by miners (19%), and male banana/sugarcane 
workers (17%).[15] Construction workers are also affected, with a prevalence of 
9%.[24] Individuals with other occupations seem to be less affected, e.g., coffee 
workers and service workers, with prevalences that do not exceed 7.5%.[15, 18, 31] 
A recent publication reported excess mortality due to CKD in the last 16 years 
(1997-2013) in Central America. The age-standardized mortality rate increased 
in Nicaragua from 23.9 deaths per 100 000 population in 1997 to 36.7 deaths 
per 100 000 population in 2013; in El Salvador, mortality increased from 18.7 to 
47.4 deaths per 100 000 population in the same period. These rates are 
approximately nine and twelve times higher in El Salvador and Nicaragua than 
in other countries in Central America.[33]  
 
1.3.2 Potential causes of CKDu 
A variety of hypotheses regarding the aetiology and factors contributing to 
CKDu in Mesoamerica have been proposed. However, no clear causal 
mechanisms have been identified. The leading hypotheses are occupational 
heat stress, recurrent dehydration, pesticide exposure, environmental toxin 
(heavy metal) exposure, and infectious diseases. The non-occupational 
hypotheses include self-medication with NSAIDs, homemade alcohol 
consumption, and genetic predisposition.[12, 13]  
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1.3.2.1 Heat stress/dehydration 
Agricultural and non-agricultural workers in Mesoamerica work under extremely 
hot conditions with intense physical demands for long hours each day. Given 
these conditions, volume depletion due to recurrent acute or severe dehydration 
episodes in sugarcane workers has been proposed to cause subclinical acute 
kidney injury (AKI) due to reduced renal blood flow, leading to ischaemia.[34-39]  
 
To date, several studies have explored the role of heat-stress/cyclical 
dehydration and decreased kidney function. Environmental studies of 
sugarcane workers in Costa Rica and El Salvador have shown that at 
approximately 9:00 a.m. heat/humidity exceeds the recommendation 
(WBGT>27ºC) of the Occupational Safety Health Administration (OSHA).[22, 40, 
41] The most common symptoms reported by sugarcane workers have been 
headache (71%), tachycardia (46%), muscle cramps in the arms/legs (39%), 
dysuria (36%), fever (28%), and nausea (26%).[42] However, scientific evidence 
is inconclusive as to whether these symptoms are pathognomonic of heat 
stress, either among sugarcane workers, or in workers in other occupations 
around the world.  
 
Cross-shift studies among harvesters in El Salvador have shown that 
sugarcane workers suffer from an asymptomatic increase in Scr, uric acid, urea 
nitrogen, and urine specific gravity levels, as well decreased serum potassium 
and sodium levels after their shifts.[22] The post-shift (work time of 4 hours) Scr 
levels increased 10%. This change might occur due to a substantial loss of 
body water and salt, resulting in vasoconstriction secondary to dehydration. 
 22 
However, the absence of differences in haematocrit, serum osmolarity and a 
decrease in urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels 
after the shift are evidence arguing against a recurrent dehydration-AKI 
hypothesis.[22] Similar findings were reported among burnt sugarcane 
harvesters in Brazil, where 5 out of 28 (17.8%) workers experienced an 
increase in serum creatinine levels greater than 0.3 mg/dL after their work shifts 
(compatible with AKI), as well as increases in serum creatine, phosphokinase 
and specific urinary gravity levels after the work shift.[43] In addition, a study 
among agricultural workers from California reported an incidence of AKI 
(increase in serum creatinine levels ≥0.3 mg/dL post-shift) of 12% (35/283 
workers) among males and females. Of these only 3 workers suffered heat 
strain. The main risk factors associated with AKI were an experience of heat 
strain (OR: 1.35, 95% CI 1.04-1.74) and piece rate work (OR: 4.24, 95% CI 
1.56-11.52).[44]  
 
Two prospective occupational studies with short-term follow-up periods 
examined the changes in renal biomarkers among cane workers in 
Nicaragua.[23, 45] The first study reported significant clinical changes in some 
kidney biomarkers, such as a 20% increase in the serum creatinine level, a 
four-fold increase in uNGAL levels, a 41% increase in BUN levels, and an 
approximately four-fold increase in urinary uric acid levels across the harvest 
period. Furthermore, participants experienced changes in weight and electrolyte 
disturbances (hyponatremia and hypokalaemia), suggesting a volume depletion 
due to dehydration.[23] The authors of the study proposed the crystalluria theory, 
which is based on the following assumptions: work under hot conditions with 
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poor hydration can produce volume depletion with subsequent salt loss, an 
increase in serum osmolarity and a subclinical muscular injury that can induce 
high uric acid levels with a low urine pH and crystalluria, followed by tubular 
injury.[46-48] However, uric acid crystals have not been observed in renal tissues 
from sugarcane workers in El Salvador and Nicaragua.[28, 29, 49]  
 
The second study observed a change in kidney function among sugarcane 
workers across the harvest period (6 months). The job categories that 
experienced a significant change in eGFR were seed cutters -8.6 mL/min/1.73 
m2 (95% CI: -16.7 to -0.5) and water irrigators -7.4 mL/min/1.73 m2 (95% CI: -
12.6 to -2.1). However, the eGFR changes among cane cutters (-5.0 
mL/min/1.73 m2; 95% CI: -10.5 to 0.6) and pesticide applicators (-3.8 
mL/min/1.73 m2; 95% CI: -9.9 to 2.3) were not statistically significant, although 
both jobs are considered to have a very heavy work load and are performed in a 
hot environment. Moreover, no changes in eGFR were observed among factory 
workers (3.2 mL/min/1.73 m2).[45] In addition, cane cutters and water irrigators 
experienced approximately two-fold increases in the urinary levels of NGAL and 
IL-18. Meanwhile, the NAG level increased in almost all job categories. Only 5% 
of cane workers displayed an increase in the urine albumin-creatinine ratio 
(UACR) exceeding 30 mg/g.[26]  
 
Recently, a small cross-sectional study and a subsequent follow-up study of a 
group of cane workers with decreased kidney function (DKF) at late harvest 
reported that the prevalence of DKF was 10.4% (34/326) among young 
sugarcane workers across the harvest period (median Scr level of 1.64 mg/dL). 
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DKF was most common among cane cutters (19%) than among other cane jobs 
(2.9%). Twenty-nine workers diagnosed with DKF showed improvements in Scr 
levels of 0.39 mg/dL (median Scr level of 1.64 mg/dL to 1.25 mg/dL) during the 
first 6 months of follow-up. However, twenty-five of the 29 participants that were 
followed 12 months after the baseline experienced a non-significant decrease in 
Scr levels of 0.37 mg/dL compared to the previous study visit. In addition, thirty-
eight percent workers (11/29) experienced a dramatic decrease in eGFR 
(>30%) during the course of the study. Of these workers, ten workers had an 
eGFR <60 mL/min/1.73 m2.[50] Based on these results, a group of workers with 
chronic CKDu were followed and were diagnosed with AKI simply because they 
crossed the threshold of 0.3 mg/dL during the harvest season. 
 
To date, the results from epidemiological studies investigating the relationships 
between heat stress exposure, AKI and subsequent CKDu remain inconclusive. 
This lack of conclusive data may be due to insufficiently robust heat exposure 
assessments, a non-optimal study design or inadequately sensitive biomarkers 
to accurately quantify the exposure and effects.[22, 46, 51] To date, the strongest 
evidence supporting this proposed mechanism of CKDu has been obtained 
from animal models.[48, 52] Thus, more studies in humans are urgently needed to 
test these suggested mechanisms, to explore other exposure methods and 
potential mechanisms and to study other occupations with similar 
characteristics around the globe.  
 
1.3.2.2 Agrochemical exposure 
Pesticides have been used intensively and extensively in agriculture to protect 
crops from insects and other pests in low-middle-income countries (LMICs).[53] 
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These chemicals are applied at the ground level (manual backpack sprayers or 
hydraulic sprayers) and through aerial spraying; thus, agricultural workers, their 
families and the communities surrounding the plantations are directly or 
indirectly exposed to pesticides.[53] Short- or long-term exposure to pesticides 
can induce acute or chronic health effects on various organs, including the 
gastrointestinal tract, respiratory system, cardiovascular system, nervous 
system and kidneys.[54-57]  
 
Organophosphates (OPs) and organochloride pesticides (e.g., glyphosate, 2,4-
dichlorophenoxyacetic acid, chlorpyrifos and other OPs) have been proposed 
as leading or contributing factors to CKDu in Mesoamerica and other 
countries.[20, 58-64] The assumed nephrotoxic effects of these agents are based 
on case reports of workers who developed AKI after the intentional ingestion of 
dimpylate and methamidophos,[65, 66] but little experimental data has suggested 
a chronic renal tubular cytotoxicity.[67, 68] Eleven epidemiological studies have 
examined the associations between pesticide exposure and CKDu in 
Mesoamerica, all of which were based on binary variables (yes/no). Only two 
studies reported a positive correlation between agrochemical exposure and 
CKDu; the first study showed a positive correlation between self-reported 
pesticide inhalation and CKD (OR: 3.14, 95% CI: 1.12-8.78), but not other 
exposure parameters, such as short- or long-term exposure, exposure 
frequency, mixing or applying these chemicals.[21] The second study reported a 
correlation between self-reported pesticide exposure, regardless of the 
absorption pathway, with CKD (p<0.0001) in a univariate analysis, but not in the 
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model adjusted for age, gender, body mass index (BMI), hypertension, 
diabetes, and a family history of CKD.[69]  
 
In contrast, a study conducted in a coffee-farming agricultural community found 
that pesticide exposure (applying, mixing or both) was not associated with 
decreased kidney function among farmers.[31] Similar findings were reported by 
Laws, et al., where pesticide applicators in the sugarcane industry did not 
experience significant changes in eGFR or uNGAL levels compared to factory 
workers throughout the harvest season.[45] Thus, uNGAL may not be the 
appropriate biomarker to detect damage caused by pesticide exposure. 
 
Recently, a systematic review was conducted investigating the association 
between pesticide exposure and CKD. Twenty-one epidemiological articles 
were included in the final analysis, and 62% of these studies reported positive 
correlations between pesticide exposure and CKD. However, these studies had 
methodological limitations due to incomplete adjustments for confounding 
factors, selection bias and exposure measurements, and these aspects affected 
the study quality. Thus, the evidence for a role for pesticide exposure in CKD 
remains inconclusive.[62]  
 
1.3.2.3 Heavy metal exposure 
Heavy metals that have been associated with kidney damage include lead (Pb), 
cadmium (Cd), chromium (Cr), arsenic (As), mercury (Hg) and lithium (Li). 
Recently, Tsai, et al. examined the longitudinal associations between cadmium 
(Cd), chromium (Cr) and lead (Pb) exposure and changes in kidney function 
among Taiwanese adults aged 19-84 years from the National Nutrition and 
 27 
Health Survey from 2005-2008. A decrease in eGFR was associated with high 
levels of Cr (-5.9 mL/min/1.73 m2; 95% CI: -9.7 to -2.2) and Pb (-6.6 
mL/min/1.73 m2; 95% CI: -9.7 to -3.5), but not Cd (2.0 mL/min/1.73 m2; 95% CI: 
-3.2 to 7.2), and the trend towards a reduced eGFR was similar among males 
and females. However, when the analysis was adjusted for potential 
confounding factors (age, education, BMI, smoking, nutrient intake of sodium 
and urinary volume) and stratified by tertiles of urinary Cd, levels of urinary Cr (-
12.6 mL/min/1.73 m2; 95% CI: -20.4 to -4.9) and urinary Pb (-11.2 mL/min/1.73 
m2; 95% CI: -17.0 to -5.4) were both associated with decline in kidney function 
only in the highest Cd tertile (>1.02 µg/L). This study suggests an interaction 
between levels of Cd and exposure to Pb and Cr in mediating any renal 
effects.[70]  
 
Similar findings were reported in a cohort study by Harari, et al. (2018),[71] 
where an increased Pb level (>29 µg/L) was associated with lower eGFR based 
on serum creatinine and cystatin c levels (-2.6 mL/min/1.73 m2; 95% CI: -4.0 to 
-1.2) or only creatinine levels (-2.9 mL/min/1.73 m2; 95% CI: -4.3 to -1.5). High 
lead levels (>29 µg/L) were still associated with a decrease in eGFR over a 21-
year follow-up period after adjusting for an age >58 years, sex, hypertension, a 
history of diabetes, waist circumference (>82 cm), smoking and alcohol 
consumption.[71] These studies reported positive correlations between Pb and 
Cr exposure with kidney function,[70, 71] and these metals have been shown to 
induce chronic tubulointerstitial damage and nephrosclerosis due to intranuclear 
lead inclusions in studies of tubular epithelial cells in vitro.[72]  
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Cadmium poisoning can lead to or contribute to renal dysfunction due to chronic 
occupational exposure, contaminated food or an unhealthy lifestyle (smoking). 
The effects of Cd on the kidney include impaired proximal tubular cell 
reabsorption, which results in increased urinary excretion of tubular proteins.[73] 
Renal damage is characterized by tubular atrophy, chronic glomerular damage, 
and interstitial fibrosis.[74]  
 
To date, little evidence is available about the potential role of arsenic (As) in 
kidney disease. However, As plays an important role in oxidative stress and 
inflammation. These two possible mechanisms may drive endothelial 
dysfunction and subsequent kidney damage. In addition, long-term exposure to 
inorganic As in drinking water (>100 μg/L) was reported to be associated with 
kidney damage among a Taiwanese population.[75] Additionally, urinary levels of 
four heavy metals (As, Cd, Hg and Pb) were measured in a renal biopsy study 
in Nicaragua.[28] All of these metals were within the permissible limits for heavy 
metals in urine.[28] In summary, knowledge about the roles of heavy metals in 
the pathogenesis of CKDu is still lacking. 
 
1.3.2.4 Infectious diseases 
The most well-known infectious diseases associated with CKD are human 
immunodeficiency virus (HIV), hepatitis B and C virus. However, a list of 
zoonotic diseases has been proposed to induce acute kidney injury (AKI), 
including dengue, malaria, leptospirosis, and hanta virus. Similar pathogens 
have therefore have been suggested to cause CKD in patients with severe 
infections.[76, 77] Furthermore, organisms such as Leptospira have been 
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proposed as a cause of CKDu in hotspots in Mesoamerica, Sri Lanka, India, 
and other countries, because workers at risk of the disease (sugarcane 
workers, miners, rice workers, and agriculture workers) are also at high risk of 
exposure to water sources contaminated by infected animals.[78-80]  
 
Several Leptospira outbreaks have been reported since 1995 due to natural 
disasters (tropical storms and hurricane) that have hit Nicaragua. The 
departments with the highest cumulative incidence rate of leptospirosis were 
León with 36.03/10,000 populations (522 cases), Chinandega with 36.03/10,000 
populations (305 cases) and Managua 7.60/10,000 populations (175 cases) 
from 2004-2010.[81] Based on these data, a research group reviewed the 
leptospiral serology amongst a number of different occupations and found high 
rates of Leptospira infections among prawn workers (109/1000 workers), water 
irrigation and drainage workers (62/1000 workers) and cane collectors and cane 
cutters (36/1000 workers); however, the authors did not evaluate kidney 
function.[79]    
 
Riefkohl A, et al. (2018), reported a high Leptospira seropositivity among 
Nicaraguan cane cutters (59%), water irrigators and seeders (37%). However, 
this high seropositivity was not associated with impaired kidney function in 
individuals with normal kidney function at pre- and post-harvest assessments. 
When using a linear regression analysis to compare sugarcane applicants with 
renal dysfunction at the pre-harvest assessment and Leptospira seropositivity, a 
suggestive inverse correlation was observed (eGFR mean difference: -10.08, 
95% CI: -24.12 to 3.96), but not for NGAL (mean difference: -1.59, 95% CI: 0.81 
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to 3.11), IL-18 (mean difference: 0.84, 95% CI: 0.42 to 1.70), or NAG (mean 
difference: 1.44, 95% CI: 0.85 to 2.43), because the study was 
underpowered.[78] Thus, the evidence supporting a role for Leptospira infection 
in the aetiology of MeN remains limited.  
 
Other studies have examined the association between Leptospira exposure and 
kidney disease in East Asia. A community-based survey recruited 3045 
participants in Taiwan, with a subsequent follow-up of over two years to 
evaluate the risk of CKD in patients with leptospirosis.[82] The prevalence of 
leptospirosis was 33% in this population and 49% among males. A lower 
leptospirosis prevalence was found among patients with stage 3-5 CKD (14%) 
compared to patients with all stages of CKD (22%). The adjusted linear 
regression model showed that a positive reaction for Leptospira antibodies was 
strongly correlated with lower eGFR (-3.04 mL/min/1.73 m2, 95% CI: -4.15 to -
1.93), and this correlation remained positive when the analysis was stratified by 
diabetes mellitus status. At the end of the follow-up period (2009-2011), 
subjects with a high titre of the Leptospira antibody (MAT titre >400) had a 
lower eGFR (-13 mL/min/1.73 m2) and a higher KIM-1/creatinine ratio than 
subjects with a MAT titre 100-200 and MAT-negative subjects. Thus, chronic 
leptospirosis (MAT titre >400) might induce CKD in areas where Leptospira is 
endemic.[82]  
 
Dengue fever can induce AKI, nephrotic syndrome, glomerulopathy and other 
tubular abnormalities due to direct damage by immune complexes composed of 
antigens and antiviral antibodies. The prevalence of AKI secondary to dengue 
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fever ranges from 3.3 to 14.2% among infected adults.[83-85] A prospective 
cohort study evaluated the renal outcomes following AKI in patients hospitalized 
with dengue. The incidence of AKI was 13.7% (72/526 patients) and 9 of 10 
patients (93%) had AKI on the first day of hospital admission; 7% were admitted 
to the hospital without AKI and were later diagnosed with AKI. Of these patients, 
19 (26.8%) showed a full renal recovery at hospital discharge and the AKI of 
thirty-five patients did not recover at the time of discharge. At the end of the 
follow-up period (12 weeks), only eight patients (11.2%) did not exhibit a 
restoration of kidney function. Finally, the risk factors associated with a poor 
renal outcome (<60 mL/min/1.73 m2) were sex (female), older patients, diabetes 
mellitus, the use of NSAIDs, a secondary infection, and no recovery upon 
discharge.[86] Because CKD is defined as a persistent loss of kidney function 
that is documented to persist for more than 3 months, the existing studies of 
kidney function in patients infected with dengue are insufficient to assess long-
term outcomes of kidney function. Consequently, researchers have not currently 
determined whether dengue is associated with CKD, although suggestive 
associations with AKI have been reported.  
 
The scientific evidence regarding an association between chikungunya virus 
and AKI has not been well described to date. Recently, a case-control study 
among patients with chikungunya in Bangladesh reported that 10% (11/107 
chikungunya cases) developed AKI (≥0.3 mg/dL increase in serum creatinine 
levels at hospital admission) during the course of this disease.[87] Similar 
findings were reported by Perti T, et al. (2016), who showed that the prevalence 
of AKI was 22% (33 out of 153 patients) among veterans diagnosed with 
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chikungunya who presented a high risk of hospitalization (RR, 1.64; 95% CI, 
1.33–2.04). The other comorbidities and clinical findings contributing to hospital 
admission included CKD, congestive heart failure, diabetes, chronic lung 
disease, tachycardia, leucocytosis and a high level of hepatic transaminitis.[88] 
However, these two studies have several limitations. First, the results cannot be 
extrapolated to other populations because the studies were based on hospital 
records and the sample size was small. Second, elderly participants were 
recruited, which might increase the risk of complication during clinical course. 
Thus, chikungunya virus must be systematically investigated to determine 
whether infected individuals in the general population are at risk of developing 
AKI. 
 
1.3.2.5 Nephrotoxic medications 
Non-steroidal anti-inflammatory drugs (NSAIDs) are associated with AKI and 
with accelerating the progression of CKD.[89] These drugs decrease the volume 
of renal blood flow by reducing prostaglandin synthesis and inducing acute 
tubular injury.[89, 90] However, a case-control study by Perneger TV, et al. (1994) 
found that chronic paracetamol ingestion may be more nephrotoxic than 
NSAIDs (ibuprofen/diclofenac), as the authors identified a three-fold increase in 
the risk of progression to end stage renal disease (ESRD) in subjects with an 
annual intake of paracetamol ≥366 pills/year. However, a cumulative lifetime 
intake of NSAIDs ≥5000 pills/lifetime was associated with a nearly nine-fold 
increased risk of progression to ESRD.[91] However, although a number of 
studies have examined NSAID exposure, none have identified a positive 
correlation with CKDu.[92]  
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1.3.2.6 Phyto/mycotoxins 
A number of researchers have speculated that phytotoxins or mycotoxins are 
possible causes of CKDu.[12, 13] Balkan nephropathy (BEN) is now thought to be 
caused by consuming wheat grain products contaminated with aristolochic acid 
(AA). This disease primarily affects people aged between 30 to 60 years who 
live in the rural areas of the Balkans and is characterized by chronic 
tubulointerstitial nephritis and a slow progression to ESRD. Patients with this 
disease display a high incidence of urothelial cancer after kidney damage 
occurred.[93-95] The Aristolochia species has been identified in Central America, 
but to date, increase rates of urinary tract malignancy have not been 
reported.[12, 76, 96, 97]  
 
The mycotoxin Ochratoxin A (OTA) is mainly produced by two Aspergillus 
species (A. ochraceus and A. niger) and Penicillium species (P. verrucosum 
and P. carbonarius). This molecule causes a wide range of health effects due to 
its hepatotoxic, carcinogenic, neurotoxic and nephrotoxic properties. Humans 
are exposed through three different routes: dietary intake, dermal contact and 
inhalation. OTA-induced kidney damage is described as an enlargement of the 
tubular membrane, collagen inclusions, a diffuse density and size of brush 
border processes due to oxidative stress and a depletion of intracellular 
glutathione followed by apoptosis.[98-100] Although the histological findings are 
similar to MeN,[28, 29, 49] as is the case with AA, the increase in the mortality rate 
from CKDu has not been mirrored by increases in death caused by urothelial 
cancers, which are known to be caused by OTA. Thus, the current 
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epidemiological evidence does not support a possible role for OTA in 
pathogenesis of CKDu. 
 
Finally, the above literature review demonstrated that there is an excess of 
CKDu in Mesoamerica and elsewhere. The causes of this disease are still not 
fully understood. Table 4 summarises the current knowledge about the most 
common risk factors for traditional and non-traditional CKD in Mesoamerica and 
South Asia.[1, 12, 13, 60, 61, 76, 101-103] 
 
Table 4: Most common risk factors for traditional and non-traditional 
chronic kidney disease in different settings 
Risk factors 
CKD in high income 
countries 
CKD in 
Mesoamerica 
CKD in Sri Lanka, and 
India 
Age Older adults 
Young and middle 
age adults 
Young and middle age 
adults  
Sex 
CKD more common in 
women but ESRD more 
common in men 
CKD and ESRD 
more common in 
men 
CKD and ESRD more 
common in men 
Ethnicity 
Many causes of CKD more 
common in certain 
ethnicities (e.g. diabetic 
kidney disease in South 
Asians, proteinuric CKD in 
African-americans) 
Hispanic South Asian  
Altitude No association described  
More common at 
low altitude 
Described in the 
lowland dry zone 
Socioeconomic status 
More common in those of 
lower socioeconomic 
status 
More common in 
those of lower 
socioeconomic 
status 
More common in those 
of lower socioeconomic 
status 
Family history of CKD Common  Common Common 
Obesity Common Uncommon Uncommon 
Hypertension Common Uncommon* Uncommon* 
Diabetes mellitus Common Uncommon* Uncommon* 
Kidney stones Well described Uncommon Uncommon 
Smoking Common Uncommon Uncommon 
Alcohol consumption 
Association described in 
some populations 
Association 
described  
Association described  
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Risk factors 
CKD in high income 
countries 
CKD in 
Mesoamerica 
CKD in Sri Lanka, and 
India 
Nephrotoxic medications 
(e.g. phenacetin) 
Described in some regions Rarely described Rarely described 
Nephrotoxins (Ochratoxin 
A, Aristolochic acid) 
Described in some regions 
Not systematically 
studied 
Not systematically 
studied 
Heavy metals (cadmium, 
lead, mercury, and 
arsenic) 
Described in some regions 
No replicated 
associations  
No replicated 
associations  
Infectious diseases 
(Leptospira, Hanta virus) 
Not described 
Not systematically 
studied 
Not systematically 
studied 
Low birth weight Well described 
Not systematically 
studied 
Not systematically 
studied 
Occupations Not described 
Agricultural 
workers (mainly 
sugarcane 
workers) 
Farmers and paddy 
workers 
Heat-stress Not described Common 
Not systematically 
studied 
Physical exertion Not described Common 
Not systematically 
studied 
Dehydration or volume 
depletion 
Not described Common 
Not systematically 
studied 
Agrochemicals exposure 
Association at a population 
level 
Not systematically 
studied 
Not systematically 
studied 
* Diabetes, hypertension and heavy proteinuria are often used as clinical exclusion for 
a diagnosis of CKDu but these risk factors may co-exist in some of those with disease. 
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1.4 Thesis rationale, hypothesis, aim and objectives 
1.4.1 Thesis rationale 
CKDu has emerged as an important public health problem in Mesoamerica 
(Nicaragua, El Salvador, Costa Rica, Guatemala and Southern México) and is a 
form of kidney disease that is not caused by the traditional risk factors for CKD, 
such as diabetes, hypertension, and obesity. This disease is estimated to be 
responsible for the death of more than 20,000 young adults in the last three 
decades, and this number continues to increase at an alarming rate.[16, 33, 104-106] 
The most frequently affected individuals are young sugarcane workers, 
subsistence workers, miners, and construction workers who are living on the 
Pacific coast of Nicaragua.[12-14, 104]  
 
In addition, CKDu has social implications, because it affects the economically 
productive population, is a major cause of disability and limitations to generate 
income, increases out-of-pocket medical expenses, and requires other 
members in a given family to dedicate part of their time to care for the affected 
patient.[107] Even when health authorities have tried to respond, the actions are 
limited, such as a resource-consuming domestic peritoneal dialysis programme 
in affected areas, which is implemented in high poverty regions. 
 
The causes and aetiology of this disease are not yet completely understood. 
Many hypotheses have been suggested, and the current leading theory is that 
the combination of repeated heat stress, dehydration and strenuous work in a 
hot environment is a predominant driving factor of disease development. 
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Environmental contaminants (heavy metals and pesticides), self-medication and 
infectious diseases may also contribute.[12, 13, 101, 108, 109]  
 
A number of epidemiological studies have assessed the prevalence of CKDu 
among young agricultural workers and the general population who live at 
different altitudes in Mesoamerica. These studies have identified possible risk 
factors for CKDu, but none have been able to identify the cause(s) of this 
disease. This lack of causality is perhaps because more than 90% of the 
studies have employed a cross-sectional design, which has several limitations. 
These limitations include difficultly in determining whether the outcome followed 
exposure over time, a susceptibility to low response rate and misclassification 
due to recall bias and reverse causation. On the other hand, longitudinal studies 
may overcome some of these problems and allow researchers to confirm or 
reject the aforementioned hypotheses to help establish causality. 
 
1.4.2 Hypothesis 
The hypothesis underlying this work is that CKDu is caused by a combination of 
risk factors related to the local agricultural industry, such as recurrent heat 
exposure and/or exogenous toxins.  
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The work described in this thesis is part of a larger ongoing programme of work 
which aims to understand causation of CKDu using a range of global ongoing 
studies. Specific aims of this thesis are as outlined in section 1.4.3.  
There are aspects of work not addressed in this thesis which are being done as 
part of the larger programme, for instance the cohort described in this thesis is 
being expanded at present to investigate further hypothesis of causation. 
 
1.4.3 Aims and objectives 
1.4.3.1 Aims of the thesis 
The aim of this thesis was to advance the understanding of the causes of CKDu 
using a number of epidemiological research studies. 
 
1.4.3.2 Specific objectives 
1. To review the current knowledge and gaps in our understanding of the 
potential causes of CKDu in the Pacific coast of Central America. 
2. To understand which risk factors are associated with the decline of eGFR 
among a healthy young population at risk of developing CKDu.  
3. To determine if repeated routine creatinine tests combined with baseline 
urinary measurements of urinary neutrophil gelatinase-associated lipocalin 
(uNGAL) levels can identify the sub-group of individuals at risk of a future 
rapid decline in kidney function.   
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A systematic review was conducted to achieve the first objective (Paper I). 
Peer-reviewed scientific papers were collected from a variety of sources 
because epidemiological studies about CKDu have been published in many 
different journals. 
 
A community-based prospective longitudinal study was conducted among a 
young, apparently healthy population in northwest Nicaragua to achieve the 
second objective. The study involved the collection of biological samples (blood, 
urine) and water samples, and the administration of a questionnaire that 
collected data on a variety of characteristics and exposure factors 
(sociodemographic data, current and past occupation, heat stress and pesticide 
exposure, lifestyle, self-medication, heat-stress symptoms, etc.) (Papers II and 
III). Paper II specifically discusses the rationale for conducting a community-
based cohort study and describes the main findings obtained at the baseline 
study visit. Paper III investigated the natural history and factors associated with 
a decline in kidney function in a high-risk population. 
 
A simple predictive score was created based on our existing community-based 
prospective cohort study to achieve the third objective. The purpose was to 
determine if repeated routine creatinine tests combined with baseline urinary 
measurements of urinary neutrophil gelatinase-associated lipocalin (uNGAL) 
levels can identify the subgroup of individuals at risk of a future rapid decline in 
kidney function (Paper IV). Table 3 summarizes the objectives and study design 
details. 
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   Table 5: Thesis objectives and study designs 
Objectives Paper title Study design Population Data sources Exposure Outcome 
1. To review the current knowledge 
and gaps in our understanding of 
the potential causes of CKDu in the 
Pacific coast of Central America. 
What do epidemiological studies tell 
us about chronic kidney disease of 
undetermined cause in Meso-
America? A systematic review and 
meta-analysis   
Systematic 
review 
Adults and 
adolescents 
PubMed 
EMBASE 
Web of Science 
Heat stress, dehydration, 
pesticide exposure, NSAIDs, 
occupational exposure, 
environmental toxins and 
infectious diseases 
CKDu 
 
2. To understand which risk factors 
are associated with the decline of 
eGFR among a healthy young 
population at risk of developing 
CKDu. 
Rationale, description and baseline 
findings of a community-based 
prospective cohort study of kidney 
function amongst the young rural 
population of northwest Nicaragua  
Prospective 
cohort study 
Young adults aged 
between 18 – 30 
years without a 
diagnosis of CKD, 
diabetes or HT 
Primary 
Sociodemographic data, 
occupational, workplace 
conditions, environmental, 
lifestyle, and infectious 
diseases 
Decline in 
eGFR over 
time Decline in kidney function among 
apparently healthy young adults at 
risk of Mesoamerican nephropathy 
3. To determine if repeated routine 
creatinine tests combined with 
baseline measurements of urinary 
neutrophil gelatinase-associated 
lipocalin (uNGAL) levels can 
identify the sub-group of individuals 
at risk of a future rapid decline in 
kidney function. 
Identification of young adults at risk 
of an accelerated loss of kidney 
function in an area affected by 
Mesoamerican nephropathy 
Case-control 
study nested 
in a 
prospective 
cohort study 
Young adults aged 
between 18 – 30 
years without a 
diagnosis of CKD, 
diabetes or HT 
Primary 
Sociodemographic data, 
outdoor work and laboratory 
results (uNGAL, UACR) 
Prediction 
decline of 
eGFR 
Abbreviations: CKDu: chronic kidney disease of unknown origin; eGFR: estimated glomerular filtration rate; CKD: chronic kidney disease; HT: hypertension; NSAIDs: non-
steroidal anti-inflammatory drugs, uNGAL: urinary neutrophil gelatinase-associated lipocalin, UACR: urinary albumin-creatinine ratio.  
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1.4.4 Thesis structure 
This thesis includes 6 chapters that are structured into different sections: 
background, methods, the results and discussion. This first chapter provides 
information about the thesis rationale, hypothesis, aim and objectives. The 
specific objectives were addressed by a variety of study designs (Table 3). A 
systematic review and formal meta-analysis of the current knowledge of CKDu 
in Mesoamerica is presented in the second chapter to complete the background 
section (Objective 1). 
 
The third chapter describes the methods, data sources, study populations and 
materials used in the community-based longitudinal study over the two-year 
period. It also presents the general results obtained at the baseline study visit 
(Objective 2). The fourth chapter investigates the natural history of and factors 
associated with the loss of kidney function in a high-risk population (Objective 
2). The fifth chapter assesses whether repeated routine creatinine tests 
combined with baseline urinary measurements of urinary neutrophil gelatinase-
associated lipocalin (uNGAL) levels can identify the sub-group of individuals at 
risk of a future rapid decline in kidney function among an apparently healthy 
young male population in Nicaragua (Objective 3). 
 
Finally, the sixth chapter summarizes and discusses the main results of each 
study, describes the strengths and limitations of the thesis and considers the 
implications for clinical practice and future research on this topic.   
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Chapter 2. Systematic review of the current knowledge and gaps in the 
knowledge of chronic kidney disease of unknown origin. 
 
2.1 Introduction to paper I 
This paper was published in Clinical Kidney Journal (CKJ) and presents a 
systematic review and meta-analysis of the current epidemiological evidence 
and gaps in our knowledge of CKDu in Mesoamerica. 
 
Twenty-five epidemiological studies were included in this analysis of risk factors 
for CKDu. Studies included participants of different ages who were living in 
diverse communities, mostly at sea level. Overall, the assessment of the quality 
of the epidemiological studies was medium. The quality of the occupational and 
community-based studies was affected by a substantial lack of follow-up data, 
potential for reverse causation, a lack of complete adjustment for confounding 
factors and the use of single measurements of serum creatinine to diagnose 
CKDu. The principal risk factors associated with CKDu were male sex, a family 
history of CKD, lowland altitude, and high water-intake. Also, sugarcane work 
appears to be associated with an elevated risk of CKDu in Mesoamerica. 
However, in this review, no positive correlations between pesticide exposure, 
NSAIDs, alcohol consumption, heat stress and CKDu were identified. 
 
The study search strategies, inclusion and exclusion criteria, study quality 
assessments and funnel plots mentioned in the paper as supplementary 
material are included in this chapter. 
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2.6 Supplementary material 
 
Supplementary table 1: PubMed search strategy. 
Search  Results Search type 
1 
("Kidney Diseases"[Mesh] OR "Chronic Kidney 
Disease"[tiab] OR "chronic kidney disease"[tiab] 
OR "chronic kidney diseases"[tiab] OR "chronic 
renal disease"[tiab] OR "chronic renal 
diseases"[tiab] OR ckdu[tiab]) 
462868 
2 
("Mesoamerican Nephropathy"[Mesh] OR 
"mesoamerican nephropathy"[tiab] OR "Decreased 
Kidney Function"[tiab] OR "decreased kidney 
function"[tiab] OR "Chronic Kidney Disease"[tiab] 
OR "Chronic Kidney Disease of non-
traditional"[tiab] OR "chronic kidney disease of 
unknown"[tiab] OR "Nefrolempa"[tiab] OR 
ckdu[tiab] OR ckdnt[tiab]) 
30799 
3 
("Agriculture"[Mesh] OR "Chemistry, 
Agricultural"[Mesh] OR "Agricultural Workers' 
Diseases"[Mesh] OR "Pesticides"[Mesh] OR 
"Pesticides" [Pharmacological Action] OR 
"Pesticide Residues"[Mesh] OR 
"Agrochemicals"[Mesh] OR "Metals, 
Heavy"[Mesh:NoExp] OR "Aluminum"[Mesh] OR 
"Fluorides"[Mesh] OR "Arsenic"[Mesh] OR 
"Cadmium"[Mesh] OR "Lead"[Mesh] OR 
"Groundwater"[Mesh] OR “agriculture"[tiab] OR 
“agricultural"[tiab] OR “farm"[tiab] OR 
“pesticide"[tiab] OR “pesticides"[tiab] OR 
“agrochemical"[tiab] OR “heavy metal”[tiab] OR 
“heavy metals”[tiab] OR "Aluminum"[tiab] OR 
"Fluorides"[tiab] OR "fluoride"[tiab] OR 
"Arsenic"[tiab] OR "Cadmium"[tiab] OR 
“dehydration”[tiab] OR “heat stress”[tiab] OR “Heat 
Stress”[tiab] OR “Heat-Related”[tiab] OR “heat 
related”[tiab] OR “Heat exposure”[tiab] OR 
“Sugarcane”[tiab] OR “sugarcane”[tiab] OR 
“harvesters”[tiab] OR “NSAIDs”[tiab] OR 
"Groundwater"[tiab] OR “ground water”[tiab] OR 
“hard water”[tiab] OR (water[tiab] AND 
hardness[tiab])) 
546886 
4 
((“Quasi-experimental studies”(pt) OR "randomized 
controlled trial"[pt] OR "controlled clinical trial"[pt] 
OR "randomized"[tiab] OR "randomised"[tiab] OR 
"randomization"[tiab] OR "randomisation"[tiab] OR 
5950820 
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Search  Results Search type 
"placebo"[tiab] OR "drug therapy"[sh] OR 
"randomly"[tiab] OR "trial"[tiab] OR "groups"[tiab] 
OR "Clinical trial"[pt] OR “clinical trial”[tiab] OR 
“clinical trials”[tiab] OR "evaluation 
studies"[Publication Type] OR "evaluation studies 
as topic"[MeSH Terms] OR "evaluation study"[tiab] 
OR "evaluation studies"[tiab] OR "intervention 
studies"[MeSH Terms] OR "intervention 
study"[tiab] OR "intervention studies"[tiab] OR 
"case-control studies"[MeSH Terms] OR "case-
control"[tiab] OR "cohort studies"[MeSH Terms] 
OR "cohort"[tiab] OR "longitudinal studies"[MeSH 
Terms] OR "longitudinal”[tiab] OR 
"longitudinally"[tiab] OR "prospective"[tiab] OR 
"prospectively"[tiab] OR "retrospective 
studies"[MeSH Terms] OR "retrospective"[tiab] OR 
"follow up"[tiab] OR "comparative 
study"[Publication Type] OR "comparative 
study"[tiab] OR "systematic"[subset] OR "meta- 
analysis"[Publication Type] OR "meta-analysis as 
topic"[MeSH Terms] OR "meta-analysis"[tiab] OR 
"meta-analyses"[tiab]) OR "cross-sectional 
study"[tiab] OR "cross-sectional studies"[tiab] OR 
"community-based survey"[tiab] OR "descriptive 
studies"[tiab] NOT (Editorial[ptyp] OR "Letter"[ptyp] 
OR "Comment"[ptyp]) NOT (animals[mh]) 
5 
("Central America"[Mesh] OR "Nicaragua"[tiab] OR 
"El Salvador"[tiab] OR "Honduras"[tiab] OR 
"Guatemala"[tiab] OR "Panama"[tiab] OR "Costa 
Rica"[tiab] OR ¨Mexico"[tiab]) 
17787 
6 
(((((("Mesoamerican Nephropathy"[Mesh] OR 
"mesoamerican nephropathy"[tiab] OR "Decreased 
Kidney Function"[tiab] OR "decreased kidney 
function"[tiab] OR "Chronic Kidney Disease"[tiab] 
OR "Chronic Kidney Disease of non-
traditional"[tiab] OR "chronic kidney disease of 
unknown"[tiab] OR "Nefrolempa"[tiab] OR 
ckdu[tiab] OR ckdnt[tiab])))) AND (("Kidney 
Diseases"[Mesh] OR "Chronic Kidney 
Disease"[tiab] OR "chronic kidney disease"[tiab] 
OR "chronic kidney diseases"[tiab] OR "chronic 
48 
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Search  Results Search type 
renal disease"[tiab] OR "chronic renal 
diseases"[tiab] OR ckdu[tiab])))) AND 
(("Agriculture"[Mesh] OR "Chemistry, 
Agricultural"[Mesh] OR "Agricultural Workers' 
Diseases"[Mesh] OR "Pesticides"[Mesh] OR 
"Pesticides" [Pharmacological Action] OR 
"Pesticide Residues"[Mesh] OR 
"Agrochemicals"[Mesh] OR "Metals, 
Heavy"[Mesh:NoExp] OR "Aluminum"[Mesh] OR 
"Fluorides"[Mesh] OR "Arsenic"[Mesh] OR 
"Cadmium"[Mesh] OR "Lead"[Mesh] OR 
"Groundwater"[Mesh] OR “agriculture"[tiab] OR 
“agricultural"[tiab] OR “farm"[tiab] OR 
“pesticide"[tiab] OR “pesticides"[tiab] OR 
“agrochemical"[tiab] OR “heavy metal”[tiab] OR 
“heavy metals”[tiab] OR "Aluminum"[tiab] OR 
"Fluorides"[tiab] OR "fluoride"[tiab] OR 
"Arsenic"[tiab] OR "Cadmium"[tiab] OR 
“dehydration”[tiab] OR “heat stress”[tiab] OR “Heat 
Stress”[tiab] OR “Heat-Related”[tiab] OR “heat 
related”[tiab] OR “Heat exposure”[tiab] OR 
“Sugarcane”[tiab] OR “sugarcane”[tiab] OR 
“harvesters”[tiab] OR “NSAIDs”[tiab] OR 
"Groundwater"[tiab] OR “ground water”[tiab] OR 
“hard water”[tiab] OR (water[tiab] AND 
hardness[tiab])))) AND (("Central America"[Mesh] 
OR "Nicaragua"[tiab] OR "El Salvador"[tiab] OR 
"Honduras"[tiab] OR "Guatemala"[tiab] OR 
"Panama"[tiab] OR "Costa Rica"[tiab] OR 
¨Mexico"[tiab])) 
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Supplementary table 2: Embase search strategy. 
Search  Results Search 
type 
1 
Kidney Diseases.af. or Chronic Kidney Disease.ab. 
or chronic kidney diseases.ab. or chronic kidney 
disease.ab. or Chronic Renal Disease.ab. or 
chronic renal disease.ab. or chronic renal 
diseases.ab. or ckdu.ab. 
68314 
2 
Mesoamerican Nephropathy.af. or mesoamerican 
nephropathy.ab. or Decreased Kidney Function.ab. 
or decreased kidney function.ab. or Chronic Kidney 
Diseases.ab. or chronic kidney disease.ab. or 
Chronic Kidney Disease of unknown.ab. or Chronic 
Kidney Disease of non-traditional.ab. or 
Nefrolempa.ab. or ckdu.ab. or ckdnt.ab. 
43475 
3 
(Agriculture.af. or Chemistry.ab. or Agricultural.ab. 
or Agricultural Workers Diseases.ab. or 
Pesticides.ab. or Pesticide residues.ab. or 
Agrochemicals.ab. or Metals, Heavy.ab. or 
Aluminum.ab. or Fluorides.ab. or Arsenic.ab. or 
Lead.ab. or Groundwater.ab. or agriculture.ab. or 
agricultural.ab. or farm.ab. or pesticide.ab. or 
pesticides.ab. or agrochemical.ab. or heavy 
metal.ab. or heavy metals.ab. or fluorides.ab. or 
fluoride.ab. or dehydration.ab. or heat stress.ab. or 
Heat Stress.ab. or Heat-Related.ab. or heat 
related.ab. or Heat exposure.ab. or Sugarcane.ab. 
or sugarcane.ab. or harvesters.ab. or NSAIDs.ab. 
or Groundwater.ab. or ground water.ab.) and 
hardness water.ab. 
6 
4 
Central America.af. or Nicaragua.ab. or El 
Salvador.ab. or Honduras.ab. or Costa Rica.ab. or 
Guatemala.ab. or Panama.ab. or Mexico.ab. or 
Mesoamerica.ab. 
64088 
5 
(quasi-experimental studies.af. or randomized 
controlled trial.af. or controlled clinical trial.ab. or 
randomized.ab. or randomised.ab. or 
randomization.ab. or randomisation.ab. or 
placebo.ab. or drug therapy.ab. or Trial.ab. or 
2232648 
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Search  Results Search 
type 
clinical trials.ab. or evaluation studies as topic.ab. 
or case-control.ab. or longitudinal studies.ab. or 
prospective.ab. or retrospective.ab. or meta-
analyses.ab. or cross-sectional studies.ab. or 
cross-sectional study.ab. or community-based 
survey study.ab. or intervention studies.ab. or 
intervention study.ab.) not Editorial Letter.ab. not 
Comment.af. not Animal.af. 
6 limit 1 to (adolescents and adults human and Spanish and English language) 51828 
7 1 and 2 and 6 63 
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Supplementary table 3: Web of Science search strategy. 
Search  Results Search 
type 
1 
(TS=(¨Kidney Diseases¨ OR ¨chronic kidney disease¨ 
OR ¨chronic kidney diseases¨ OR ¨chronic renal 
disease¨ OR ¨chronic renal diseases¨ OR ¨chronic 
kidney failure¨ OR ¨chronic renal failure¨ OR ¨ckdu¨) 
AND CU=("Nicaragua" OR "Honduras" OR "Costa 
Rica" OR "Panama" OR "Guatemala" OR "El 
Salvador" OR "Mexico")) AND LANGUAGE: 
(English) 
661 
2 
(TS=(¨mesoamerican nephropathy¨ OR ¨decreased 
kidney function¨ OR ¨decreased kidney function of 
unknown¨ OR decreased kidney function of non-
traditional¨ OR ¨CKDu¨ OR ¨CKDnt¨) AND 
CU=(¨Nicaragua¨ OR ¨Costa Rica¨ OR ¨Guatemala¨ 
OR ¨Honduras¨ OR ¨Mexico¨ OR ¨Ël Salvador¨)) AND 
LANGUAGE: (English) 
117 
3 
(TS=("Agriculture" OR "Agricultural" OR "Pesticides" 
OR "Pesticides" OR "Agrochemicals" OR "Heat 
stress" OR "heat stress" OR "sugarcane workers" OR 
"dehydration" OR "heavy metals" OR "heavy metal" 
OR "Aluminum" OR "Fluoride" OR "fluorides" OR 
"Arsenic" OR "Cadmium" OR "Groundwater" OR 
"ground water" OR "hard water" OR (water AND 
"hardness")) AND CU=("Nicaragua" OR "Honduras" 
OR "Costa Rica" OR "Panama" OR "Guatemala" OR 
"El Salvador" OR "Mexico")) AND LANGUAGE: 
(English) 
8630 
4 
(TS=("risk" OR "risks" OR "epidemiology" OR 
"adverse effects" OR "harm" OR "exposure" OR 
"exposed" OR "aetiology") AND CU=("Nicaragua" OR 
"Honduras" OR "Costa Rica" OR "Panama" OR 
"Guatemala" OR "El Salvador" OR "Mexico")) AND 
LANGUAGE: (English) 
18142 
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Search  Results Search 
type 
5 
(TS=("Intervention studies" OR "intervention study" 
OR "intervention studies" OR "Randomized" OR 
"randomised" OR "randomization" OR 
"randomisation" OR "placebo" OR "randomly" OR 
"trial" OR "groups" OR "Clinical trial" OR "clinical 
trials" OR "evaluation study" OR "evaluation studies" 
OR "case-control" OR "cohort" OR "longitudinal" OR 
"longitudinally" OR "prospective" OR "prospectively" 
OR "retrospective" OR "follow up" OR "comparative 
study" OR "systematic review" OR "meta-analysis" 
OR "metaanalysis" OR "cross sectional study" OR 
"survey study" OR "Cross-sectional studies" OR 
"cross sectional survey" OR "intervention study" OR 
"intervention studies") AND CU=("Nicaragua" OR 
"Honduras" OR "Costa Rica" OR "Panama" OR 
"Guatemala" OR "El Salvador" OR "Mexico")) AND 
LANGUAGE: (English and Spanish) 
25011 
6 #1 AND #2 AND #3 AND #4 AND #5 10 
7 #1 AND #2 AND #3 AND #4 20 
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Supplementary table 4: Inclusion and exclusion criteria for defining study 
eligibility 
Items  Included Excluded 
Participants  Adolescent and adult 
human participants 
Animal studies 
Study settings Population, community 
setting or occupational 
workers from Mesoamerica 
 
Exposure of 
interest 
• Heat stress 
• Dehydration 
• Pesticides 
• NSAIDs 
• Occupational exposure 
• Environmental toxin 
(heavy metals, silica, 
etc.) 
• Infectious diseases 
Traditional risk factors: 
• Hypertension 
• Diabetes  
• Glomerulonephritis 
Outcomes of 
interest 
Reduced estimated 
glomerular filtration rate, 
elevated serum creatinine 
levels or chronic kidney 
disease of undetermined 
cause 
 
Study 
methodology  
Cross-sectional studies, 
case-control studies, cohort 
studies reporting original 
data. 
Case reports, editorial 
letters, case series  
Descriptive studies without a 
comparison group. 
Publication 
details 
Any publication date 
Language: English and 
Spanish 
Articles published in other 
languages, such as German, 
Chinese or Portuguese 
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Supplementary table 5: Risk factors for CKDu (eGFR<60 mL/min) reported in epidemiological studies in Mesoamerica 
Authors Country 
Risk factors associated reported in epidemiological studies 
Urinary 
biomarkers 
of kidney 
function Age 
Sex  Education level  Occupations Altitude  Hypertension       Diabetes  NSAIDs  
Heat 
stress  
Heavy 
metal         
Water 
intake Alcohol           
Pesticide 
exposure  
Bolus 
(Isotonic 
solutions) 
at work        
Hyperuricaemia  
Family 
history 
of 
CKDu  
(Male 
vs 
Female) 
(Low vs 
High) Sugarcane Agriculture Cotton Mining Coffee Construction 
Reference 
occupation 
(Low vs 
High) (Yes vs No) 
(Yes vs 
No) 
(Yes vs 
No) 
(Yes vs 
No) 
(High 
vs 
Normal) 
 (High 
vs 
Low) 
(Yes vs 
No) 
(Apply 
vs No 
apply) 
(Yes vs 
No) (Yes vs No) 
(Yes 
vs No) 
Cohort studies                       
Wesseling 
C, et al 
(2016)[23] 
Nicaragua Yes Male Yes Yes NA NA NA NA NA Administrative 
work 
NR No No No Yes NR NR NR NR NR Yes NR NGAL, KIM-
1, Hsp 
Laws R, et 
al (2016)[26] 
Nicaragua Yes Male NR Yes NA NA NA NA NA Factory work NR NR NR NR Yes NR No NR Yes No NR NR NGAL, IL-
18, NAG 
Laws R, et 
al (2015)[45] 
Nicaragua Yes Male NR Yes NA NA NA NA NA Factory work NR NR NR NR Yes NR Yes NR NR No NR NR Not studied 
Cross-sectional studies                       
Kupferman 
J, et al 
(2016)[27] 
Nicaragua Yes Male NR No NR NR NR NR NR 
No past or 
current work 
in the 
sugarcane 
industry 
NR Yes No No NR NR NR NR NR NR NR NR Not studied 
Wesseling 
C, et al 
(2016)[24] 
Nicaragua Yes Male Yes Yes Yes NR NR NR Yes Agriculture NR No No No Yes NR Yes No Yes Yes Yes NR Not studied 
Lebov J, et 
al (2015)[30] 
Nicaragua Yes Male Yes NR NR NR NR NR NR NR NR Yes No NR NR NR Yes Yes NR NR NR No Not studied 
Laux T, et al 
(2012)[31] 
Nicaragua Yes Female NR NA Yes NA NA No NA Economically 
inactive 
population 
NA No Yes No NR NR NR NR No NR NR NR Not studied 
Torres C, et 
al (2010)[15] 
Nicaragua Yes Male NR Yes Yes NR Yes NR NR Coffee/fishing 
and service 
Yes Yes No No NR NR NR No NR NR NR NR Not studied 
González-
Quiroz M. 
(2010)[110] 
Nicaragua Yes Male NR Yes Yes NR NA NR NR Yes vs no NR Yes No No Yes NR Yes No No NR NR NR Not studied 
Garcia-
Trabanino 
R, et al 
(2015)[22] 
El 
Salvador Yes Male NR Only NA NA NA NA NA 
Only 
sugarcane 
work 
Yes No No No Yes NR Yes No No NR Yes NR NAG 
Orantes C, 
et al 
(2014)[32] 
El 
Salvador 
Yes Male NR NR Yes NR NR NR NR Non-
agricultural 
work 
NR No No No NR NR NR NR No NR NR No Not studied 
Peraza S, et 
al (2012)[18]  
El 
Salvador 
Yes Male NR NR Yes Yes NA No No Never worked 
in agriculture 
Yes No No No NR NR NR No NR NR NR NR Not studied 
Orantes C, 
et al 
(2011)[20] 
El 
Salvador 
Yes Male NR NR No NR NR NR NR Non-
agricultural 
work 
NR Yes No No NR NR NR No No NR NR Yes Not studied 
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Authors Country 
Risk factors associated reported in epidemiological studies 
Urinary 
biomarkers 
of kidney 
function Age 
Sex  Education level  Occupations Altitude  Hypertension       Diabetes  NSAIDs  
Heat 
stress  
Heavy 
metal         
Water 
intake Alcohol           
Pesticide 
exposure  
Bolus 
(Isotonic 
solutions) 
at work        
Hyperuricaemia  
Family 
history 
of 
CKDu  
(Male 
vs 
Female) 
(Low vs 
High) Sugarcane Agriculture Cotton Mining Coffee Construction 
Reference 
occupation 
(Low vs 
High) (Yes vs No) 
(Yes vs 
No) 
(Yes vs 
No) 
(Yes vs 
No) 
(High 
vs 
Normal) 
 (High 
vs 
Low) 
(Yes vs 
No) 
(Apply 
vs No 
apply) 
(Yes vs 
No) (Yes vs No) 
(Yes 
vs No) 
Garcia-
Trabanino 
R, et al 
(2005)[111] 
El 
Salvador Yes Male NR NR Yes NR NR NR NR 
Non-
agricultural 
work 
Yes Yes Yes NR NR NR NR No No NR NR NR 
Not studied 
 
 Case-control studies                    
Raines N, 
et al 
(2014)[21] 
Nicaragua Yes Male NR Yes Yes NR NR NR NR 
No 
sugarcane 
work or 
agricultural 
work 
Yes No No No NR NR No No Yes Yes NR NR Not studied 
O’Donnell 
J, et al 
(2010)[19] 
Nicaragua Yes Male No No No No NA NA NR 
No 
agricultural 
work, cotton 
work or 
sugarcane 
work 
Yes Yes No No No No No No No NR NR NR Not studied 
Sanoff S, 
et al 
(2010)[69] 
Nicaragua Yes Male NR No Yes No NA NR NR 
No 
agricultural 
work or 
sugar mill 
work 
NR No No NR NR NR Yes Yes No NR NR No Not studied 
Ecological studies                       
Wesseling 
C, et al 
(2015)[106] 
Costa Rica Yes Male NA Yes Yes NA NA NA NA NA NA NA NA NA Environmental Temperature NA NA NA NA NA NA NA NA 
Laux T, et 
al 
(2015)[112] 
Guatemala Yes Male NA Yes NR NA NA NA NA NA NA NA NA NA Environmental 
Temperature 
NA NA NA NA NA NA NA NA 
VanDervort 
D, et al 
(2014)[113] 
El 
Salvador NR NR NA Yes Yes Yes NR No NA NA NR NA NA NA 
Environmental 
Temperature NA NA NA NA NA NA NA NA 
 
  Risk factors associated with CKDu   Risk factors not associated with CKDu   Reference group for occupation   Risk factors that were not studied or reported 
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Black diamond data markers represent PORs; horizontal lines represent the 95% CIs; the size of the grey square 
marker indicates the statistical weight of the study using the random effects meta-analysis. A diamond data marker 
denotes the overall POR and 95% CI for the outcome of interest. 
Abbreviations:  NSAIDs: non-steroidal anti-inflammatory drugs 
 
 
 
 
 
 
 
  
Supplementary figure 1: Forest plots of associations of alcohol consumption 
(A), non-steroidal anti-inflammatory drug use (B) and heat stress (C) 
estimates with chronic kidney disease of undetermined caused (eGFR<60 
mL/min) 
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   Supplementary table 6: Quality assessment of occupational studies including the rationale (n=5) 
Author Study 
design 
Selection bias Loss to follow-up 
Non-differential 
misclassification 
exposure 
Information bias of exposure 
Non-differential 
misclassification of 
outcome 
Information bias of 
outcome 
Confounding Reverse causation 
Wesseling C, et 
al (2016)[24] 
Cross-
sectional 
Low: High 
participation rate 
(86%) in all 
occupations 
N/A: Cross-sectional 
study 
Medium: water 
intake, self-report of 
nephrolithiasis, self-
reports of urinary 
tract infection and 
use of NSAIDs 
 
Medium: The retrospective 
assessment of some 
exposures was prone to 
recall bias, but a 
standardized questionnaire 
was administered by well-
trained interviewers and a 
certain number of 
questionnaires were 
selected for re-testing by a 
fieldwork assistant to 
confirm the information. 
Low: The use of 
the CKD-EPI 
equation has not 
been validated in 
the Nicaraguan 
population. 
 
High: The use of a 
non-standard eGFR 
threshold for 
determining the 
outcome (eGFR <80 
mL/min/1.73 m2) and 
a single measure of 
eGFR were only 
prone to 
misclassification of 
AKI. 
 
Medium: 
Restricted to 
sugarcane 
cutters, but not 
adjusted for 
age 
High: Some exposures 
such as water intake, 
urinary tract infection and 
the use of NSAIDs, may 
be prone to reverse 
causation. 
Wesseling C, et 
al (2016)[23] 
Cohort 
(Changes 
in GFR 
across the 
harvest 
period) 
Low: High 
participation rate 
(88%) at baseline 
(1104 of 1249 
workers sampled 
at pre/harvest 
screens) 
High: 50% of enrolled 
participants were fired 
at the middle of the 
harvest 
Medium: water 
intake, self-report of 
nephrolithiasis, 
diabetes and use of 
NSAIDs 
 
Low: Exposure data were 
collected prospectively and 
a standardized 
questionnaire was 
administered by well-trained 
interviewers; a certain 
number of questionnaires 
were selected for re-testing 
by a fieldwork assistant to 
confirm the information. 
 
Low: The use of 
the CKD-EPI 
equation has not 
been validated in 
the Nicaraguan 
population. 
 
Low: Kidney function 
was measured 
prospectively during 
the harvest season. 
Medium: 
Adjusted for 
sex and age, 
but not for 
other known 
risk factors for 
CKD 
High: Some exposures, 
such as water intake, 
nephrolithiasis, and the 
use of NSAIDs, may be 
prone to reverse 
causation. 
Laws R, et al 
(2016)[26] 
Cohort 
(Changes 
in GFR 
across the 
harvest 
period) 
Low: High 
participation rate 
(88%) at baseline 
(1104 of 1249 
workers sampled 
at pre/harvest 
screens) 
High: 55% of 
sugarcane workers 
were to lost follow up 
at late harvest for 
many reasons: 
stopped working, 
moved to different 
regions, and financial 
and logistical 
constraints 
Medium: self-report 
of water and sugar 
intake 
 
Low: Exposure data were 
collected prospectively. 
Low: The use of 
the CKD-EPI 
equation has not 
been validated in 
the Nicaraguan 
population. 
 
 
Low: Kidney function 
and urinary 
biomarkers were 
measured 
prospectively before 
and during late 
harvest. 
Medium: 
Adjusted for 
sex, age, and 
years worked 
at the 
company, but 
not for other 
known risk 
factors for CKD 
High: Some exposures, 
such as water intake, 
may be prone to reverse 
causation. 
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Author Study 
design 
Selection bias Loss to follow-up 
Non-differential 
misclassification 
exposure 
Information bias of exposure 
Non-differential 
misclassification of 
outcome 
Information bias of 
outcome 
Confounding Reverse causation 
Laws R, et al 
(2015)[45] 
Cohort 
(Changes 
in GFR 
across the 
harvest 
period) 
Low: High 
participation rate 
(88%) at baseline 
High: 55% of 
sugarcane workers 
were lost to follow-up 
at late harvest for 
many reasons: 
stopped working, 
moved to different 
regions, and financial 
and logistical 
constraints  
Medium: self-report 
of water and 
electrolyte solution 
intake before and 
during late harvest 
 
Low: Exposure data were 
collected prospectively. 
Low: The use of 
the CKD-EPI 
equation has not 
been validated in 
the Nicaraguan 
population. 
 
Low: Kidney function 
was measured 
prospectively before 
and during late 
harvest. 
Medium: 
Adjusted for 
sex, age, and 
years worked 
at the 
company, but 
not for other 
known risk 
factors for CKD 
High: Some exposures, 
such as water intake, 
may be prone to reverse 
causation. 
Garcia-
Trabanino R, et 
al (2015)[22] 
Cohort  
(Changes 
in GFR 
across 
shifts) 
Low: High 
participation rate 
(84%) among 
sugarcane 
workers 
N/A: Cross-sectional 
study 
Medium: self-report 
of nephrolithiasis, 
diabetes, use of 
NSAIDs, diuretics, 
and sweet drinks 
 
Medium: Retrospective 
assessments of some 
exposures are prone to 
recall bias, but a 
standardized questionnaire 
was administered by well-
trained interviewers, and a 
certain number of 
questionnaires were 
selected for re-testing by a 
fieldwork assistant to 
confirm the information. 
 
Low: The use of 
the CKD-EPI 
equation has not 
been validated in 
the Nicaraguan 
population. 
 
Low: Two measures 
of eGFR across 
shifts were only 
prone to detect AKI. 
High: 
Unadjusted for 
known risk 
factors for CKD 
High: Some exposures, 
such as nephrolithiasis 
and the use of NSAIDs, 
may be prone to reverse 
causation. 
Abbreviations: NSAIDs; non-steroidal anti-inflammatory drugs, CKD; chronic kidney disease, N/A; not applicable, N/R: not reported, eGFR; estimated glomerular filtration rate, AKI; acute kidney 
injury. 
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Supplementary table 7: Quality assessment of community-based studies including the rationale (n=20) 
Author Study design Selection bias 
Loss to follow-
up 
Non-differential 
misclassification 
exposure 
Information bias of exposure 
Non-differential 
misclassification 
of outcome 
Information bias of outcome Confounding Reverse causation 
González M, et 
al (2017)[114] 
Cohort 
Low: High participation rate 
(97%) for young adults 
aged between 18 to 30 
years. 
N/R: Only 
baseline 
values were 
reported. 
Medium: self-
reported labour 
history and 
NSAID use or 
water intake 
Medium: Retrospective 
assessments of some 
exposures are prone to recall 
bias. However, a standardized 
questionnaire was administered 
by well-trained interviewers, and 
a certain number of 
questionnaires were selected for 
re-testing by a fieldwork 
assistant to confirm the 
.information 
Low: The use of 
the CKD-EPI 
equation has not 
been validated in 
the Nicaraguan 
population. 
High: Arbitrary cut-off point 
for eGFR <90 mL/min and 
a single measure of eGFR 
were only prone to 
misclassification of AKI. 
Medium: 
Stratified by 
sex. 
Participants 
with diabetes 
or hypertension 
were excluded 
from the study. 
High: Some 
exposures, such as 
labour history, 
NSAID use, and 
water intake, are 
prone to reverse 
causation. 
Minnings K, et 
al (2016)[115] 
Cross-sectional 
study with a 
selected follow-
up 
Medium: 75% of response 
participation 
High: Only 
those with low 
eGFR were 
followed-up 
Medium: self-
reported labour 
and medical 
history 
 
Medium: Retrospective 
assessments of some 
exposures are prone to recall 
bias. 
Low: Use of the 
non-validated 
MDRD equation 
for the 
Nicaraguan 
population. 
 
High: Kidney function was 
determined based on a 
creatinine level of 1.5 
mg/dL for males and 1.2 
mg/dL for females or an 
eGFR <60 mL/min/1.73 
m2. However, a single 
measure of eGFR was 
only prone to 
misclassification of AKI 
High: 
Unadjusted for 
known risk 
factors for CKD 
High: Some 
exposures, such as 
labour history, HTN 
and nephrolithiasis, 
are prone to reverse 
causation. 
Kupferman J, 
et al (2016)[27] 
Cross-sectional 
Low: All participants were 
recruited from families with 
CKDu in the community. 
N/A: Cross-
sectional study 
Medium: self-
report of 
diabetes, past 
or present work 
in the 
sugarcane 
industry and 
NSAID use 
 
Medium: Retrospective 
assessments of some 
exposures are prone to recall 
bias, and all questionnaires 
were reviewed in the field. 
Low: The use of 
the CKD-EPI 
equation has not 
been validated in 
the Nicaraguan 
population. 
 
Low: The diagnosis of 
CKDu was re-confirmed by 
determining serum 
creatinine levels. 
Medium: 
Adjusted for 
eGFR, age and 
use of uric acid 
medication 
High: Some 
exposures, such as 
past or present work 
in the sugarcane 
industry and NSAID 
use, are prone to 
reverse causation. 
Lebov J, et al 
(2015)[30] Cross-sectional 
Low: The participation rate 
was 91%. Participants aged 
between 18 to 70 years old 
were selected from a 
surveillance system based 
on demography. 
N/A: Cross-
sectional study 
Medium: self-
report of 
diabetes, blood 
pressure and 
water intake 
Medium: Retrospective 
assessments of some 
exposures are prone to recall 
bias. However, interviewers 
were trained, and a fieldwork 
assistant reviewed the 
questionnaires in the field. 
Low: Use of the 
non-validated 
MDRD equation 
for the 
Nicaraguan 
population 
Medium: The single 
measure of eGFR was 
only prone to 
misclassification of AKI. 
Low: Adjusted 
for age, sex, 
diabetes, and 
high 
blood pressure. 
High: Some 
exposures, such as 
HTN and water 
intake, are prone to 
reverse causation. 
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Author Study design Selection bias 
Loss to follow-
up 
Non-differential 
misclassification 
exposure 
Information bias of exposure 
Non-differential 
misclassification 
of outcome 
Information bias of outcome Confounding Reverse causation 
Raines N, et al 
(2014)[21] 
Cross-
sectional/nested 
case-control 
Medium: The participation 
rate was 62% among 
people aged 15 to 69 years 
and controls were selected 
from participants of a cross-
sectional study. 
N/A: Cross-
sectional study 
Medium: self-
reported water 
intake, sugar 
intake, NSAID 
use, and 
pesticide 
exposure 
Medium: Retrospective 
assessments of some 
exposures are prone to recall 
bias. However, interviewers 
were trained, and the 
questionnaire was validated 
prior data collection. All 
equipment was calibrated daily. 
Low: The use of 
the CKD-EPI 
equation has not 
been validated in 
the Nicaraguan 
population. 
Medium: A single measure 
of eGFR is only prone to 
misclassification of AKI 
Medium: 
Adjusted for 
sex and age, 
but not for 
other known 
risk factors for 
CKD 
High: Some 
exposures, such as 
water intake, NSAID 
use, and pesticide 
exposure, are prone 
to reverse 
causation. 
Laux T, et al 
(2012)[31] 
Cross-sectional 
Low: All participants 
between 20 to 60 years 
were recruited at 
community level and 
participation rate was 90%. 
N/A: Cross-
sectional study 
Medium: self-
report of 
diabetes, and 
history of 
nephrotoxic 
drug use 
 
Medium: retrospective 
assessment of some exposures 
prone to recall bias 
Low: Research team conducted 
the interviews by applying a 
validated questionnaire in a 
similar population. Scale and 
sphygmomanometer were 
calibrated every day. 
Low:  Use of 
non-validated 
MDRD equation 
for Nicaraguan 
population 
Medium: Single measure 
of eGFR only prone 
misclassification of AKI 
Medium: 
Adjusted for 
BMI, 
hypertension 
and diabetes 
High: Some 
exposures such as 
NSAID use is prone 
to reverse causation 
O’Donnell J, et 
al (2010)[19] 
Cross-
sectional/nested 
case-control 
Low: Participants over 18 
years were recruited at 
community level and the 
participation rate was 91%. 
Controls were randomly 
selected from participants 
of a cross-sectional study 
N/A: Cross-
sectional study 
Medium: self-
report of 
diabetes, labour 
history, NSAIDs 
and antibiotic 
use 
 
Medium: retrospective 
assessment of some exposures 
prone to recall bias and 
research assistant applied a 
standardized questionnaires and 
calibrated instruments (scale 
and sphygmomanometer). 
Training of interviewers. 
Low:  Use of 
non-validated 
MDRD equation 
for Nicaraguan 
population 
Medium: Single measure 
of eGFR only prone 
misclassification of AKI 
and Serum creatinine level 
was determined by 
StatSensor device and re-
analysed by using an 
IDMS-standardized 
creatinine assays 
Medium: 
Adjusted for 
sex and age 
but not for 
other known 
risk factors for 
CKD 
High: Some 
exposures such as 
labour history, 
NSAIDs use are 
prone to reverse 
causation 
Sanoff S, et al 
(2010)[69] Case-control 
High: Controls were 
selected from groups of 
volunteers with high history 
of alcohol consumption. 
Participants rate was 99% 
N/A: Cross-
sectional study 
Medium: self-
report of 
diabetes, 
occupational 
history, and 
water 
consumption. 
 
High: Participants were selected 
from a groups high level of 
exposure and retrospective 
assessment of some exposures 
prone to recall bias 
Low:  Use of 
non-validated 
MDRD equation. 
Medium: Single measure 
of eGFR only prone 
misclassification of AKI 
Low: Adjusted 
for age, 
gender, 
hypertension, a 
reported history 
of diabetes, a 
family history of 
end stage 
kidney disease, 
and body mass 
index. 
High: Some 
exposures such as 
labour history and 
NSAIDs use are 
prone to reverse 
causation 
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Author Study design Selection bias 
Loss to follow-
up 
Non-differential 
misclassification 
exposure 
Information bias of exposure 
Non-differential 
misclassification 
of outcome 
Information bias of outcome Confounding Reverse causation 
Torres C, et al 
(2010)[15] Cross-sectional 
Low: Participants between 
20 to 60 years were 
recruited at community 
level and the Participation 
rate was 83%. 
N/A: Cross-
sectional study 
Medium: self-
report of 
diabetes and 
self-reported of 
urinary tract 
infection. 
 
Medium: retrospective 
assessment of some exposures 
prone to recall bias 
Low:   Use of 
CKD-EPI 
equation which 
has not been 
validated in the 
Nicaraguan 
population 
Medium: Single measure 
of eGFR only prone 
misclassification of AKI 
Low: Adjusted 
for age, sex, 
hypertension, 
obesity and 
diabetes 
High: Some 
exposures such as 
self-report of urinary 
tract infection are 
prone to reverse 
causation 
González-
Quiroz M. 
(2010)[110] 
Cross-sectional 
Low: Participants between 
20 to 60 years were 
recruited by random 
selection sample and the 
Participation rate was 97%. 
N/A: Cross-
sectional study 
Medium: self-
report of labour 
history, water-
intake, diabetes, 
nephrolithiasis 
and urinary tract 
infection 
Medium: retrospective 
assessment of some exposures 
prone to recall bias, but well 
training interviewers applied a 
standardized questionnaire. 
Research team reviewed all 
questionnaire at field 
Low:   Use of 
CKD-EPI 
equation which 
has not been 
validated in the 
Nicaraguan 
population 
Medium: Single measure 
of eGFR only prone 
misclassification of AKI 
Low: Adjusted 
for age, sex, 
hypertension, 
obesity and 
diabetes 
High: Some 
exposures such as 
water intake, 
nephrolithiasis and 
occupation are 
prone to reverse 
causation 
Orantes C, et 
al* (2016)[116] Cross-sectional 
Low: Participants under 18 
years were recruited at 
community level and 
participation rate was 
97.8%. 
N/A: Cross-
sectional study 
N/R: No 
exposure data 
was reported in 
this study 
N/R: No exposure data was 
reported in this study 
Low:  Use of 
non-validated 
Schwartz 
equation. 
Low: Objective definition of 
outcome (eGFR <60 
mL/min/1.73 m2, with or 
without markers of kidney 
damage) with two 
measurements of serum 
creatinine within three 
months’ difference proved 
the CKD diagnosis. 
High: 
Unadjusted for 
known risk 
factors for CKD 
N/R: No exposure 
data was reported in 
this study 
Orantes C, et 
al* (2015)[117] Cross-sectional 
Low: Women were 
recruited from agriculture 
community 
N/A: Cross-
sectional study 
Medium: self-
report of 
diabetes, use of 
NSAIDs, and 
occupations. 
Medium: retrospective 
assessment of some exposures 
prone to recall bias but all 
instruments and tools were 
calibrated. Measurements were 
done by certified personnel 
Low:  Use of 
non-validated 
MDRD equation. 
 
Low: Objective definition of 
outcome (eGFR <60 
mL/min/1.73 m2) with two 
measurements of serum 
creatinine within three 
months’ difference proved 
the CKD diagnosis 
High: 
Unadjusted for 
known risk 
factors for CKD 
High: Some 
exposures such as 
use of NSAIDs, and 
occupation are 
prone to reverse 
causation 
Vela X, et al* 
(2014)[118] Cross-sectional 
Low: Participants were 
recruited from a farming 
communities and the 
participation rate was 
91.4% 
N/A: Cross-
sectional study 
Medium: self-
reported use of 
NSAIDs, 
antibiotics, and 
occupations. 
Medium: retrospective 
assessment of some exposures 
prone to recall bias but all 
instruments and tools were 
calibrated. Measurements were 
done by certified personnel 
Low:   Use of 
CKD-EPI 
equation which 
has not been 
validated in the 
Nicaraguan 
population 
Low: Objective definition of 
outcome (eGFR <60 
mL/min/1.73 m2) with two 
measurements of serum 
creatinine within three 
months’ difference proved 
the CKD diagnosis 
High: 
Unadjusted for 
known risk 
factors for CKD 
High: Some 
exposures such as 
use of NSAIDs and 
occupation are 
prone to reverse 
causation 
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Author Study design Selection bias 
Loss to follow-
up 
Non-differential 
misclassification 
exposure 
Information bias of exposure 
Non-differential 
misclassification 
of outcome 
Information bias of outcome Confounding Reverse causation 
Orantes C, et 
al* (2014)[32] 
Cross-sectional 
Low: Participants were 
recruited at the community 
level and the participation 
rate was 100%. 
N/A: Cross-
sectional study 
Medium: self-
reported 
diabetes, use of 
NSAIDs, and 
occupation. 
 
Medium: Retrospective 
assessments of some 
exposures are prone to recall 
bias, but all instruments and 
tools were calibrated. 
Measurements were performed 
by certified personnel. 
Low:  Use of a 
non-validated 
MDRD equation. 
Low: An objective 
definition of outcome 
(eGFR <60 mL/min/1.73 
m2) with two 
measurements of serum 
creatinine levels within 
three months confirmed 
the CKD diagnosis. 
Low: Adjusted 
for known risk 
factors for CKD 
High: Some 
exposures, such as 
the use of NSAIDs 
and occupation, are 
prone to reverse 
causation. 
Peraza S, et al 
(2012)[18]  Cross-sectional 
Low: Participants aged 
between 20 to 60 years 
were recruited at the 
community level, and the 
participation rate was 77%. 
N/A: Cross-
sectional study 
Medium: self-
report of 
diabetes, 
nephrolithiasis 
and the use of 
NSAIDs 
 
Medium: Retrospective 
assessments of some 
exposures are prone to recall 
bias, but a standardized 
questionnaires and calibrated 
instruments (scale and 
sphygmomanometer) 
were used.  
Low: The use of 
the CKD-EPI 
equation has not 
been validated in 
the Nicaraguan 
population. 
Medium: The single 
measure of eGFR is only 
prone to misclassification 
of AKI. 
Low: Adjusted 
for age, sex, 
hypertension 
and diabetes 
High: Some 
exposures, such as 
nephrolithiasis and 
the use of NSAIDs, 
are prone to reverse 
causation. 
Orantes C, et 
al* (2011)[20] Cross-sectional 
Medium: Participants were 
recruited at the community 
level from individuals with a 
long history of pesticide 
use, and the participation 
rate was 88.3%. 
N/A: Cross-
sectional study 
Medium: self-
reported use of 
NSAIDs, 
medicinal 
plants, 
infectious 
diseases and 
occupation 
Medium: Retrospective 
assessments of some 
exposures are prone to recall 
bias, but all instruments and 
tools were calibrated. 
Measurements were performed 
by certified personnel. 
Low: Use of a 
non-validated 
MDRD equation. 
Low: An objective 
definition of outcome 
(eGFR <60 mL/min/1.73 
m2) with two 
measurements of serum 
creatinine levels within 
three months confirmed 
the CKD diagnosis. 
High: 
Unadjusted for 
known risk 
factors for CKD 
High: Some 
exposures, such as 
the use of NSAIDs, 
use of medicinal 
plants, infectious 
diseases and 
occupation, are 
prone to reverse 
causation. 
Garcia-
Trabanino R, et 
al (2005)[111] 
Cross-sectional 
High: The participation rate 
was 29% (353 of 1220 
subjects). 
N/A: Cross-
sectional study 
Medium: self-
report of 
medical history 
and occupation. 
Medium: Retrospective 
assessments of some 
exposures are prone to recall 
bias. 
Medium:  Use of 
a cut-off serum 
creatinine level 
>1.5 mg/dl 
Medium: An objective 
definition of outcomes 
(proteinuria and chronic 
renal failure) 
High: 
Unadjusted for 
known risk 
factors for CKD 
High: Some 
exposures, such as 
HTN and 
occupation, are 
prone to reverse 
causation. 
Wesseling C, et 
al (2015)[106] Ecological 
Low: All Costa Rican 
provinces were included in 
the study. 
N/A: 
Ecological 
study 
Low: 
Determined 
from the 
National 
Weather 
Surveillance 
System 
Low: Climate data from the 
National Weather Surveillance 
System and exposure data 
based on vital statistics 
Medium: Low 
overall 
recognition of 
CKD 
High: Recognition of CKD 
could vary by area. 
High: 
Unadjusted for 
known risk 
factors for CKD 
Low: Ecological 
study 
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Author Study design Selection bias 
Loss to follow-
up 
Non-differential 
misclassification 
exposure 
Information bias of exposure 
Non-differential 
misclassification 
of outcome 
Information bias of outcome Confounding Reverse causation 
Laux T, et al 
(2015)[112] Ecological 
Low: Participants were 
recruited at dialysis 
programmes from different 
regions in Guatemala. 
N/A: 
Ecological 
study 
Low: 
Determined 
from the 
National 
Weather 
Surveillance 
System 
Low: Climate data were 
obtained from the National 
Weather Surveillance System. 
High: Not all 
patients have 
access to dialysis 
treatment.  
High: Some regions have 
fewer dialysis units than 
other regions within the 
country.  
High: 
Unadjusted for 
known risk 
factors for CKD 
Low: Ecological 
study 
VanDervort D, 
et al (2014)[113] Ecological 
Low: All regions from El 
Salvador were included in 
the study. 
N/A: 
Ecological 
study 
Low: 
Determined 
from an 
agricultural 
census and 
ambient 
temperature 
Low: Exposure data were 
obtained from the Ministry of 
Environment and Natural 
Resources and the Ministry of 
Economy. CKD data were 
obtained from the National 
Health System. 
Medium: Low 
overall 
recognition of 
CKD  
 
High: Recognition of CKD 
could vary by area. 
High: 
Unadjusted for 
known risk 
factors for CKD 
Low: Ecological 
study 
*Five studies from El Salvador applied the following CKD definition: persistence of renal damage markers for ≥3 months or GFR <60 mL/min. 
Abbreviations: NSAIDs; non-steroidal anti-inflammatory drugs, CKDu; chronic kidney disease of undetermined cause, CKD; chronic kidney disease, N/A; not applicable, N/R: not reported, eGFR; 
estimated glomerular filtration rate, AKI; acute kidney injury. 
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Supplementary figure 2: Funnel plot showing the associations between male 
sex, pesticide exposure and alcohol consumption with CKDu (eGFR<60 
mL/min) using the log OR and its standard error (n=8) 
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Chapter 3. Rationale and baseline findings from a community-based 
longitudinal prospective cohort study among young, apparently healthy 
participants 
 
3.1 Introduction to paper II 
This paper was published in BioMed Central Nephrology Journal (BMC 
Nephrology) and presents the rationale, description and baseline findings of a 
community-based prospective cohort study of kidney function among the young 
rural population of Northwest Nicaragua. 
 
This chapter presents and discusses the rationale and baseline results from a 
prospective cohort study designed to assess the sociodemographic 
characteristics, occupational and non-occupational exposures, lifestyle, 
dehydration symptoms, etc. The primary outcome was to describe features of a 
population of young adults without known kidney disease living in communities 
with a high prevalence of CKDu in Nicaragua. 
 
Although participants with a previous diagnosis of CKD were excluded, the 
prevalence of potentially reduced kidney function (eGFR <90 mL/min/1.73 m2) 
was 11% among males and 1% among females. Of participants with an 
eGFR<90 mL/min/1.73 m2, 15% reported only working in agriculture, 10% in 
sugarcane only and 12% in sugarcane and any other work, including 
agriculture. In summary, this study recruited young adults without known kidney 
function impairments and without any conventional risk factors for CKD 
(diabetes and hypertension) to investigate the natural history of CKDu. 
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The baseline questionnaire and tables that describes the sociodemographic 
characteristics and potential factors for heat stress were included in this paper 
as supplementary materials. The baseline questionnaire is included in this 
chapter as appendix B. 
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3.5 Supplementary material 
Supplementary table 1: Demographic and anthropometric characteristics, 
lifestyle factors and medical history among baseline participants in the 
cohort study 
Variables Men (n: 263) Women (n: 87) 
eGFR (<90 mL/min/1.73 m2)* eGFR (<90 mL/min/1.73 m2)* 
Yes (n: 29, 
11.0%) 
No (n: 234, 
90.0%) 
P-
value 
Yes (n: 1, 
1.1%) 
No (n: 86, 
98.9%) 
P-
value 
Age (yrs), mean ± SD** 24.7± 2.9 23.1 ± 3.8 0.022 28.0 ± 0.0 23.6 ± 3.5 0.202 
Systolic blood pressure, 
mean ± SD** 
125.1 ± 10.3 118.1 ± 9.1 0.002 113.0 ± 0.0 111.1 ± 11.5 0.765 
Diastolic blood pressure, 
mean ± SD** 
75.2 ± 7.1 68.8 ± 7.3 0.001 86.0 ± 0.0 68.8 ± 8.7 0.135 
Heart rate, mean ± SD** 72.6 ± 9.8 70.3 ± 8.4 0.256 86.0 ± 0.0 77.3 ± 8.3 0.209 
BMI, mean ± SD** 24.0 ± 3.7 22.8 ± 3.5 0.092 21.4 ± 0.0 26.3 ± 6.1 0.359 
BMI > 25 kg/m2*** 6 (20.7%) 41 (17.5%) 0.674 0 (0%) 40 (46.5%) --- 
Education (yrs), mean ± 
SD** 
6.2 ± 4.1 6.2 ± 3.4 0.719 6.0 ± 0.0 7.2 ± 3.1 0.765 
Household income per 
person in family 
(córdobas; 26.72 = 1 
US$), mean ± SD  ** 
7340 ± 4823 7794 ± 5620 0.802 4000.0 ± 0 6491 ± 4597 0.536 
Total number of family 
members who depend on 
the household income** 
4.3 ± 1.6 4.9 ± 2.4 0.461 3.0 ± 0.0 4.5 ± 2.2 0.324 
Age of first job, paid or 
unpaid, mean ± SD** 14.3 ± 3.2 14.6 ± 3.2 0.756 18.0 ± 0.0 15.3 ± 3.8 0.389 
Ever smoked*** 20 (69.0%) 122 (52.1%) 0.086 0 (0%) 2 (2.3%) --- 
Ever drank alcohol*** 25 (86.2%) 156 (66.6%) 0.032 1 (100.0%) 12 (14.0%) --- 
NSAIDs*** 22 (75.9%) 195 (83.3%) 0.318 0 (0%) 79 (91.9%) --- 
Nephrotoxic antibiotics*** 6 (20.7%) 27 (11.5%) 0.161 0 (0%) 16 (18.6%) --- 
Hypertension*** 2 (6.9%) 2 (0.9%) 0.061 0 (0%) 6 (7.0%) --- 
History diabetes*** 0 (0%) 0 (0%) --- 0 (0%) 0 (0%) --- 
History kidney stones*** 0 (0%) 1 (0.4%) --- 0 (0%) 3 (3.4%) --- 
History urinary tract 
infections (UTI)*** 
8 (27.5%) 48 (20.5%) 0.470 0 (0%) 35 (40.6%) --- 
* eGFR was defined as eCKD-Epi GFR <90 mL/min/1.73 m2. ** Kruskal-Wallis test for non-normally distributed 
continuous variables.  *** Chi-square test for categorical variables or Fisher’s exact test at expected frequencies 
<5. 
Abbreviations: BMI: body mass index, eGFR: estimated glomerular filtration rate, NSAIDs: non-steroidal anti-
inflammatory drugs. 
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Supplementary table 2: Potential risk factors for heat stress among men 
and women 
 
*eGFR was defined as eGFR <90 mL/min/1.73 m2; ** Kruskal-Wallis test for non-normally distributed continuous 
variables;*** Chi-square test for categorical variables or Fisher’s exact test at expected cell frequencies <5. 
 
 
 
 
 
 
 
 
 
 
Variables Men (n: 263) Women (n: 87) 
eGFR (<90 mL/min/1.73 m2)* eGFR (<90 mL/min/1.73 
m2)* 
Yes (n: 29, 
11.0%) 
No (n: 234, 
90.0%) 
P-value Yes (n: 1, 
1.1%) 
No (n: 86, 
98.9%) 
Years of working life, mean ± 
SD** 
10.2 ± 3.9 8.4 ± 4.7 0.032 10.0 8.2 ± 4.9 
Work hours per day, mean ± 
SD** 
7.1 ± 1.9 7.2 ± 2.4 0.890 10.0 8.0 ± 2.0 
Total duration breaks per day 
(minutes), mean ± SD** 
29.8 ± 27.1 22.7 ± 20.1 0.378 60.0 45.0 ± 45.2 
Number of breaks per day, 
mean ± SD 
2.4 ± 1.5 2.5 ± 1.6 0.651 3.0 2.3 ± 1.0 
Very rapid work pace (%)*** 5 (17.2%) 91 (38.8%) 0.022 No 27 (31.3%) 
Hot environment in current 
job (%)*** 
5 (17.2%) 47 (20.1%) 0.717 No 3 (3.5%) 
Lifting weights > 50 pounds 
(%)*** 
6 (20.6%) 54 (23.0%) 0.773 No 5 (5.8%) 
Physical effort in the last week 16 (55.1%) 133 (56.8%) 0.864 No 44 (51.1%) 
Ever fainted due to work 
(%)*** 
2 (6.8%) 8 (3.4%) 0.304 No 5 (5.8%) 
Weight loss in current job 
(self-reported)*** 
8 (27.5%) 85 (36.3%) 0.353 No 30 (34.8%) 
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Chapter 4. Community-based longitudinal study- An unparalleled decline 
in kidney function among young adults 
 
4.1 Introduction to paper III 
This paper has been published in Journal of the American Society of 
Nephrology (JASN) and presents the natural history of and factors associated 
with the loss of kidney function in a high-risk rural population in northwest 
Nicaragua. This study used prospective longitudinal data to identify the 
subgroups of kidney function trajectories among young adults aged 18-30 
years. Details of the cohort protocol were described in the rationale and 
baseline findings were published paper II and described in chapter 3.  
 
A key aim was to describe the natural history of CKDu over time. Cross-
sectional studies have described that CKDu undergoes a fast progression to 
end stage renal disease, but no reports have previously examined the rate of 
decline in kidney function. This result prompted us to design a study to 
understand the prognosis and how disabling or lethal this disease is among a 
disadvantage population. 
 
A further aim was to identify risk factors associated with a future rapid decline in 
kidney function. The associations of a number of proposed risk factors 
(sociodemographic data, occupational exposure, heat-stress, self-medication, 
habits, dehydration symptoms, etc.) with the rapid decline were examined and a 
sensitivity analysis was conducted with the exposure data that were collected 
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solely after the harvest season (six months after the first visit for most 
participants). 
 
Initially, the longitudinal data were analysed using a multilevel model, however, 
there was evidence of poor model fit and violation of the statistical assumptions 
required for such models. Residuals were not randomly distributed around 
individual slopes and did not follow a normal distribution. Based on this issue, 
we decided to use a growth mixture modelling approach because this allow us 
to identify classes of individual with similar trajectory of decline over time or with 
similar clinical outcome. This approach was the most appropriate method for 
fully capturing information about interindividual variations, heterogeneity of 
different groups within a population and the statistical assumptions underlying 
growth mixture modelling were met. However, this analysis raises a limitation 
when the number of affected people in each subgroup of decline in kidney 
function is too small leading to reduced power to detect association. 
 
Tables and figures that describe the sociodemographic characteristics and 
sensitivity analysis were included in this paper as supplementary materials. All 
of these tables and figures are included in this chapter as section 4.5. 
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4.5. Supplementary material  
 
1. Supplementary Methods 
2. Regulatory approval reference numbers 
3. References 
4. Supplementary Tables  
a. Supplementary Table 1: Symptoms reported over the last 6 months that 
were reported at baseline 
b. Supplementary Table 2: Baseline demographic and lifestyle 
characteristics of male study participants stratified by assigned eGFR 
trajectory group 
c. Supplementary Table 3: Baseline demographic and lifestyle 
characteristics of female study participants stratified by assigned eGFR 
trajectory group 
d. Supplementary Table 4. Occupational characteristics, heat symptoms 
and liquid intake at visit 2 for males recruited at the first study visit only, 
stratified by assigned eGFR trajectory group 
e. Supplementary Table 5. Age- and education level-adjusted associations 
of the rapid decline trajectory with exposures at visit 2 among male study 
participants  
f. Supplementary Table 6: Age- and education level-adjusted associations 
of baseline kidney dysfunction with baseline exposures in male study 
participants  
g. Supplementary Table 7: Age- and education level-adjusted multivariate 
analysis of associations of baseline exposures with changes in eGFR 
over the follow-up period in the male population. 
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5. Supplementary Figures 
a. Supplementary Figure 1: Distribution of eGFR trajectories in the study 
population.  
b. Supplementary Figure 2: Serum creatinine levels in the different eGFR 
trajectory groups over time. 
 
1. Supplementary Methods 
Communities and population: The study was conducted in 9 rural 
communities in the Leon and Chinandega regions of northwest Nicaragua. Most 
members of these communities had not previously participated in CKD research 
studies, but no one had participated in previous studies. Following engagement 
activities, the study team enumerated the de jure population aged 18-30 years 
in each village by visiting dwellings and liaising with families and community 
leaders. A comparison with current local government data suggests that the 
sampling frame n=520 represented 10-15% of the total population (including 
children) of the area. Internal and external migration indicates that numbers of 
adults in this age range are relatively underrepresented in these rural 
communities.  
 
Questionnaire data, clinical measures and water samples: We collected 
exposure variables using a questionnaire, the details of which are available 
elsewhere.1 In addition, at the second visit, we also asked participants to report 
any use of glyphosate, paraquat, methomyl, and cypermethrin with assistance 
from a visual catalogue.  
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Questionnaires collected the following data at baseline and each study visit:  
A. Demographics: age, education, household income per month, water 
sources, and social security status. 
B. Occupational history: current occupation, previous history of sugarcane 
work, predominant sugarcane job if the individual ever worked in the 
sugarcane industry, current and historical banana work, previous job 
duration, and number of sugarcane harvests or pre-harvests worked.  
C. Current occupational exposures: daily work hours, duration of breaks, 
location of work, experience of a hot working environment, availability of 
shade during work breaks, physical effort last week at work, weight loss at 
work. 
D. Lifestyle factors: grams of alcohol consumed over the last year, smoking in 
pack-years, liquid (water and soft drinks) intake in the last 24 hours, and use 
of nephrotoxic medications at any time.  
E. Self-reported symptoms in the last 6 months, which were separated into the 
following categories: (i) heat-related/dehydration symptoms: headache, 
tachycardia, muscle cramps in the arms or legs, fever, nausea, difficulty 
breathing, muscle weakness, dizziness, vomiting, fainting, dysuria, dry 
mouth, very dark urine, very little urine, extreme tiredness and confusion;2-4 
(ii) self-reported weight loss; (iii) self-reported diagnoses of urinary tract 
infections in the previous year. Original symptom questionnaire responses 
for the whole population are summarized in Supplementary Table 1. 
 
Height, weight and blood pressure were measured using standard procedures 
and calibrated devices.  
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Water was collected from participants' primary water source at baseline and the 
second visit only. Water was collected and stored in polypropylene containers at 
4°C. Water hardness was calculated from the sum of concentrations of calcium 
and magnesium cations (as calcium carbonate, in mg/L), which were measured 
using inductively coupled plasma mass spectrometry at Imperial College 
London. 
 
Urine and serum markers: All biosamples were stored at 4°C upon collection, 
frozen at the end of the study day (-20°C, for up to 2 weeks), and then stored at 
-80°C following transfer to the UK. A dipstick (Siemens Multistix, SG10) 
analysis was performed on previously frozen urine samples to semi-
quantitatively assess protein concentrations and specific gravity. Albumin levels 
were quantified using a colorimetric method with a bromocresol green Albumin 
Assay Kit (Sigma-Aldrich, MAK124). Baseline urine samples from men that had 
been previously frozen and stored at -80°C for 2.5 years were analysed for 
neutrophil gelatinase-associated lipocalin (NGAL) levels. Samples from fifty-five 
individuals in the stable kidney function group were randomly selected, and 
samples from all individuals displaying a rapid decline in kidney function or who 
exhibited established renal dysfunction at baseline were examined. NGAL 
levels were measured using enzyme-linked immunoassay (ELH-Lipocalin2, 
RayBiotech) according to the manufacturer’s instructions. Albumin and NGAL 
levels are reported as ratios to urinary creatinine levels measured using the 
Jaffe method (Sigma-Aldrich, C4255). 
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Serum creatinine (Scr) and cystatin C (Scys) levels were both measured in a 
single batch analysis of all 1581 stored study samples at the Nuffield 
Department of Population Health Wolfson Laboratories from the Clinical Trials 
Services Unit (CTSU), Oxford University using quality control referenced to 
isotope dilution mass spectrometry traceable international standards. The Scr 
levels were quantified using a Beckman AU680 Chemistry Analyser (Jaffe 
compensated method) and Scys levels were measured using a Siemens BN 
ProSpec (nephelometry). Mean expanded uncertainty values were: 3% at both 
2.2 mg/dL and 4.7 mg/dL for Scr; and 8% at 0.7 mg/L and 6% at 2.1 mg/L for 
Scys. The CKD EPI formula for serum creatinine - cystatin C levels was then 
used to estimate the GFR.  
 
Exposure variables: The original frequencies of self-reported symptoms (prior 
to recording) are presented in Supplementary Table 1. Prior to association 
analyses, income was recorded using the World Bank definition of poverty of an 
income of US $1.90/day and education level of illiteracy or attendance at 
primary-level education versus attendance at secondary- or higher-level 
education. Current occupation was grouped into sugarcane work, other 
agricultural work, and other occupations/economically inactive population; the 
predominant sugar cane role was categorized by potential heat exposure as 
(cane/seed) cutters, seeders or other roles. Work breaks categorized as <10 
minutes or >10 minutes; self-reported occupational agrochemical exposure was 
reported as the use of any of glyphosate, paraquat, cypermethrin, or methomyl; 
and the degree of physical effort in last week at work was reported as none or 
slight versus moderate or hard. Lifestyle risk factors included daily average 
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alcohol consumption over the last year, which was defined as none (0 grams for 
both sexes) versus any (1-60 grams for males and 1-40 grams for females), and 
current smoking status classified as never smokers (0 pack-years) or light 
smokers (1-20 pack-years). Non-steroidal anti-inflammatory drug use was 
recorded as daily or regularly versus occasionally or never. The self-reported 
diagnosis of urinary tract infections was also recorded. Self-reported symptoms 
were categorized as positive for any one heat-related/dehydration symptom, 
along with fever, dysuria and self-reported weight loss. 
 
Three variables related to fluid consumption were analysed: water sources 
(piped water or water from a dug well/drilled well) and total liquid intake in last 
24 hours (≤5 litres/day, and >5 litres/day). Water hardness was grouped based 
as soft/moderately hard (0-120 mg/L), and hard/very hard (≥121 mg/L).  
 
Additional statistical methods 
Continuous variables were summarized as means and standard deviations or 
medians and interquartile ranges, and categorical variables are reported as 
frequencies/percentages. For further analyses, non-normally distributed 
continuous variables were categorized, and ordinal variables were recorded to 
avoid small cell numbers (see Supplementary Table 1). 
  
We found that a multivariate linear model exhibited a poor fit with non-normally 
distributed residuals, as eGFR trajectories clustered in sub-populations and 
differed between men and women. Therefore, we used a growth mixture 
modelling (GMM) approach. We identified three subpopulations of eGFR 
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trajectories in men and two in women, primarily using the Bayesian Information 
Criterion suggested for this setting.5 Adjustments for the season of follow-up 
visit did not substantially affect the estimation of eGFR trajectories and thus 
were not included in the model. 
 
Associations between individual exposure variables and outcomes were 
examined using probability-weighted multinomial logistic regression analysis. 
Individuals’ probabilities of each kidney function status were obtained from the 
GMM. These models were adjusted for age and educational level, as these 
variables might confound the associations between casual factors of interest 
and outcomes. The 95% confidence intervals of odds ratios that did not include 
unity were accepted as significant. As these association models consisted of 
exploratory analyses, no formal adjustments for multiple testing were 
performed.  
 
The original study sample of 350 individuals was calculated to achieve 90% 
power to detect associations with an acceleration of the decrease in eGFR of 
5.0 mL/min/1.73 m2/year in a linear model to which at least 20% of the 
population were exposed at an alpha of 0.01. Given the change in analytical 
strategy, we performed a post hoc power calculation. Using a chi-squared test 
to detect differences in kidney function status (e.g., stable versus rapid decline) 
associated with an exposure (to which half the population are exposed), a 
greater than 80% power would detect an odds ratio of 3.8 or greater. With a 
non-exposed prevalence of 4.5%, this value reflects a similar power to detect an 
exposure that multiplies the risk by 3.3. This estimate is conservative, as the 
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analysis was based on a probability-weighted kidney function status, an 
outcome that is a more precise measure of the disease spectrum than an 
absolute categorical grouping. 
 
The coefficients for exposures from the poorly fitted multivariate model, in which 
eGFR measures clustered within participants, including a random intercept and 
slope, are included as Supplementary Table 7 (for information purposes). 
 
Analyses were performed using Stata v14 (Stata Corp.), Prism v7 (GraphPad 
Software) and Mplus (Muthén & Muthén) software. 
 
2. Ethical approval and consent to participate  
All participants signed a written informed consent form to participate in the 
follow-up study, in accordance with the Declaration of Helsinki. The study was 
approved by the Bioethical Review Board at the Medical Faculty of UNAN-León 
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Supplementary table 1: Symptoms reported over the last 6 months that 
were reported at baseline 
Symptom  Overall (%) 
(n=350) 
Males  
(n=263) 
Females  
(n=87) 
Heat-related/dehydration symptoms    
Headache (n, %)    
Yes 139 (39.7) 103 (39.2) 36 (41.4)  
No 211 (60.3) 160 (60.8) 51 (58.6) 
Tachycardia (n, %)    
Yes 40 (11.4) 27 (10.3) 13 (14.9)  
No 310 (88.6) 236 (89.7) 74 (85.61) 
Muscle cramps in the arms or legs (n, %)    
Yes 42 (12.0) 32 (12.2) 10 (11.5)  
No 308 (88.0) 231 (87.8) 77 (88.5) 
Muscle weakness (n, %)    
Yes 6 (1.7) 2 (0.8) 4 (4.6)  
No 344 (98.3) 261 (99.2) 83 (95.4) 
Fever (n, %)    
Yes 36 (10.3) 32 (12.2) 4 (4.6)  
No 314 (89.7) 231 (87.8) 83 (95.4) 
Nausea (n, %)    
Yes 25 (7.1) 22 (8.4) 3 (3.5)  
No 325 (92.9) 241 (91.6) 84 (96.5) 
Difficulty breathing (n, %)    
Yes 16 (4.6) 11 (4.2) 5 (5.8)  
No 334 (95.4) 252 (95.8) 82 (94.2) 
Dizziness (n, %)    
Yes 26 (7.4) 15 (5.7) 11 (12.6)  
No 324 (92.6) 248 (94.3) 76 (87.4) 
Vomiting (n, %)    
Yes 8 (2.3) 8 (3.0) 0 (0)  
No 342 (97.7) 255 (97.0) 87 (100.0) 
Fainting (n, %)    
Yes 7 (2.0) 5 (1.9) 2 (2.3)  
No 343 (98.0) 258 (98.1) 85 (97.7) 
Dysuria (n, %)    
Yes 94 (26.9) 72 (27.4) 22 (25.3)  
No 256 (73.1) 191 (72.6) 65 (74.7) 
Dry mouth (n, %)    
Yes 75 (21.4) 56 (21.3) 19 (21.8)  
No 275 (78.6) 207 (78.7) 68 (78.2) 
Very dark urine (n, %)    
Yes 21 (6.0) 12 (4.6) 9 (10.3)  
No 329 (94.0) 251 (95.4) 78 (89.7) 
Very little urine (n, %)    
Yes 30 (8.6) 16 (6.1) 14 (16.1)  
No 320 (91.4) 247 (93.9) 73 (83.9) 
Extremely tired (n, %)    
Yes 29 (8.3) 19 (7.2) 10 (11.5)  
No 321 (91.7) 244 (92.8) 77 (88.5) 
Confusion (n, %)    
Yes 12 (3.4) 8 (3.0) 4 (4.6)  
No 338 (96.6) 255 (97.0) 83 (95.4) 
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Supplementary table 2: Baseline demographic and lifestyle characteristics of 
male study participants stratified by assigned eGFR trajectory group* (n=263) 
Characteristic 
Preserved and stable 
kidney function  
 (n=213) 
Rapid decline in 
eGFR 
(n=25) 
Dysfunction at 
baseline 
 (n=25) 
Age, years; mean (SD) 23.6 (3.8) 23.3 (3.6) 25.4 (2.9) 
Educational level; n (%)    
 Illiteracy/primary  121 (56.8) 14 (56.0) 16 (64.0) 
 Secondary/higher  92 (43.2) 11 (44.0) 9 (36.0) 
Body mass index; n, (%)    
 Normal 176 (82.6) 18 (72.0) 21 (84.0) 
 Overweight/obese 37 (17.4) 7 (28.0) 4 (16.0) 
Systolic blood pressure mmHg; median (IQR) 118 (110 – 124) 120 (113 – 127) 126 (119 – 129) 
Diastolic blood pressure mmHg; median 
(IQR) 
69 (63 – 73) 70 (66 – 76) 74 (68 – 78) 
Income; n (%)    
 Poor 108 (50.7) 16 (64.0) 14 (56.0) 
 Not poor 105 (49.3) 9 (36.0) 11 (44.0) 
Family history of CKD; n (%)    
 Yes 103 (48.4) 11 (44.0) 12 (48.0) 
 No 110 (51.6) 14 (56.0) 13 (52.0) 
Alcohol consumption; n (%)    
 Any  112 (52.6) 16 (64.0) 13 (52.0) 
 None 101 (47.4) 9 (36.0) 12 (48.0) 
Smoking history; n (%)    
 Light smokers 81 (38.0) 10 (40.0) 12 (48.0) 
 Never smokers 132 (62.0) 15 (60.0) 13 (52.0) 
NSAID use; n (%)    
 Daily-regularly 21 (9.9) 3 (12.0) 5 (20.0) 
 Never-occasionally 192 (90.1) 22 (88.0) 20 (80.0) 
Water sources; n (%)    
 Piped water 115 (54.0) 12 (48.0) 12 (48.0) 
 Dug well/drilled well 98 (46.0) 13 (52.0) 13 (52.0) 
Water hardness; n (%)    
 Soft/moderately hard 51 (23.9) 7 (28.0) 9 (36.0) 
 Hard/very hard 162 (76.1) 18 (72.0) 16 (65.0) 
Total liquid intake in the last 24 hrs; n (%)    
 ≤ 5.0 litres  86 (40.4) 10 (40.0) 9 (36.0) 
 >5.0 litres 127 (59.6) 15 (60.0) 16 (64.0) 
Current occupation; n (%)    
 Sugarcane 38 (17.8) 3 (12.0) 4 (16.0) 
 Agricultural work 98 (46.0) 18 (72.0) 15 (60.0) 
 Other occupations/EIP 77 (36.2) 4 (16.0) 6 (24.0) 
Main sugarcane role (if ever worked in 
sugarcane) (%) 
   
 Cane/seed cutter 103 (48.4) 15 (60.0) 19 (76.0) 
 Seeder 39 (18.3) 5 (20.0) 3 (12.0) 
 Other cane jobs 30 (14.1) 2 (8.0) 1 (4.0) 
 Never worked in sugarcane 41 (19.3) 3 (12.0) 2 (8.0) 
Current or historical banana work; n (%)    
 Yes 27 (12.9) 5 (20.0) 15 (60.0) 
 No 186 (87.3) 20 (80.0) 10 (40.0) 
Years in sugarcane; mean (SD) 2.7±2.9 2.7±2.7 3.6±2.8 
Years in agriculture; mean (SD) 4.3±4.5 4.0±3.9 5.4±4.5 
Work carried out; † n (%)    
 Indoors 62 (29.1) 1 (4.0) 6 (24.0) 
 Outdoors 151 (70.9) 24 (96.0) 19 (76.0) 
Work in a hot environment; † n (%)    
 Irregularly 71 (33.3) 13 (52.0) 8 (32.0) 
 Regular/frequently 142 (66.7) 12 (48.0) 17 (68.0) 
Shade availability; † n (%)    
 Yes or inside 159 (74.7) 11 (44.0) 20 (80.0) 
 No 54 (25.3) 14 (56.0) 5 (20.0) 
Duration of breaks; † n (%)    
 ≤ 10 minutes 63 (29.6) 11 (44.0) 12 (48.0) 
 >10 minutes 150 (70.4) 14 (56.0) 13 (52.0) 
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Characteristic 
Preserved and stable 
kidney function  
 (n=213) 
Rapid decline in 
eGFR 
(n=25) 
Dysfunction at 
baseline 
 (n=25) 
Physical effort at work; ‡ n (%)    
 None/slight  94 (44.1) 9 (36.0) 11 (44.0) 
 Moderate/hard 119 (55.9) 16 (64.0) 14 (56.0) 
Agrochemicals; †, § n (%)    
 Yes 109 (51.2) 16 (64.0)  10 (40.0) 
 No  104 (48.8) 9 (36.0) 15 (60.0) 
Heat/dehydration symptoms; † n (%)    
 Yes 139 (65.3) 18 (72.0)  18 (72.0) 
 No 74 (34.7) 7 (28.0) 7 (28.0) 
UTI diagnosis in the previous year; n (%)    
 Yes 42 (19.7) 5 (20.0) 9 (36.0) 
 No 171 (80.3) 20 (80.0) 16 (64.0) 
Weight loss; † n (%)    
 Yes 42 (19.7) 7 (28.0) 6 (24.0) 
 No 171 (80.3 18 (72.0) 19 (76.0) 
Dysuria †    
 Yes 61 (28.6) 8 (32.0) 3 (12.0) 
 No 152 (71.4) 17 (68.0) 22 (88.0) 
Fever†    
 Yes 21 (9.9) 5 (20.0) 6 (24.0) 
 No 192 (90.1) 20 (80.0) 19 (76.0) 
Baseline eGFR, mL/min/1.73 m2; median 
(IQR) 117.9 (107.6 - 125.4) 
116.5 (102.6 - 
123.8) 55.5 (49.4 - 67.5) 
Second eGFR, mL/min/1.73 m2; median 
(IQR) 114.7 (104.5 - 122.3) 101.4 (91.2 - 108.9) 51.6 (44.6 - 64.6) 
Third eGFR, mL/min/1.73 m2; median (IQR) 115.3 (104.0 - 123.1) 103.0 (85.7 - 108.9) 55.0 (43.9 - 65.7) 
Fourth eGFR, mL/min/1.73 m2; median (IQR) 113.4 (105.5 - 121.6) 74.3 (62.7 - 84.3) 48.5 (39.0 - 56.8) 
Final eGFR, mL/min/1.73 m2; median (IQR) 113.7 (103.8 - 121.9) 77.1 (66.6 - 84.3) 53.2 (45.0 – 59.7) 
Abbreviations: CKD: chronic kidney disease; NSAID: non-steroidal anti-inflammatory drug; eGFR: 
estimated glomerular filtration rate using the CKD EPI equation based on creatinine and cystatin c levels; 
UTI: urinary tract infection. EIP: economically inactive population. Agricultural work includes all non-
sugarcane agricultural work. *Participants assigned to the group with the highest probability in the growth 
mixture model. †Over the last 6 months; ‡over the last week; §data were collected at the second visit and 
include glyphosate, cypermethrin, paraquat and methomyl. 
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Supplementary table 3: Baseline demographic and lifestyle characteristics of female study 
participants stratified by assigned eGFR trajectory group* (n=87) 
Characteristic Preserved and stable eGFR  (n=84) 
Rapid decline in eGFR 
(n=3) 
Age, years; mean (SD) 24.3 ± 3.6 21.7 ± 3.0 
Educational level; n (%)   
 Illiteracy/primary  41 (48.8) 2 (66.7) 
 Secondary/higher  43 (51.2) 1 (33.3) 
Body mass index; n, (%)   
 Normal 46 (54.8) 1 (33.3) 
 Overweight/obese 38 (45.2) 2 (66.7) 
Systolic blood pressure mmHg; median (IQR) 109 (102 – 117) 125 (103 – 133) 
Diastolic blood pressure mmHg; median (IQR) 67 (63 – 72) 74 (67 – 75) 
Income; n (%)   
 Poor 50 (59.5) 1 (33.3) 
 Not poor 34 (40.5) 2 (66.7) 
Family history of CKD; n (%)   
 Yes 37 (44.1) 2 (66.7) 
 No 47 (55.9) 1 (33.3)  
Alcohol consumption; n (%)   
 Any  7 (8.3) 1 (33.3) 
 None 77 (91.7) 2 (66.7) 
Smoking history; n (%)   
 Light smokers 1 (1.2) 0 (0) 
 Never smokers 83 (98.8) 3 (100.0) 
NSAID use; n (%)   
 Daily-regularly 11 (13.1) 1 (33.3) 
 Never-occasionally 73 (86.9) 2 (66.7) 
Water sources; n (%)   
 Piped water 45 (53.6) 2 (66.7) 
 Dug well/drilled well 39 (46.4) 1 (33.3) 
Water hardness; n (%)   
 Soft/moderately hard 28 (33.3) 2 (66.7) 
 Hard/very hard 56 (66.7) 1 (33.3) 
Total liquid intake in the last 24 hrs; n (%)   
 ≤ 5.0 litres  70 (83.3) 3 (100.0) 
 >5.0 litres 14 (16.7) 0 (0) 
Current occupation; n (%)   
 Sugarcane 10 (11.9) 0 (0) 
 Agricultural work 6 (7.1) 1 (33.3) 
 Other occupations/EIP 68 (81.0) 2 (66.7) 
Main sugarcane role (if ever worked in sugarcane); n (%)   
 Cane/seed cutter 0 (0) 0 (0) 
 Seeder 21 (25.0) 0 (0) 
 Other cane jobs 9 (10.7) 0 (0) 
 None  54 (64.3) 3 (100.0) 
Current or historical banana work; n (%)   
 Yes 9 (10.7) 0 (0) 
 No 75 (89.3) 3 (100.0) 
Years in sugarcane; mean (SD) 0.6±1.7 0±0 
Years in agriculture; mean (SD) 1.2±3.4 0.3±0.5 
Work carried out; † n (%)   
 Indoors 65 (77.4) 2 (66.7) 
 Outdoors 19 (22.6) 1 (33.3) 
Work in a hot environment; † n (%)   
 Irregularly 43 (51.2) 2 (66.7) 
 Regular/frequently 41 (48.8) 1 (33.3) 
Shade availability; † n (%)   
 Yes or inside 62 (73.8) 2 (66.7) 
 No 22 (26.2) 1 (33.3) 
Duration of breaks; † n (%)   
 ≤ 10 minutes 14 (16.7) 1 (33.3) 
 >10 minutes 70 (83.3) 2 (66.7) 
Physical effort at work; ‡ n (%)   
 None/slight  42 (50.0) 1 (33.3) 
 Moderate/hard 42 (50.0) 2 (66.7) 
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Characteristic Preserved and stable eGFR  (n=84) 
Rapid decline in eGFR 
(n=3) 
Agrochemicals; †, § n (%)   
 Yes 12 (14.3) 0 (0) 
 No  72 (85.7) 3 (100.0) 
Heat/dehydration symptoms; † n (%)   
 Yes 63 (75.0) 2 (66.7) 
 No 21 (25.5) 1 (33.3) 
UTI diagnosis in the previous year; n (%)   
 Yes 34 (40.5) 1 (33.3) 
 No 50 (59.5) 2 (66.7) 
Weight loss; † n (%)   
 Yes 8 (9.5) 0 (0) 
 No 76 (90.5) 3 (100.0) 
Dysuria †   
 Yes 21 (25.0) 1 (33.3) 
 No 63 (75.0) 2 (66.7) 
Fever†   
 Yes 4 (4.8) 0 (0) 
 No 80 (95.2) 3 (100.0) 
Baseline eGFR, mL/min/1.73 m2; median (IQR) 121.8 (115.8 – 127.1) 136.3 (123.3 – 136.4) 
Second eGFR, mL/min/1.73 m2; median (IQR) 118.9 (109.1 – 128.2) 107.5 (91.5 – 136.7) 
Third eGFR, mL/min/1.73 m2; median (IQR) 119.5 (113.0 – 126.6) 102.3 (93.1 – 108.2) 
Fourth eGFR, mL/min/1.73 m2; median (IQR) 119.4 (112.7 – 124.9) 99.9 (95.9 – 108.0) 
Final eGFR, mL/min/1.73 m2; median (IQR) 121.4 (112.1 – 126.6) 102.2 (102.0 – 103.1) 
Abbreviations: CKD: chronic kidney disease; NSAID: non-steroidal anti-inflammatory drug; eGFR: 
estimated glomerular filtration rate using the CKD EPI equation based on creatinine and cystatin c levels; 
UTI: urinary tract infection. EIP: economically inactive population. Agricultural work includes all non-
sugarcane agricultural work. *Participants assigned to the group with the highest probability in the growth 
mixture model. †Over the last 6 months; ‡over the last week; §data were collected at the second visit and 
include glyphosate, cypermethrin, paraquat and methomyl. 
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Supplementary table 4: Occupational characteristics, heat symptoms and liquid intake at visit 2 for 
males recruited at the first study visit only, stratified by assigned eGFR trajectory group* (n=213) 
Characteristic 
Preserved 
and stable 
eGFR 
(n=176) 
Rapid decline 
in eGFR 
(n=18) 
Dysfunction 
at baseline 
(n=19) 
Total liquid intake in the last 24 hrs; 
n (%) 
   
≤ 5.0 litres 18 (10.2) 2 (11.1) 2 (10.5) 
>5.0 litres 158 (89.8) 16 (88.9) 17 (89.5) 
Current occupation; n (%)    
Sugarcane 89 (50.6) 10 (55.6) 5 (26.3) 
Agricultural work 54 (30.7) 4 (22.2) 11 (57.9) 
Other occupations/EIP 33 (18.7) 4 (22.2) 3 (15.8) 
Predominant sugarcane role; † n (%)    
Cane/seed cutter 32 (18.1) 9 (50.0) 4 (21.1) 
Seeder 33 (18.8) 4 (22.2) 0 (0) 
Other cane jobs 39 (22.2) 0 (0) 4 (21.1) 
Not worked in sugarcane  72 (40.9) 5 (27.8) 11 (57.9) 
Months in sugarcane; † mean (SD) 2.9±2.7 4.2±2.5 1.2±2.2 
Months in agriculture; † mean (SD) 1.6±2.3 0.4±1.4 3.0±2.5 
Work carried out; † n (%)    
Indoors 39 (22.2) 3 (16.7) 5 (26.3) 
Outdoors 137 (77.8) 15 (83.3) 14 (73.7) 
Work in a hot environment; † n (%)    
Irregularly 36 (20.5) 4 (22.2) 7 (36.8) 
Regular/frequently 140 (79.5) 14 (77.8) 12 (63.2) 
Shade availability; † n (%)    
Yes or inside 161 (91.5) 17 (94.4) 18 (94.7) 
No 15 (8.5) 1 (5.6) 1 (5.3) 
Duration of breaks; † n (%)    
≤ 10 minutes 69 (39.2) 8 (44.4) 7 (36.8) 
>10 minutes 107 (60.8) 10 (55.6) 12 (63.2) 
Physical effort at work; ‡ n (%)    
Slight  60 (34.1) 5 (27.8) 4 (21.1) 
Moderate/hard 116 (65.9) 13 (72.2) 15 (78.9) 
Weight loss at work; † n (%)    
Yes 41 (23.3) 3 (16.7) 2 (10.5) 
No 135 (76.7) 15 (83.3) 17 (89.5) 
Heat/dehydration symptoms; † n (%)    
Yes 127 (72.2) 12 (66.7) 14 (73.7) 
No 49 (27.8) 6 (33.3) 5 (26.3) 
Dysuria †    
Yes 58 (32.9) 3 (16.7) 3 (15.8) 
No 118 (67.1) 15 (83.3) 16 (84.2) 
Fever†    
Yes 36 (20.4) 10 (55.6) 7 (36.8) 
No 140 (79.6) 8 (44.4) 12 (63.2) 
Abbreviations: EIP: economically inactive population. Agricultural work includes all non-sugarcane 
agricultural work. *Participants assigned to the group with the highest probability in the growth mixture 
model. †Over the last 6 months; ‡over the last week.   
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Supplementary table 5: Age- and education level-adjusted associations* of the rapid decline 
trajectory with exposures at visit 2 among in male study participants (n=213) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: OR: odds ratio; Agricultural work includes all non-sugarcane agricultural work. EIP: 
economically inactive population. *Probability weighted according to results of growth mixture model; †over 
the last 6 months; ‡over the last week.  
 
 
Characteristic Preserved and stable eGFR (n=176) 
 Rapid decline in eGFR 
(n=18) 
Reference   OR 95% CI 
Alcohol consumption      
 Any 1.00  1.04 0.38 to 2.78 
 None 1.00  Reference Reference 
Total liquid intake in the last 24 
hrs  
    
 ≤ 5.0 litres 1.00  1.08 0.22 to 5.16 
 >5.0 litres 1.00  Reference Reference 
Current occupation     
 Sugarcane 1.00  0.84 0.24 to 2.96 
 Agricultural work 1.00  0.59 0.13 to 2.59 
 Other occupations/EIP 1.00  Reference Reference 
Main sugarcane role†      
 Cane/seed cutter 1.00  3.84 1.17 to 12.58 
 Seeder 1.00  1.59 0.38 to 6.52 
 Other cane Jobs 1.00  -- -- 
 Not worked in sugarcane 1.00  Reference Reference 
Months in sugarcane†  1.00  1.20 0.98 to 1.46 
Months in agriculture†  1.00  0.71 0.49 to 1.02 
Work carried outa     
 Outdoors 1.00  1.25 0.33 to 4.65 
 Indoors 1.00  Reference Reference 
Work in a hot environment†     
 Regular/frequently 1.00  0.81 0.24 to 2.70 
 Irregularly 1.00  Reference Reference 
Shade availability†      
 No 1.00  0.58 0.07 to 4.75 
 Yes or inside 1.00  Reference Reference 
Duration of breaks†     
 ≤ 10 minutes 1.00  1.27 0.47 to 3.42 
 >10 minutes 1.00  Reference Reference 
Physical effort at work‡      
 Moderate/hard 1.00  1.27 0.43 to 3.77 
 Slight  1.00  Reference Reference 
Heat/dehydration symptoms†      
 Yes 1.00  0.81 0.28 to 2.29 
 No 1.00  Reference Reference 
Dysuria †     
 Yes 1.00  0.42 0.11 to 1.52 
 No 1.00  Reference Reference 
Fever†     
 Yes 1.00  5.77 2.03 to 16.33 
 No 1.00  Reference Reference 
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Supplementary table 6: Age- and education level-adjusted associations* of baseline kidney 
dysfunction with baseline exposures in male study participants 
Abbreviations: OR: odds ratio; NSAID: non-steroidal anti-inflammatory drug; UTI: urinary tract infection; EIP: 
economically inactive population. Agricultural work includes all non-sugarcane agricultural work. *Probability weighted 
according to results of growth mixture model; †over the last 6 months; ‡over the last week; §data were collected at the 
second visit, and include glyphosate, cypermethrin, paraquat and methomyl. 
 
Characteristic Preserved and stable 
eGFR 
 Baseline dysfunction 
Reference  OR 95% CI 
Alcohol consumption      
 Any 1.00  0.85 0.36 to 1.99 
 None 1.00  Reference Reference 
NSAID use      
 Daily/regularly 1.00  2.00 0.65 to 6.10 
 Never/occasionally 1.00  Reference Reference 
Water sources      
 Piped water 1.00  0.74 0.32 to 1.74 
 Dug well/drilled well 1.00  Reference Reference 
Water hardness      
 Softly/moderately hard 1.00  2.13 0.86 to 5.29 
 Hard/very hard 1.00  Reference Reference 
Total liquid intake in the last 24 hrs      
 >5.0 litres/day 1.00  1.18 0.49 to 2.83 
 ≤ 5.0 litres/day 1.00  Reference Reference 
Current occupation      
 Sugarcane 1.00  1.82 0.46 to 7.20 
 Agricultural work 1.00  2.26 0.81 to 6.32 
 Other occupations/EIP 1.00  Reference  Reference 
Main sugarcane role (if ever worked in 
sugarcane) 
    
 Cane/seed cutter 1.00  3.16 0.69 to 14.47 
 Seeder 1.00  1.36 0.21 to 8.79 
 Other cane jobs 1.00  0.59 0.05 to 7.01 
 Never worked in sugarcane 1.00  Reference Reference 
Current or historical banana work     
 Yes 1.00  9.40 3.79 to 23.30 
 No 1.00  Reference Reference 
Years in sugarcane  1.00  1.03 0.90 to 1.18 
Years in agriculture  1.00  1.02 0.93 to 1.11 
Work carried out†     
 Outdoors 1.00  1.39 0.51 to 3.78 
 Indoors 1.00  Reference Reference 
Work in a hot environment†     
 Regular/frequently 1.00  1.03 0.42 to 2.55 
 Irregularly 1.00  Reference Reference 
Shade availability†     
 No 1.00  0.79 0.27 to 2.23 
 Yes or inside 1.00  Reference Reference 
Duration of breaks†     
 ≤ 10 minutes 1.00  2.36 1.01 to 5.55 
 >10 minutes 1.00  Reference Reference 
Physical effort at work‡     
 Moderate/hard 1.00  1.00 0.43 to 2.33 
 None/slight  1.00  Reference Reference 
Agrochemicals†,§     
 Yes 1.00  0.61 0.26 to 1.45 
 No  1.00  Reference Reference 
Heat/dehydration symptoms†      
 Yes 1.00  1.22 0.47 to 3.12 
 No 1.00  Reference Reference 
Dysuria†     
 Yes 1.00  0.33 0.09 to 1.17 
 No 1.00  Reference Reference 
Fever†     
 Yes 1.00  2.58 0.88 to 7.54 
 No 1.00  Reference Reference 
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Supplementary table 7: Age- and education level-adjusted multivariate analysis of associations of 
baseline exposures with changes in eGFR over the follow-up period in the male population* 
Characteristic n Difference in rate of change in 
eGFRScr-Scys (mL/min/1.73 
m2/year) 
95% confidence 
interval 
Alcohol consumption     
 Any 141 -0.19 -2·14 to 1·75 
 None 122 Reference [-1·99] Reference  
NSAID use     
 Daily/regularly 29 -1.04 -4·13 to 2·04 
 Never/occasionally 234 Reference [-1·96] Reference  
Water sources     
 Piped water 139 -0.71 -2·65 to 1·23 
 Dug well/drilled well 124 Reference [-1·69] Reference  
Water hardness     
 Softly/moderately hard 67 -0.37 -2·58 to 1·82 
 Hard/very hard 196 Reference [-1·95] Reference  
Total liquid intake in the last 24 hrs     
 >5.0 litres/day 85 -0.33 -2·42 to 1·74 
 ≤ 5.0 litres/day 178 Reference [-1·97] Reference  
Current occupation     
 Sugarcane 45 -0.28 -3·23 to 2·67 
 Agricultural work 131 -2.51 -4·65 to -0·37 
 Other occupations/EIP 87 Reference [-0·67] Reference  
Main sugarcane role (if ever worked in 
sugarcane) 
   
 Cane/seed cutter 137 -0.25 -2·92 to 2·41 
 Seeder 47 -1.18 -4·44 to 2·07 
 Other cane jobs 33 0.04 -3·51 to 3·59 
 Never worked in sugarcane 46 Reference [-1·81] Reference  
Current or historical banana work    
 Yes 47 0.90 -1·57 to 3·39 
 No 216 Reference [-2·46] Reference  
Years in sugarcane  -- -1.10 -2.03 to -0.17 
Years in agriculture  -- 0.11 -0.47 to 0.69 
Work carried out†    
 Outdoors 194 -3.08 -5·23 to -0·92 
 Indoors 69 Reference [0·19] Reference  
Work in a hot environment†    
 Regular/frequently 171 1.17 -0·84 to 3·18 
 Irregularly 92 Reference [-2·82] Reference  
Shade availability†    
 No 73 -3.70 -5·79 to -1·61 
 Yes or inside 190 Reference [-1·01] Reference  
Duration of breaks†    
 ≤ 10 minutes 86 -2.16 -4·22 to -0·09 
 >10 minutes 177 Reference [-1·37] Reference  
Physical effort at work‡    
 Moderate/hard 149 -1.31 -3·25 to 0·62 
 None/slight  114 Reference [-1·35] Reference  
Agrochemicals†,§    
 Yes 135 -1.26 -3·20 to 0·67 
 No  128 Reference [-1·45] Reference  
Heat/dehydration symptoms†     
 Yes 175 -0.69 -2·75 to 1·35 
 No 88 Reference [-1·62] Reference  
Dysuria †    
 Yes 72 -0.26 -2·45 to 1·92 
 No 191 Reference [-1·99] Reference  
Fever†    
 Yes 32 -1.74 -4·71 to 1·22 
 No 231 Reference [-1·89] Reference  
Abbreviations: NSAID: non-steroidal anti-inflammatory drug; UTI: urinary tract infection; EIP: economically 
inactive population. Agricultural work includes all non-sugarcane agricultural work. *Coefficients estimated 
from the eGFR*time interaction. The model displayed a poor fit and the data are provided for information 
purposes only. †Over the last 6 months; ‡over the last week; §data were collected at the second visit, and 
include glyphosate, cypermethrin, paraquat and methomyl. 
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5. Supplementary Figures 
 
 
 
 
Supplementary figure 1: Distribution of eGFR trajectories in the study 
population. The decrease in eGFR was calculated by the ordinary least squares 
method. The sub-group of individuals with a rapid decrease in eGFR represents 
a small but distinct group of values centring at -20 mL/min/1.73 m2/year 
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Supplementary figure 2: Serum creatinine levels in the different eGFR trajectory 
groups over time 
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Chapter 5. Identification of young adults at risk of an accelerated loss of 
kidney function in an area affected by Mesoamerican nephropathy 
 
5.1 Introduction to paper IV 
This manuscript was published in BioMedical Central Nephrology (BMC 
Nephrology). This paper presents a case-control study nested in a cohort study 
to determine if repeated routine creatinine tests combined with baseline urinary 
measurements of NGAL levels and can identify the sub-group of individuals at 
risk of a future rapid decline in kidney function. The study population comprised 
the three sub-groups of kidney function trajectories for males (213 participants 
with a preserved/normal eGFR, 25 subjects with rapid decline in kidney function 
and 25 individuals with established renal dysfunction at baseline). 
 
The outcome was the predictive score to identify individuals susceptible decline 
in kidney function. Methods used to identify the eGFR trajectories and kidney 
biomarkers are described in Chapter 4. Initially, the eGFR at the first visit was 
included in the model (area under the curve: 0.51); addition of uNGAL levels at 
visit 1 did improve the model, but the model improvement was insufficient to 
discriminate early kidney damage in this population (area under the curve: 
0.75). Based on this finding, other eGFR levels at six and twelve months after 
baseline were included to improve the final model (area under the curve: 0.89). 
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The results show that inclusion of uNGAL did not improve the models with 
eGFR to identify those people at risk of decline in kidney function. However, a 
question arises of whether other markers such as uric acid, heat shock protein 
72 (HSP 72), and interleukin-6 can be more predictive for early kidney damage. 
In summary, it is urgent to identify a novel kidney marker that could predict a 
decline in kidney function. 
 
All outputs of each predictive models were included in this paper as 
supplementary materials in section 5.5. 
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5.5 Supplementary materials  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary figure 1: Bland-Altman plot of eGFR based on serum 
creatinine levels measured in Nicaragua and serum creatinine levels 
measured in London 
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Supplementary table 1: Multivariate adjusted logistic regression analysis 
for eGFR and uNGAL associated with established renal dysfunction at 
baseline among apparently healthy young males 
 Abbreviations: SE: standard error, uNGAL: urinary neutrophil gelatinase-associated lipocalin, eGFRScr: estimated 
glomerular filtration rate based on locally measured creatinine levels. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Factors Model 1 (n=80)  Model 2 (n=80) 
Without uNGAL levels  With uNGAL levels 
Coefficient SE 95% CI P-value  Coefficient SE 95% CI P-value 
eGFRScr at 
baseline 
-0.14 0.03 -0.22 to -0.07 <0.001  -0.15 0.04 -0.24 to -0.06 <0.001 
Urinary 
NGAL 
-- -- -- --  3.16 1.44 0.34 to 5.99 0.028 
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Supplementary table 2: Multivariate adjusted logistic regression analysis of eGFR and uNGAL associated with a rapid 
decline in kidney function at baseline among apparently healthy young males 
Factors Figure 2A  Figure 2B 
Model 3 without uNGAL levels (n=79)  Model 4 with uNGAL levels (n=79)  Model 5 without uNGAL levels (n=68) 
Coefficient SE 95% CI P-
value 
 Coefficient SE 95% CI P-
value 
 Coefficient SE 95% CI P-
value 
eGFRScr at 
baseline 
0.003 0.01 -0.02 to 0.03 0.808  0.004 0.01 -0.02 to 0.03 0.798  -0.01 0.01 -0.04 to 0.02 0.507 
Urinary NGAL - - - -  0.81 0.45 -0.06 to 1.70 0.070  - - - - 
eGFRScr at 
second study 
visit 
- - - -  - - - -  -0.06 0.02 -0.10 to -0.01 0.015 
eGFRScr at third 
study visit 
- - - -  - - - -  - - - - 
Abbreviations: SE: standard error, uNGAL: urinary neutrophil gelatinase-associated lipocalin, eGFRScr: estimated glomerular filtration rate based on locally measured creatinine levels. 
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Continued: Supplementary table 2: Multivariate adjusted logistic regression analysis for eGFR and uNGAL associated 
with a rapid decline in kidney function at baseline among apparently healthy young males 
Factors Figure 2B  Figure 2C 
Model 6 with uNGAL levels (n=68)  Model 7 without uNGAL levels (n=73)  Model 8 with uNGAL levels (n=73) 
Coefficient SE 95% CI P-
value 
 Coefficient SE 95% CI P-
value 
 Coefficient SE 95% CI P-
value 
eGFRScr at 
baseline 
-0.01 0.01 -0.04 to 0.02 0.501  0.01 0.01 -0.01 to 0.05 0.328  0.01 0.01 -0.01 to 0.05 0.330 
Urinary NGAL 0.54 0.95 -0.57 to 1.65 0.310  - - - -  0.56 0.56 -0.54 to 1.67 0.319 
eGFRScr at 
second study 
visit 
-0.05 0.02 -0.10 to -0.006 0.025  - - - -  - - - - 
eGFRScr at third 
study visit 
- - - -  -0.06 0.01 -0.09 to -0.02 <0.001  -0.05 0.01 -0.09 to -0.02 0.001 
Abbreviations: SE: standard error, uNGAL: urinary neutrophil gelatinase-associated lipocalin, eGFRScr: estimated glomerular filtration rate based on locally measured creatinine levels. 
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Continued: Supplementary table 2: Multivariate adjusted logistic 
regression analysis for eGFR and uNGAL associated with a rapid decline 
in kidney function at baseline among apparently healthy young males 
Abbreviations: SE: standard error, uNGAL: urinary neutrophil gelatinase-associated lipocalin, eGFRScr: estimated 
glomerular filtration rate based on locally measured creatinine levels. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Factors Figure 2D 
Model 9 without uNGAL levels (n=67)  Model 10 with uNGAL levels (n=67) 
Coefficient SE 95% CI P-
value 
 Coefficient SE 95% CI P-
value 
eGFRScr at 
baseline 
-0.004 0.01 -0.04 to 0.03 0.812  -0.004 0.01 -0.04 to 0.03 0.798 
eGFRScr at second 
study visit 
-0.02 0.02 -0.07 to 0.02 0.404  -0.01 0.02 -0.06 to 0.03 0.485 
eGFRScr at third 
study visit 
-0.06 0.02 -0.10 to -0.02 0.002  -0.06 0.02 -0.10 to -0.02 0.002 
Urinary NGAL - - - -  0.44 0.66 -0.86 to 1.74 0.508 
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Supplementary table 3: Multivariate adjusted logistic regression analysis 
of factors associated with established renal dysfunction at baseline 
among apparently healthy young males 
 Abbreviations: SE: standard error, uNGAL: urinary neutrophil gelatinase-associated lipocalin, UACR: urinary albumin 
creatinine ratio, eGFRScr: estimated glomerular filtration rate based on locally measured creatinine levels. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Factors Model 1 (n=74)  Model 2 (n=74) 
Without uNGAL levels  With uNGAL levels 
Coefficient SE 95% CI P-
value 
 Coefficient SE 95% CI P-
value 
Age 0.14 0.22 -0.29 to 0.57 0.525  0.12 0.22 -0.30 to 0.56 0.563 
Season          
Summer  0.0 -- -- --  0 -- -- -- 
Winter 1.00         
Outdoor work          
Yes  7.14 4.14 -0.97 to 15.26 0.084  7.57 5.42 -3.05 to 18.20 0.162 
No 1.00     1.00    
Urinary ACR          
≥30 mg/g 0 -- -- --  0 -- -- -- 
<30 mg/g 1.00     1.00    
Urinary NGAL -- -- -- --  3.31 1.87 0.35 to 6.99 0.077 
eGFRScr at 
baseline 
-0.26 0.10 -0.47 to -0.05 0.014  -0.27 0.13 -0.54 to -0.005 0.045 
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Supplementary table 4: Multivariate adjusted logistic regression analysis of factors associated with a rapid decline in 
kidney function at baseline among apparently healthy young males 
Factors Figure 2A  Figure 2B 
Model 3 without uNGAL levels (n=78)  Model 4 with uNGAL levels (n=78)  Model 5 without uNGAL levels (n=67) 
Coefficient SE 95% CI P-
value 
 Coefficient SE 95% CI P-
value 
 Coefficient SE 95% CI P-
value 
Age -0.06 0.06 -0.19 to 0.06 0.354  -0.06 0.06 -0.20 to 0.06 0.327  -0.11 0.09 -0.29 to 0.05 0.187 
Season               
Summer  0 -- -- --  0 -- -- --  0 -- -- -- 
Winter 1.00     1.00     1.00    
Outdoor work               
Yes  1.59 1.08 -0.54 to 3.72 0.144  1.77 1.10 -0.39 to 3.94 0.110  1.42 1.12 -0.78 to 3.63 0.206 
No 1.00     1.00     1.00    
Urinary ACR               
≥30 mg/g 0 -- -- --  0 -- -- --  0 -- -- -- 
<30 mg/g 1.00     1.00     1.00    
Urinary NGAL - - - -  0.97 0.49 -0.0008 to 1.94 0.050  - - - - 
eGFRScr at 
baseline 
-0.004 0.01 -0.03 to 0.02 0.789  -0.004 0.01 -0.03 to 0.02 0.794  -0.02 0.02 -0.06 to 0.01 0.237 
eGFRScr at 
second study 
visit 
- - - -  - - - -  -0.06 0.02 -0.11 to -0.01 0.018 
eGFRScr at third 
study visit 
- - - -  - - - -  - - - - 
Abbreviations: SE: standard error, UACR: urinary albumin creatinine ratio, uNGAL: urinary neutrophil gelatinase-associated lipocalin, eGFRScr: estimated glomerular filtration rate based on locally 
measured creatinine levels. 
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Continued: Supplementary table 4: Multivariate adjusted logistic regression analysis of factors associated with a rapid 
decline in kidney function at baseline among apparently healthy young males 
Factors Figure 2B  Figure 2C 
Model 6 with uNGAL levels (n=67)  Model 7 without uNGAL levels (n=72)  Model 8 with uNGAL levels (n=72) 
Coefficient SE 95% CI P-
value 
 Coefficient SE 95% CI P-
value 
 Coefficient SE 95% CI P-
value 
Age -0.11 0.08 -0.29 to 0.06 0.202  -0.18 0.10 -0.38 to 0.01 0.068  -0.18 0.09 -0.37 to 0.01 0.066 
Season               
Summer  0 -- -- --  0 -- -- --  0 -- -- -- 
Winter 1.00     1.00     1.00    
Outdoor work               
Yes  1.48 1.13 -0.73 to 3.71 0.190  3.12 2.01 -0.81 to 7.07 0.120  3.35 2.14 -0.84 to 7.55 0.117 
No 1.00     1.00     1.00    
Urinary ACR               
≥30 mg/g 0 -- -- --  0 -- -- --  0 -- -- -- 
<30 mg/g 1.00     1.00     1.00    
Urinary NGAL 0.63 0.62 -0.58 to 1.84 0.310  - - - -  0.76 0.63 -0.48 to 2.01 0.229 
eGFRScr at 
baseline 
-0.02 0.02 -0.06 to 0.01 0.243  -0.0001 0.01 -0.03 to 0.03 0.996  0.0006 0.01 -0.03 to 0.03 0.972 
eGFRScr at 
second study visit 
-0.05 0.02 -0.10 to -0.004 0.034  - - - -  - - - - 
eGFRScr at third 
study visit 
- - - -  -0.07 0.02 -0.11 to -0.03 <0.001  -0.07 0.02 -0.11 to -0.03 <0.001 
Abbreviations: SE: standard error, uNGAL: urinary neutrophil gelatinase-associated lipocalin, ACR: urinary albumin creatinine ratio, eGFRScr: estimated glomerular filtration rate based on locally 
measured creatinine levels. 
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Continued: Supplementary table 4: Multivariate adjusted logistic 
regression analysis of factors associated with a rapid decline in kidney 
function at baseline among apparently healthy young males 
 
Abbreviations: SE: standard error, uNGAL: urinary neutrophil gelatinase-associated lipocalin, UACR: urinary albumin 
creatinine ratio, eGFRScr: estimated glomerular filtration rate based on locally measured creatinine levels. 
 
 
 
 
 
 
 
 
 
 
 
 
Factors Figure 2D 
Model 9 without uNGAL levels (n=66)  Model 10 with uNGAL levels (n=66) 
Coefficient SE 95% CI P-
value 
 Coefficient SE 95% CI P-
value 
Age -0.25 0.12 -0.50 to 0.002 0.05
3 
 -0.23 0.12 -0.49 to 0.01 0.065 
Season          
Summer  0 -- -- --  0 -- -- -- 
Winter 1.00     1.00    
Outdoor work          
Yes  3.40 2.24 -1.00 to 7.81 0.13
0 
 3.47 2.29 -1.02 to 7.97 0.130 
No 1.00     1.00    
Urinary ACR          
≥30 mg/g 0 -- -- --  0 -- -- -- 
<30 mg/g 1.00     1.00    
Urinary 
NGAL 
- - - -  0.42 0.73 -1.01 to 1.86 0.561 
eGFRScr at 
baseline 
-0.02 0.02 -0.07 to 0.01 0.23
9 
 -0.02 0.02 -0.06 to 0.01 0.254 
eGFRScr at 
second study 
visit 
-0.03 0.02 -0.08 to 0.02 0.26
9 
 -0.02 0.02 -0.08 to 0.03 0.360 
eGFRScr at 
third study 
visit 
-0.08 0.02 -0.12 to -0.03 0.00
1 
 -0.07 0.02 -0.12 to -0.03 0.001 
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Supplementary figure 2: ROC curves for the model predicting stable 
kidney function versus established renal dysfunction. The 95% 
confidence intervals for the ROC curves (0.5) are displayed. 
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Supplementary figure 3: ROC curves for the model predicting stable 
kidney function versus a rapid decline in kidney function. The 95% 
confidence intervals for ROC curves (0.5) are displayed. 
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Chapter 6: Overall discussion  
The core of the thesis has been the first community-based cohort study among 
apparently healthy young people in Nicaragua. In addition, I learned to use a 
number of other epidemiological approaches to advance our understanding of 
CKDu, including a systematic review and a community-based prospective 
cohort study, as well as a nested case-control study.  
 
The specific objectives of the thesis (1.4.3) were: (1) to review the current 
knowledge and gaps in our understanding of the potential causes of CKDu in 
the Pacific coast of Central America; (2) to understand which risk factors are 
associated with decline of eGFR among a healthy young population at risk of 
developing CKDu; and (3) to determine if repeated routine creatinine tests 
combined with baseline information (age, season, and work performed) and 
measurements of urinary neutrophil gelatinase-associated lipocalin (uNGAL) 
levels and the urinary albumin-creatinine ratio (UACR) can identify the subgroup 
of individuals at risk of a future rapid decline in kidney function. Addressing 
objective 3 will enable researchers to identify a clinical case definition that can 
be used in further epidemiological studies. 
 
The main findings will be summarized and discussed in terms of the overall 
strengths and limitations of the approaches used (Sections 6.1 and 6.2). The 
clinical and public health implications of the research (individual/family, medical, 
government/healthcare system and industry implications) will be described in 
section 6.3. The academic research implication and future research questions 
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will be presented in sections 6.4 and 6.5. Finally, an overview of my personal 
learning and conclusions are discussed in sections 6.6 and 6.7. 
 
6.1 Summary and synthesis of the research findings 
6.1.1 What was already known about this topic 
In the last two decades, chronic kidney disease of unknown origin (CKDu) has 
emerged as major public health problem in Mesoamerica. Excess mortality due 
to CKDu among young agricultural workers has been reported in many 
countries across the region.[12, 13, 16, 33, 104-106] This disease has some unique 
characteristics, including its lack of association with well-established causes of 
kidney disease in developed countries, such as diabetes, hypertension and 
glomerulonephritis. Furthermore, according to epidemiological studies, CKDu is 
mostly prevalent (but not restricted to) in young male agricultural workers who 
are often in their 30s and are geographically distributed along the Pacific coast 
in Mesoamerica. Positive correlations have been identified with certain factors, 
such as the male sex, low altitude, agricultural work, and high water intake.[12, 14, 
101, 106, 108, 109] The clinical manifestations include minimal proteinuria, 
normotensive, anaemia, electrolyte disorders (hyponatremia and 
hypokalaemia), hyperuricaemia, and small echogenic kidneys.[22, 23, 27] The 
clinicopathological picture involves tubulointerstitial damage and glomerular 
enlargement.[28, 29, 49, 119]  
The specific causes and aetiological pathways remain to be identified. The 
hypothesized causes of CKDu include cyclical dehydration episodes linked to 
extreme working conditions (heat stress and physical exertion) plus an 
inadequate hydration pattern/solution that possibly occurs concomitantly with 
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other factors, such as self-medication (nonsteroidal anti-inflammatory drugs), 
infectious diseases (leptospirosis, hanta and dengue), environmental toxins 
(pesticides, heavy metals, and mycotoxin) and genetic susceptibility, since 
entire families are affected in some communities.[12, 13, 76, 101, 120, 121] However, 
substantial knowledge gaps and an absence of empirical evidence regarding 
the natural history of the disease over time and the cause(s) of CKDu remain.  
6.1.2 What the study adds 
Upon reviewing the literature, I concluded that the current knowledge is still 
limited, because studies have not identified the natural history and cause(s) of 
the disease. My systematic review showed that cross-sectional studies and 
occupational longitudinal studies have been affected by methodological 
problems, which include misclassification, reverse causation, a substantial of 
loss follow-up that affected the study power, and short follow-up periods (6 
months). These limitations may account for the inconclusive findings reported to 
date.[122] 
I was involved in establishing the first community-based cohort study dedicated 
to studying this issue. We attempted to recruit healthy young adults without 
CKD at baseline. We excluded 5% of men in the target age group who reported 
a diagnosis of kidney disease at baseline; this prevalence is approximately one 
hundred times higher than the CKD prevalence for this age group in the UK.[123] 
In total, 350 participants were followed for two years. The descriptive analysis of 
eGFR slopes over time is shown below (Figure 1). A normal distribution of 
slopes with a mean of approximately 0 is observed, but at the lower tail, a 
second cluster, or “bump”, in a subgroup with rapidly declining kidney function 
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at -20 mL/min/1.73 m2/year is observed. This second cluster almost certainly 
reflects individuals experiencing the early stages of MeN. 
 
 
 
 
 
 
 
 
 
 
 
 
 
This distribution of decreasing eGFR slopes over time explains why the 
multivariate analysis did not display a good fit: the slopes of eGFR over time 
were not normally distributed. In response to this limitation, the growth mixture 
model helped us to address the non-normal distribution of eGFR slopes. Three 
distinct groups of trajectories of decline in kidney function in males (normal 
kidney function, rapid decline in kidney function and establish renal dysfunction) 
and two in females (normal kidney function and rapid decline in kidney function) 
were identified. The male group with a rapid decline in kidney function was 
currently involved in agricultural work and outdoor work with a lack of shade 
availability during work breaks, but not any other particular risk factor. On the 
other hand, the few women that experienced a rapid decline in kidney function 
Figure 1: Distribution of eGFR trajectories over the two-
year follow-up in the study population 
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did not report historical or current outdoor or agricultural work or indeed any 
other risk factor.[124] Based on this finding, different aetiologies may affect 
different groups, e.g., infectious disease, phyto/mycotoxins or a poor water 
supply, etc., or alternatively, a causal exposure spread across the population 
but caused more cases of disease (through increased risk of exposure or 
exacerbating factors) in men. 
 
Importantly, we do not know whether only 10% of the population are affected, or 
whether other people with previously stable kidney function would enter this 
rapid decline group with a longer observation period.  
 
The meta-analysis identified significant positive correlations between the male 
sex, lowland altitude, water intake and a family history of CKD with CKDu.[122] 
Most of the epidemiological studies have consistently reported strong 
correlations between the male sex, lowland altitude and CKDu.[15, 18-20, 24, 30-32, 45, 
69, 106, 112, 116] Additionally, in our community-based cohort study, 10% of men 
experienced an unprecedented decline in kidney function over the 2-year follow-
up period compared to women (3.5%).[124] 
 
The association with high water intake is difficult to interpret because some 
studies have reported a positive correlation between low water-intake or high 
water-intake.[30, 69, 110] This association may be interpreted as refuting or 
supporting the hypothesis that dehydration is a risk factor for CKDu due to 
volume depletion during heavy physical work or it may simply reflect a reverse 
causation. In this context, reverse causation means that individuals with tubular 
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damage may not be able to concentrate urine, and therefore the high water-
intake may simply be a sign of early kidney damage.[122, 125] 
 
Although many cross-sectional studies and two systematic reviews have 
described a positive correlation between a family history of CKD and CKDu,[20, 
32, 69, 120, 122] this correlation was not reported in a recent community-based 
cohort study of young adults, where the family history of CKD does not appear 
to be a risk factor for a rapid decrease in eGFR, because the analysis was 
adjusted for age, education level and community.[124] It is often assumed that 
the clustering of a disease in families is due to genetic diseases, such as 
autosomal dominant polycystic kidney disease (ADPKD) and APOL1 gene 
variations.[126-129] However, diseases frequently cluster in families because 
families share disease risk factors. Thus, these genetic diseases may not 
explain the excess incidence of CKDu in a family cluster.  
 
Our community-based study identified a number of key risk factors that were 
positively correlated with a rapid decline in eGFR: outdoor work, agricultural 
work and a lack of shade availability during work breaks, reported at 
baseline.[124] These findings are consistent with the results reported by other 
epidemiological studies, which described that decreased kidney function was 
associated with agricultural work (sugarcane, banana, coffee, and subsistence 
farming).[15, 19-21, 24, 25, 31, 32]  
 
On the other hand, neither the systematic literature review nor our community-
based study found evidence of associations of a loss of renal function with heat 
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stress, agrochemical exposure, alcohol consumption, and non-steroidal anti-
inflammatory drug uses.[122, 124] All of the above risk factors have been proposed 
as the main causes for CKDu in many of the publications.[21-24, 26, 35, 39-41, 45, 46, 51, 
59-61, 69, 118, 130-133] However, the findings from the community-based cohort study, 
studies conducted at mill industries indicate that sugar cane work induces small 
increases in serum creatinine levels across the work day or across the harvest 
season, with authors suggesting that this change reflects an AKI secondary to 
heat stress.[22, 23, 43, 50] Along with kidney damage, these changes in the 
creatinine level may reflect a dehydration process that reduces the total water 
content (leading to all solutes being concentrated), increased creatinine 
production (as a consequence of high protein intake or muscle catabolism) or a 
physiological haemodynamic reduction in GFR. The observation that other 
kidney biomarkers did not show an increase in across shift testing and instead 
increased across seasons[12, 23, 35, 43, 125, 130, 134] suggests that cellular injury may 
not underlie the across shift changes in creatinine levels that occur throughout 
the work day. To date, robust evidence for a causal link between a permanent 
reduction in kidney function and heat stress is unavailable.[52] 
 
Furthermore, heat stress exposure has also been reported to reduce work 
capacity, decrease productivity and increase occupational accidents.[130, 135] 
Reduced productivity was reported among construction workers, miners, steel 
workers, etc. worldwide.[136-140] 
 
Our data suggests that self-report of exposure to agrochemicals was not a 
major risk factor for a decline in kidney function, and we have not found 
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evidence for a role for heavy metals in this disease.[141] These findings are 
consistent with the current body of evidence, which has not identified an 
association with reduced kidney function in Mesoamerica.[20, 21, 31, 62, 69, 110, 122] 
However, a study conducted among licensed pesticide applicators in the US 
has described a positive correlation with highest tertile of accumulated lifetime 
days of exposure to certain pesticides (atrazine, pendimethalin, metolachlor, 
alachlor, and paraquat), and ESRD after adjusting for age and state, but not 
social inequality or diabetes and smoking history and other risk factors, which 
may associated with the duration of work as a pesticide applicator.[63] Another 
study in a urban population within previous exposure to pesticides in Delhi, 
India, found that blood levels of organochlorine pesticide metabolites, such as 
gamma-hexachlorocyclohexane, p,p'-dichlorodiphenyltrichloroethane, and beta-
endosulfan, were associated with CKDu compared to healthy controls after 
adjusting for age, sex, BMI, and the total lipid profile. Again, the study did not 
adjust for inequalities that may drive exposure to pesticides and may explain the 
apparent association with CKDu.[142] Ultimately, better designed studies are 
needed, as the existing pesticide studies in the US, India and Sri Lanka are 
likely confounded by incomplete adjustment for socio-economic status, chronic 
disease, unhealthy behaviours and other risk factors.  
 
To aid in developing a clinical case definition, I assessed urinary neutrophil 
gelatinase-associated lipocalin (uNGAL) levels as an additional marker for the 
early identification of the rapid decline group. The prediction score from the 
model including only one eGFR measurement plus uNGAL levels showed an 
improved ability to detect individuals at risk of a rapid decline in kidney function 
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(AUC: 0.75) compared to the model without uNGAL levels (AUC: 0.51). 
However, when three eGFR measurements were added, the discrimination 
power was almost the same for the model with and without uNGAL levels (AUC: 
0.89 and AUC: 0.88 respectively). Thus, uNGAL levels do not help distinguish 
people at risk of decline in kidney function when serial measurements of eGFR 
(baseline, 6 and 12 months) are available. Hence, the latter strategy is 
preferable, rather than expending resources measuring uNGAL levels. In 
addition, for the identification of individuals with established renal dysfunction, a 
single measurement of eGFR or uNGAL levels was sufficient to identify 
membership of this subgroup, resulting in a well-fitting prediction model (AUC: 
0.98).  
 
In summary, this study has contributed to the knowledge base of CKDu by 
describing the natural history of a highly progressive form of kidney disease 
among men in northwest Nicaragua. It also highlights the urgency in 
establishing larger community-based cohort studies in different settings and 
intervention studies to examine the cause(s) and reduce the progression of 
CKDu. Cross-sectional studies are useful for understanding a static disease, but 
based on the data obtained from this cohort, the disease has a strong temporal 
element. Furthermore, due to their very nature, cross-sectional studies may not 
capture the group with a rapid decline in kidney function. Thus, this group will 
be misclassified in a cross-sectional study.  
 
Notably, occupational studies are affected by the healthy worker effect because 
mill industries only hire workers with "normal" kidney function (Scr <1.3 mg/dl) 
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for the harvest period. Hence, when workers have an abnormal Scr test, they 
lose their jobs and will move to other occupations, such as banana plantation 
work or subsistence agriculture. Hence, in the context of screening of workers 
for CKD, cross-sectional studies are unable to quantify the real magnitude of 
this disease and address reverse causation. 
 
6.2 Strengths and Weaknesses 
Individual strengths and limitations of each individual paper are described in 
Chapters 2 to 5. The overall strengths of this thesis are presented below. 
 
6.2.1 Strengths 
6.2.1.1 Study design 
This thesis is based on the first-ever community-based prospective cohort study 
among an apparently healthy young population that has assessed the natural 
history of and factors associated with decline in kidney function over a two-year 
follow-up period. A census of nine communities was performed in the population 
aged 18-30 years, and individuals without any pre-existing diagnosis of 
diabetes, glomerulonephritis or hypertension were invited to participate in the 
study. All apparently healthy men were recruited and a random sample of all 
eligible women was selected. 
 
6.2.1.2 Community engagement and study retention 
Community engagement with community leaders and participants was 
conducted before and during each study visit to achieve a participant retention 
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rate of 92% over the two-year follow-up period. Participants received their lab 
results within a week of the study visit to enhance community engagement.  
 
6.2.1.3 Single batch measurement and use of the eGFR trajectory as the 
outcome measure  
Analyses of serum creatinine and cystatin C levels were performed in a single 
batch at end of the study in Oxford, UK. Samples were analysed using quality 
control methods referenced to international standards. For example, the 
reference method for creatinine was isotope dilution mass-spectrometry (IDMS). 
The outcome of the follow-up was the eGFR trajectory calculated for each 
participant at each study visit from the growth mixture model for men and 
women. This strategy reduced misclassification and robustly identified 
individuals affected by MeN. 
 
6.2.2 Limitations 
This section presents the overall limitations of this thesis, along with the 
potential impact in terms of the lack of associations between certain exposures 
and decline in kidney function. 
 
6.2.2.1 Selection of the sample 
A community-based census was conducted among young adults aged 18-
30 years. The census identified 520 adults, which represent approximately 
10% of the total population, but if we compare these data with Nicaragua 
population pyramid, fewer young adults live in these villages than might be 
expected.[143] Several explanations for this discrepancy are possible. First, 
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as is typical for communities in many LMICs, young adults migrate to cities 
or other regions in pursuit of better job opportunities and quality of life.[144] 
Second, the overall population is small and many young adults have died 
due to CKDu. Finally, the national census data may be inaccurate, as they 
were last updated in 2005.[143] 
 
However, the entire healthy adult population in the target age range was 
recruited from the affected villages, and therefore associations with a 
decline in kidney function will be internally consistent, even if they are not 
necessarily generalizable to other regions. 
 
6.2.2.2 Exposure assessment 
6.2.2.2.1 Occupational exposure 
Work history was assessed by self-report at baseline. These data were 
collected by asking participants about their entire working life (e.g., 
What was your first occupation and for how many years have you been 
working in that occupation? How many hours per day did you work?). 
Although we used these detailed data collected at baseline, we were 
unable to establish a relationship between a previous occupation and a 
decrease in eGFR. This lack of an association may be because none 
exists, or because participants reported short-term exposure to multiple 
different occupations during their work life.  
In addition, a discrepancy was observed with the current occupation in 
the sensitivity analysis at the second visit compared with the baseline 
visit, but this can be explained by seasonal differences in exposures. As 
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seasons change, so do the risk factors. Trouble is that participants who 
lost kidney function between visit 1 and 2 may have changed behaviour 
as result of the kidney function test results, introducing reverse 
causality. Hence, results have to be interpreted with caution. 
6.2.2.2.2 Heat exposure 
6.2.2.2.2.1 Occupational heat exposure 
The evidence base addressing the health effects of occupational heat 
stress exposure has increased rapidly in recent years.[37-39, 47, 139, 145] A 
range of occupations (outdoor and indoor) are known to be associated 
with high levels of heat stress. Outdoor workers at risk of heat stress 
exposure include sugarcane workers (cane/seed cutters, seeders, 
pesticide irrigators, and water irrigators), miners, agricultural workers, 
construction workers, brick-makers, and military personnel.[22, 24, 26, 38-41, 
43, 45, 136, 146] Meanwhile, indoor workers exposed to heat stress include 
bakery workers, steel workers, factory workers, etc.[139, 140, 147]  
 
An objective assessment of heat stress is not a straight forward 
measurement. In Central America, heat exposure has been assessed 
by measuring the wet bulb globe temperature (WBGT) or using the heat 
index at the workplace.[40, 41, 147-150] Both measurements estimate the 
heat effects by quantifying the air temperature, humidity, wind speed 
and radiant heat.[40, 41, 147-150] For example, Crowe et al measured the 
heat stress exposure among manual cane cutters in Costa Rica by 
measuring the WBGT index and reported that cane cutters are working 
under excessive heat (WBGT>26ºC) for most of the work day.[40, 41] In El 
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Salvador, approximately 40% of coast cutters worked and 
approximately 10% cutters at a height of 400 mts worked at 
temperatures above 30°C (WBGT) during the 2014-2015 harvest.[130] 
 
In addition, a recent pilot study in a subgroup of cane cutters in El 
Salvador reported that their average heart rate (HR) was 54% of the 
maximum HR during one day of work, a higher frequency than soldiers 
participating in multi-day exercises. Their average core body 
temperature was 37.5ºC (95% CI: 37.7 to 37.4ºC) during a work day 
averaging a temperature of 38.4ºC (95% CI: 38.7 to 38.1ºC). For two of 
14 workers, this value exceeded 39.0ºC.[151] These severe changes in 
HR and body temperature suggest that cane workers are exposed to 
extreme heat stress due to high intensity muscular work in a hot and 
humid climatic environment. These changes activate heat loss 
mechanisms by sweating; however, sweating may impact the hydration 
status and potentially renal function. 
 
6.2.2.2.2.2 Self-reported heat stress 
A number of scientific tools to assess self-reported heat stress among 
outdoor workers have been developed. These tools include semi-
quantitative environmental parameters that have been validated using 
physiological measures.[152-154] For example, a study evaluating the heat 
stress perception index (perceived exertion and thermal sensation) 
among construction workers in India reported a good correlation between 
the self-reported index and environmental and physiological variables: 
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heart rate and WBGT.[155] Our findings, which were obtained using 
similar questions as in this index, suggested that self-reported heat 
exposure was not a risk factor for decline in kidney function. This 
discrepancy might be because the questions are not valid in the study 
population or because self-reported heat stress is not associated with a 
decline in kidney function.  
 
6.2.2.2.2.3 Symptoms related to heat 
According to recent reports, headache, weakness, dizziness, fever, 
nausea, tachycardia, fatigue, muscle cramps, and vomiting are 
associated with heat stress among sugarcane workers in Central 
America.[42] An assessment of these symptoms is based on protocols 
from the US Army, which has used these variables to assess the health 
impact of heat exhaustion among soldiers with high physical 
demands.[156] However, these symptoms are not specific to heat 
exhaustion because they are also induced by other diseases. Based on 
our data, heat-related symptoms captured by self-report are not 
associated with a decline in kidney function. Thus, a heat-related 
symptom questionnaire must be validated and/or the novel biomarkers 
that are able to capture physiological heat stress on an individual level 
must be identified.  
 
6.2.2.2.3 Agrochemicals 
Long- and short-term pesticide exposures were assessed with a 
questionnaire. However, farmers quite often did not remember the type of 
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pesticide, when or how much was applied. Similar to heat stress, validated 
questionnaires to quantify pesticide exposure at work are lacking. Despite 
this limitation, this thesis included the self-reported pesticide exposure as 
part of an exploratory analysis of CKDu, but no clear association was 
detected in this analysis. Future studies measuring pesticide metabolites in 
urine are needed to overcome problems of identification, dose and possible 
recall bias.  
 
6.2.2.3 Measurement error in eGFR 
A major challenge in epidemiological kidney research is errors in GFR 
estimates due to both biological variability (within-person and between-person) 
and measurement errors in serum creatinine levels. Intraindividual variations in 
eGFR have been observed and well-documented among healthy and unhealthy 
people because kidney function varies during the day. This variation is caused 
by multiple factors, such as strenuous exercise, high animal protein meal intake, 
and changes in plasma volume. Inter-individual variations in eGFR also arise 
from non-renal factors, e.g., sex, genetic background and muscle mass. All of 
these factors affect creatinine production and secretion.[6, 8] For example, a 
cane cutter performs strenuous physical effort and work under hot 
environmental conditions. He may have intermittent meat consumption (leading 
to variability in creatinine levels) and a higher muscle mass than others (or from 
the beginning to end of the harvest season), leading to a bias in eGFR 
estimates, and experience immediate changes in kidney function in response to 
loss of fluid, which may lead to transient increases in serum creatinine 
concentrations after work. Therefore, the small increases in serum creatinine 
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observed in sugarcane workers[22, 23, 26, 43, 45] may not reflect sources of variation 
other than short-term changes in kidney function and should be treated with 
caution. 
 
Cystatin C is less susceptible to changes in diet/muscle mass compared to 
creatinine and thus might be a more useful marker in short-term studies of 
eGFR in workers.[157, 158] The eGFR calculated based on both serum creatinine 
and cystatin c levels was measured repeatedly in the same person over time 
and assayed in a single batch at the end of the study to avoid some of these 
problems in our cohort. 
 
 The eGFR was estimated using a validated IDMS-traceable method and 
Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. 
However, the CKD-EPI formula has not been validated for Latin American or 
Mesoamerican populations to date.[2] This lack of validation may lead to 
misclassification error due to over or underestimation of the eGFR. However, 
because repeated measurements of serum creatinine and cystatin c levels were 
performed over time to estimate rate of decline in kidney function, the main 
comparison in our cohort was based on within-person changes. 
 
6.3 Clinical and public health implications 
CKDu is a silent disease in Mesoamerica that affects thousands of individuals 
among the economically active population, causes the premature death of 
young adults, and has socioeconomic implications for patients, families, 
communities, local industries and health services. 
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6.3.1 Individual/family implications 
The living conditions of the inhabitants of northwest Nicaragua are largely 
determined by the low education level and limited employment opportunities. 
Work poses significant health risks due to the psychosocial pressure and 
economic uncertainty generated by precarious employment. The working 
environment appears to be a major health hazard. The nature of the 
employment contracts (piecemeal work and temporary contracts) and the 
availability of labour (high rates of unemployment with a limited labour 
market providing few alternatives) make the workers opt for jobs where 
working conditions (high temperatures and heavy physical loads), in many 
cases, would be classed as inhumane in most countries around the world in 
contemporary times. 
 
The consequences of a CKDu diagnosis are also severe. For example, 
when a worker is diagnosed with CKDu, it has a tremendous impact on his 
and his family’s lives because he will experience decreased physical and 
mental function, leading to a worsening of the socioeconomic status, 
disability, family dysfunction, early retirement and premature death. 
Indirectly, this situation will promote school drop-out at an early age and 
increase child labour to help provide for the economic needs of the family, 
leading to a vicious cycle of health-related poverty and disease as result of 
poverty. A question for further research is whether children whose parent 
died early as a result of CKDu may be predisposed to developing CKDu as 
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result of child labour in precarious working conditions superimposed on 
physiological changes in kidney function that occur during puberty.[159]  
  
6.3.2 Medical implications 
CKDu has many implications for health providers and services. First, 
physicians from hotspot regions are diagnosing patients with CKDu late in 
the course of disease, e.g., at a time when they need renal replacement 
therapy (RRT).[160, 161] This late diagnosis is partially due to the lack of a CKD 
screening surveillance system at the primary, secondary or tertiary health 
care level. In addition, a lack of continuing professional education in the area 
of CKD has been noted, and practitioners are thus unaware of the current 
CKD definition, classification and requirements for RRT when patients have 
end-stage renal disease.[162] 
 
Second, a serious concern about the best treatment option to prevent the 
progression to end-stage renal disease (ERSD) has been reported. For 
example, based on a personal communication with Dr. Ramón García-
Trabanino1 from El Salvador, he has been conducting an empirical trial for 
more than 10 years that aims to slow the progression of CKDu. This protocol 
consists of bicarbonate and a low dose of allopurinol, and he has observed a 
deceleration of the progression to ERSD and an apparent alleviation of 
dysuria, which is very common in the early stages of CKDu. Any benefits for 
                                                             
1 Dr. Ramón García-Trabanino; Centro	 de	 Hemodiálisis,	 San	 Salvador,	 El	 Salvador;	 and	 Fondo	 Social	 de	Emergencia	para	la	Salud,	Centro	Monseñor	Oscar	Arnulfo	Romero,	Cantón	Tierra	Blanca,	El	Salvador.  
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patients receiving this type of treatment remain unknown, as there is no 
empirical evidence for this type of therapy. 
 
6.3.3 Government/healthcare system implications 
The healthcare system in Nicaragua is divided into the public health system 
(MINSA) and private health insurance. MINSA has the responsibility of 
providing access and medical care to the general population and informal 
workers (representing 80% of the working population that are not covered by 
the Nicaraguan Institute of Social Security (INSS)). INSS provides health 
care only to formally employed workers from large companies and the public 
sector, which represent between 20 to 22% of the working population.[163] 
 
MINSA has implemented substantial efforts to address the epidemic of 
CKDu in the region by opening eight small-medium-sized haemodialysis 
units (293 patients are receiving three sessions of haemodialysis per week) 
at MINSA and six small units for continuous ambulatory peritoneal dialysis in 
the hotspot area (227 patients are receiving this treatment option), but this 
effort is still insufficient given the rates of CKDu in northwest Nicaragua.[161, 
162] On the other hand, the INSS has admitted 3050 patients with CKD to the 
RRT programme from 2008-2017.[163] 
 
Despite these improvements, resources for the diagnosis and treatment 
CKD or CKDu are insufficient. For example, Nicaragua has the lowest 
number of nephrologists per million population (4.6 nephrologists per million 
population) in Central America, as well as a lack of nurses, 
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nephropathologists and other personnel trained in nephrology.[161] 
Remarkably, although the country has the highest mortality rate for CKDu in 
Mesoamerica, a substantial unmet need in the nephrology workforce 
persists.  
 
In addition, the infrastructure (nephrology centres with haemodialysis and 
peritoneal dialysis units) that manages patients with CKDu is insufficient and 
inadequate. In addition, problems with the supply of medications and 
laboratory capacity have been noted, indicating that patients with pre-end 
stage renal disease may not be diagnosed and complications are not 
treated. Indeed, the system is already so stretched and RRT is so expensive 
that the budget for additional preventative care measures is limited.[161, 162] 
Finally, a CKD surveillance system, health promotion and prevention 
strategies for CKDu at the community level are lacking. 
 
6.3.4 Industry implications  
The sugar mills started to implement a screening test prior to hiring workers 
in 2001. This programme allows the sugar mills to identify potential workers 
with normal and non-normal serum creatinine (Scr) levels. The Scr reference 
value that the industry established was initially ≤1.2 mg/dL of creatinine (this 
represents an eGFR of 87 mL/min/1.73 m2 for a 20-year-old man).[45] Due to 
the low number of people with a Scr level below the cut-off point, a new 
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reference value was defined last year (≤1.3 mg/dL)2 (representing an eGFR 
of 79 mL/min/1.73 m2 for a 20-year-old man).  
 
Based on the high number of sugarcane workers with a high creatinine level 
at the end of the harvest, the industries have decided to mechanize the 
harvest. Currently, mechanical harvesting has increased to 90% of the 
sugarcane crop in one of biggest mills in Nicaragua and approximately 70% 
in other sugar mills. Thus, sugarcane industries are hiring fewer manual 
workers (cane cutters) during the harvest.[164] However, the impact of 
increasing mechanisation on the availability of jobs is negative because the 
unemployment and poverty rates will increase in the rural areas due to the 
lack of other employment opportunities. 
 
In addition, sugarcane industries have taken action to reduce the heat stress 
and dehydration in sugarcane workers by implementing an intervention 
programme (Worker Health and Efficiency (WE) programme) during the 
harvest season in El Salvador and Nicaragua.[130] This intervention involves 
providing water, rest and shade together with an ergonomic machete and 
breathable clothing. In addition, health education and field monitoring occurs 
during the work day. This intervention programme has not been evaluated 
systematically nor implemented on a large-scale.[135, 164] Nevertheless, at 
least some parts of the sugar cane industry are aiming to improve working 
conditions and to mitigate possible effects of heat stress and heavy workload 
                                                             
2 Personal communication Denis Chavarria, Department of Occupational health and Safety, Ingenio San 
Antonio 
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on sugarcane cutters. However, to date, evidence for any possible protective 
effects on kidney function are limited.[135, 164] 
 
6.4 Academic research implications 
The cause of CKDu in Nicaragua may be so highly prevalent that it is difficult to 
detect using a relatively small and localized cohort study (i.e., all or almost all 
community members are exposed to the primary cause of disease). This 
hypothesis supports the idea of establishing a number of cohorts in different 
settings with a wider range of exposures. Therefore, a useful strategy would be 
to design and implement a generic cohort protocol for detecting progressive 
kidney disease in rural LMIC communities (for a draft see appendix C of this 
thesis). These studies might also provide the platform for targeted clinical trials 
of individuals with a progressive disease and contribute to better insights into 
the progression, causation, and methods to delay the transition to ESRD. 
 
6.5 Future research  
The work presented in this thesis does not provide evidence for subjective 
measurements of exposure to identify hypothesized risk factors. Based on 
these findings additional analyses have been done that are not part of this 
thesis. For example, we have measured heavy metals in drinking water and 
urine samples, pesticide metabolites and Ochratoxin A (OTA); a manuscript is 
currently in development based on these measurements.  
 
We were unable to identify the exposures associated with a decline in eGFR in 
this population during the first two years of follow-up. These could be due to a 
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relatively short follow-up period, the moderate sample size that was recruited in 
the first phase of this cohort or that the questionnaire did not capture the extent 
of exposure. That is why we decided to expand and extend our existing 
community-based longitudinal study from 2018 to 2020 and allow us to continue 
describing the natural history of and exploring the causality of this disease by 
using a more refined exposure matrix. In this second phase, we are following 
the existing 350 participants and recruiting to further 250. The participants will 
be visited once a year. 
 
A biobank has been developed at the Centre for Nephrology at University 
College London (UCL) for future analysis such as genetic, metabolomics and 
proteomics analysis, infectious diseases, etc.  
 
Future research efforts should address a number of questions:  
• The development and validation of a core questionnaire to capture 
occupational and non-occupational exposures, such as 
sociodemographic data, labour history, heat stress and hydration 
symptoms, medications, agrichemical exposure, etc., in different contexts 
and countries. 
• Validation of exposure biomarkers (e.g., for heat stress) or other tools 
(e.g., wearables) in different locations, both at the workplace and 
community levels. 
• Validation of equations used to calculate eGFR in local populations in 
various regions of the world. 
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• Studies of infectious disease incidence and associations with eGFR 
would help researchers explore the potential role of leptospirosis, dengue 
or chikungunya on the genesis of CKDu. 
• Studies that investigate family members and offspring of families affected 
and not affected by CKDu, including the role of child labour and careful 
phenotyping during adolescence to capture the timing/role of puberty.  
• Clinical trial protocols with promising treatments known to delay the loss 
of kidney function in other settings, e.g., oral bicarbonate and allopurinol 
therapy, or only allopurinol. This method requires the identification fast 
progressors to target interventions. 
• Larger community-based and occupational cohort studies at different 
locations and with different populations are needed, as described in the 
previous section. 
• More studies of social health determinants in varying contexts and 
countries are needed to identify how these factors interact with 
occupational behaviours. 
 
6.6 Personal learning  
My doctoral training has been a challenging journey in my life for many reasons. 
During the registration process, I realized that my English skills were insufficient 
to enrol in a PhD programme. Thus, I took an intensive English course to 
improve my writing and speaking to surmount this obstacle. 
 
I have gained new knowledge and skills in the use of the STATA software for 
first time, and during the course of my studies, I have learned to conduct 
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complex analyses of longitudinal data (multivariate analyses, growth mixture 
modelling analyses) using STATA software, which were totally new concepts to 
me. Thus, I have acquired new theoretical and practical knowledge of the 
challenges of handling longitudinal data, analysing time-dependent data and 
interpreting longitudinal data. 
 
I have developed the skills to conduct systematic reviews and meta-analyses 
for first time in my life by conducting a literature review on my research topic. 
These skills led me to sharpen my critical thinking by very carefully scrutinising 
scientific papers to identify the strengths and limitations (bias) of each study. 
 
I have gained knowledge on how to deal with and address reviewers’ comments 
during the peer review of my manuscripts.  
 
I have learned that although many research studies have been conducted in 
Mesoamerica, the current evidence on the cause(s) is similar compared to the 
state of knowledge ten years ago. Most of the occupational studies have been 
affected by insufficient or short-term follow-up data and by the healthy worker 
effect. This problem cannot be solved by conducting cross-sectional studies in 
the region. 
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6.7 Conclusions 
To my knowledge, this set of studies is the first body of work to describe the 
natural history of and factors associated with declining kidney function in a 
population at risk of developing CKDu in Nicaragua. The cohort study has 
shown the importance of repeated kidney function assessments to characterize 
the loss of kidney function in this high-risk population. This research was 
unfortunately unable to identify the cause(s) of this silent and mysterious 
disease. Thus, better exposure data are needed to obtain a better 
understanding of the aetiology. Therefore, this cohort study should be replicated 
in other communities using improved exposure assessment tools and across a 
wider range of populations as soon as possible. 
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Appendix B: Questionnaire 
 
RESEARCH 
BASELINE QUESTIONNAIRE (O_CKD_PC) 
Questionnaire code    ___________             Community code ___________  
Date __/__/___  Hour: _____  
Good morning, my name is ____________________________, I work at the National 
Autonomous University of Nicaragua, León. We are collaborating with London School of 
Hygiene and Tropical Medicine and University College London in a research Project of Chronic 
Kidney Disease in North-western Nicaragua. 
Before starting with the questionnaire, we would such as to ask you if are you agree to be part 
of this study? If you agree to enrol in this study, please sign the inform consent.  
 
Anthropometrics measurements 
Weight   .  kg      Height  .   meter 
Blood pressure:     /      mm/Hg (Systolic/diastolic)      
Samples (mark with a X if you took it)  Blood____   Urine:_____ Water_____ 
You will now be asked questions about different aspects related to your life and 
work. 
DEMOGRAPHICS  
1) Age      year old 2) Sex   1. Women       2. Men     
3) Last year of school approved   
(Write the last grade or year approved ) 
Total of schooling years: ______ 
   1.Primary              2. Secondary      
   3. Polytechnic        4. University 
 
SOCIOECONOMIC CONDITIONS  
4) How many of your family 
members living in the 
same house are currently 
working?    
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5) How much do you earn? 
C$           monthly,   
6) How much is your family 
income per month?  
(Sum the entry in Córdobas of ALL family 
members and remittances from abroad) 
        Salaries           = C$           
Family remittances = C$           
Other income = C$           
Total = C$           
7) How many people depend 
on that income?  Children    + Adults    Total=    
8) Where does the water 
you drink come from? 
(check more than one 
options)  
 
Well    River   Waterhole   Pipped water     
(if it is well, fill the additional questions) 
Perforated: 1. Yes   2. No   
Excavated: 1. Yes   2. No   
Protected:    1. Yes   2. No   
 
Agricultural plantations near the water source:  
1. Yes      (Consider crops close at 100 mts)                        
 2. No   
 
Type of crops: 
_____________________________________ 
 
9) Do you treat the 
drinking water? 
(Boiling, chlorine, etc.) 
1. Boiling    2. Chlorine    3. Home filters   
4. Other                5. None         
10) Where do you 
defecate (take a dump 
or have a dump?  1. Latrine      2. Toilet    3. Outdoor    
CURRENT OCCUPATION 
11) What is your current job? 
(Agriculture, sugarcane cutter, 
farmer, water applicator 
construction, etc) 
 
    
 
12) What task do you perform?  
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13) How many years have you been 
working in your current job?  
 
    years             months 
14) How many months in a year do 
you work?    months 
15) How many hours do you work 
daily?    hours 
16) Do you work on your own or for 
someone else? 1.On my own    
2.For someone   
17) Are you affiliated to the national 
social security system? 1. Yes   2.No   
18) What age do you had when you 
started working for the first time? _____ Year old 
 
OCCUPATIONS HISTORY 
 
19) Since you started working, what have you worked for?  
(not include those jobs with less than 3 months. Begin with the first and finish the last job (no include the current 
job). Include the unemployed period, please 
Age 
Occupation 
(example: agricultural 
worker, construction 
worker, Vendor, etc) 
What task did 
you perform? 
(Example: seeder, 
Construction, apply 
pesticide, etc.) 
How long 
have you 
been 
working 
(years) 
How 
many 
days did 
you work 
per 
week? 
How 
many 
hours 
did you 
work per 
day? 
      
      
    
   
      
 
   
   
HEAT EXPOSURES  
20) Your work is carried out mostly?: 
1. Indoors. 
2. Mostly indoors. 
3. Outdoors. 
4. Mostly outdoors 
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5. Other, specify: ________________ 
21) Do you work in a very hot working 
environment? 
1. Seldom or never. 
2. Few times. 
3. Regularly. 
4. Frequently. 
5. Always or almost always. 
22) If it is regularly or more often: ¿Do 
you have possibilities to cool off 
when you needed?  
1.No      
2. Yes   specify: ______________ 
23) Do you have breaks during your 
workday? 1. Yes   2.No   
24) What is the total duration of your 
breaks? (no including the lunch break, 
please)     minutes 
25) How often do you take breaks?    times 
26) How long do you take for your 
lunch time?     minutes 
27) Is there shade available during 
breaks in your workplace? 1.Yes   2.No   
28) Do you work at a high work speed? 
1. Yes   2.No   
29) If it is yes: Do you have possibility 
to slow down when needed?  1. Yes   2.No   
30) If it is not, explain why? __________________________________ 
31) How long time do you take to 
commute to your workplace?  
 
    minutes 
32) What is your means of 
transportation to the workplace? 
  1. Bike                         2. On foot 
  3. Open truck, sitting. 
  4. Open truck, standing 
  5. Bus.         6. Other: __________ 
33) When you have arrived at work, are 
you already get sweating heavily? 1.Yes   2.No   
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34) Do you push, throw or lift heavy 
objects or equipment? 1.Yes   2.No   
35) If handling heavy loads, what is the 
approximate weight(s) of the 
objects or equipment? 
  1. Up to 25 lbs  
  2. Between 26 y 50 lbs 
  3. Between 51 y 100 lbs 
  4. More than 100 lbs 
36) How much physical effort did you 
exert last week at work? 
  1. Slight effort  
  2. Moderate effort 
  3. Hard effort 
  4. Very hard effort 
  5. Did not work last week  
37) Have you worked on a cotton 
plantation? 1.Yes   2.No   (If it is no go to the question 38) 
If it is yes  
How long have you worked? What task did you perform?  
  
38) Do or have you worked in a banana 
plantation? 1.Yes   2.No   (if it is no go to question 39) 
If yes  
How long do or have you 
work(ed)? 
What task do or did 
you perform?  
  
39) Do you work or have you 
been working in a banana 
packaging plant? 1.Yes        Years 2.No  (If it is no go to 
question 40) 
40) If you are not currently 
working in sugarcane, 
have you worked in 
sugarcane? 
1.Yes   2.No   (if it is no go to question 41) 
If it is yes How many years have you worked? 
How many months 
have you worked in 
a year? 
What kind of 
tasks have you 
performed? 
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HYDRATATION HABITS (calculate in litres always, for  expample. 1 glass = 0.250 L 
Could you tell me about the drinks that you drank yesterday, if you drank and 
how much you drank since you woke up?  
On waking 
41) Did you drink 
something?  42) What did you drink? 
43) How much did 
you drink? 
1.Yes   2.No   
____________ __________ 
____________ __________ 
____________ __________ 
____________ Litres 
____________ Litres 
____________ Litres 
During the morning 
44) Did you drink 
something? 45)  What did you drink? 
46) How much did 
you drink? 
1.Yes   2.No   
____________ __________ 
____________ __________ 
____________ __________ 
____________ Litres 
____________ Litres 
____________ Litres 
At noon 
47) Did you drink 
something? 48)  What did you drink? 
49) How much did 
you drink? 
1.Yes   2.No   
____________ __________ 
____________ __________ 
____________ __________ 
____________ Litres 
____________ Litres 
____________ Litres 
Afternoon 
50) Did you drink 
something? 51) What did you drink? 
52) How much did 
you drink? 
1.Yes   2.No   ____________ __________ ____________ Litres 
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____________ __________ 
____________ __________ 
____________ Litres 
____________ Litres 
During dinner 
53) Did you drink 
something? 54) What did you drink? 
55) How much did 
you drink? 
1.Yes   2.No   
____________ __________ 
____________ __________ 
____________ __________ 
____________ Litres 
____________ Litres 
____________ Litres 
After dinner 
56) Did you drink 
something? 57) What did you drink? 
58) How much did 
you drink? 
1.Yes   2.No   
____________ __________ 
____________ __________ 
____________ __________ 
____________ Litres 
____________ Litres 
____________ Litres 
If the interviewee is a worker: 
59) Did you go to work yesterday?  
1.Yes   2.No   
60) If not, When you work do you drink more 
fluids?    
1. Much more   2. More   
3. The same   4. Less   
OTHER HABITS 
61) Do you currently smoke?   
1.Yes   2.No   (if it is no go to question 64) 
62) How many cigarette do you smoke 
a day?    cigarette/day 
63) What age did you start of smoking?       Years   
64) if you do not currently smoke: Did 
you smoke before? 1.Yes   2.No   (if it is no go to question 69) 
65) How many cigarettes did you 
smoke a day?    
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66) What age did you start of smoking 
and at what age did you stop of 
smoking? 
 
67) If you smoke intermittently, how 
many years have you smoked?  
  Age at start.   Age at finish 
______ Years smoked 
68) Do you currently drink alcohol?  
1.Yes   2.No   (if it is no go to question 70) 
69) What kind of alcohol do you drink?  (Include all kind alcohol beverage that the interviewee drinks) 
Type 
Quantity 
 
Frequency 
(Daily, Weekly, 
Monthly, etc.) 
Years of drinking this 
type of alcohol 
Beer          bottles 12 ounces (1 liter = 3 
bottles)     
Rum          Shoot  (1 small bottle = 13 shoots)     
Caballito/Perla/Ron 
plata        shoot  (1 small bottle = 13 shoots)     
Other   (Wine, 
vodka, tequila, etc.) 
   _______________     
70) If you do not drink now, did you 
drink before?     1.Yes      2.No (If it is no go to question 71) 
Type 
Quantity 
 
Frequency 
(daily, Weekly, 
Monthly, etc.) 
Years of drinking this 
type of alcohol 
Beer          bottles 12 ounces (1 liter = 3 bottles)     
Rum          Shoot  (1 small bottle = 13 shoots)     
Caballito/Perla/Ron 
plata/         shoot  (1 small bottle = 13 shoots)     
Other     
   (Wine, 
vodka, tequila, etc.) 
   _______________     
71) Do you take or have you taken illegal drugs?  
 
 1.Yes    2.No (If it is no, go to 
question 73) 
72)  
Answers the 
following 
questions  
1. Have you ever 
tried in your 
life? 
2. Have you 
smoked in the 
last year? 
3. Have you 
smoked in the 
last 30 days? 
1. Marijuana 1.Yes           2.No 1.Yes        2.No 1.Yes       2.No 
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2. Floripon (angel´s 
trumpet) 
1. Yes          2.No 1.Yes        2.No 1.Yes       2.No 
3. Mushrooms 1.Yes           2.No 1.Yes        2.No 1.Yes       2.No 
4. Cocaine 1.Yes           2.No 1.Yes        2.No 1.Yes       2.No 
5. Crack 1.Yes           2.No 1.Yes        2.No 1.Yes       2.No 
6. Glue 1.Yes           2.No 1.Yes        2.No 1.Yes       2.No 
7. Other drugs 
(specify): 1.Yes           2.No 1.Yes        2.No 1.Yes       2.No 
HEALTH AND WELFARE 
73) How do you consider your health status? 
       1. Very good       2.Good     3. Regular           4.Bad     5. Very bad 	
74) How often do you do exercise? 
  1. Never     2.Occasionally    3. 2 to 3 times x week     4. 4 to 5 times x week  
  5. Every days    
75) How often do you eat fruits, vegetables and salads? 
  1. Never     2.Occasionally    3. 2 to 3 times x week     4.  4 to 5 times x week  
  5. Every days    
76) ¿Do you eat your food without salt or with very Little salt? 
  1. Always     2. Most of the time    3.Few times    4.Never     5. Add salt to my food 
77) In the last 4 weeks have you felt? 
a) Back pain? 
     1. Cervical     2. Thoracic     3. Lumbosacral       4. Has not felt anything    
b) Arm or leg pain? 
     1. Shoulders     2.Elbows     3. Wrists    4. Hands    5. Knee     6.Ankles     7. Feet 
  8. Other  
78) In the last 12 months of work, have you 
suffered any injuries (injury, fracture, etc) due 
to an accident at work? 
  1. Yes     2.No   ¿Specify? 
_______________ 
Nephrotoxic medications (show the catalogue) 
79) Have you taken any of these pain 
medications that you see in the 
catalogue?   1.Yes       2.No      
80) Ibuprofen, Diclofenac,   0. Never 
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  1.Only occasionally 
  2. Regularly or intermittently  
    1.For 1 month or more (___months) 
    2.Less than a month (___weeks) 
  3.Daily 
   1.For a week or more (___week) 
   2.Less than a week (___days) 
81) Aspirin 
 0. Never 
  1.Only occasionally 
  2. Regularly or intermittently  
    1.For 1 month or more (___months) 
    2.Less than a month (___weeks) 
  3.Daily 
   1.For a week or more (___week)             
 2.Less than a week (___days) 
82) Paracetamol (acetaminofen) 
 0. Never 
  1.Only occasionally 
  2. Regularly or intermittently  
    1.For 1 month or more (___months) 
    2.Less than a month (___weeks) 
  3.Daily 
   1.For a week or more (___week) 
   2.Less than a week (___days) 
83) Could you tell me where was the pain? ________________ 
84) Have you received antibiotics for 
injection more than a week?  
Show catalogue (gentamicin, amikacin) 
 0.Never 
  1.Only occasionally  
  2. Regularly or intermittently 
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  3.Daily 
85) Could you tell me for what kind of 
infection? ________________ 
86) Do you take or have you taken 
Furosemide, phenazopyridine? 
Show catalogue 
 0.Never 
  1.Only occasionally  
  2. Regularly or intermittently 
  3.Daily 
87) Do you drink a medication for high 
blood pressure?  1.Yes      2.No      
FAMILY BACKGROUND  
88) Has a family 
member been 
diagnosed with 
CKD (Currently or 
before) 
 
1. Father _____ 
2. Mother ____ 
3. Brothers (# ____) 
4. Sisters (# ____) 
5. Cousins (# ____) 
6. Nephews (# ___) 
7. Nieces (# ____) 
8. Uncles  (#_____) 
9. None 
89) Has he worked in 
agriculture?    
 1.Yes        2.No 
a) Father _____ 
b) Mother ____ 
c) Brothers (# ____) 
d) Sisters (# ____) 
e) Cousins (# ____) 
f) Nephews (# ____) 
g) Nieces (# ____) 
h) Uncles (#_____) 
 
   
90) Has he worked in 
sugarcane?  
 1.Yes        2.No 
 
a) Father _____ 
b) Mother ____ 
c) Brothers (# ____) 
d) Sisters (# ____) 
e) Cousins (# ____) 
f) Nephews (# ____) 
g) Nieces (# ____) 
h) Uncles (#_____) 
 
PERSONAL HEALTH HISTORY 
91) Have you been diagnosed 
with any of the following 
diseases: (confirmed 
a) High blood pressure: 1.Yes   2.No   
b) Diabetes:                   1.Yes   2.No   
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by a physician and under 
treatment)? 
 
c) Nephrolithiasis           1.Yes   2.No   
d) Arthritis         1.Yes   2.No   
e) Other         1.Yes   2.No  
  
Specify     
92) Have you been medically 
diagnosed with urinary 
tract infection?  1.Yes      2.No     (if it is no go to question 94) 
93) If it is yes did they 
laboratory test the urine?  1.Yes       2.No      
94) How many times have you 
had urinary tract infections 
in the last year?    
95) How long ago was the last 
time you had a urinary 
tract infection?    months 
96) Do you have a spouse or 
partner?  1.Yes       2.No      
97) If it is yes, do you or your 
partner intend to get 
pregnant?   1.Yes       2.No      
98) How long have you been 
trying to get got pregnant?    months 
99) How many children do you 
have? Still births      Abortions        
100) Did you or your wife get 
pregnant easily?  1.Yes      2.No      
101) How long ago was you 
got the last pregnancy?    months 
102) Have you used birth 
control?  1.Yes      2.No      
103) Have you been 
diagnosed with infertility?  1.Yes       2.No      
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104) Have you had premature 
birth?  1.Yes       2.No      
105) If it is yes, how 
premature were they?     weeks 
106) Have you had a child 
who was small at birth?  1.Yes      2.No      
HEAT STRESS AND DEHYDRATION SYMPTOMS 
107) Have you fainted or 
passed out due to heat?  1.Yes       2.No     (If it is yes, go to question 110) 
108) If it is yes, has it been on 
your job?  1.Yes      2.No      
109) If it is yes, what task 
were you doing? ______________________ 
110) Have you lost weight in 
the last 6 months?  1.Yes       2.No  (if it is yes, go to question 114)    
111) If it is yes, in what 
circumstance? 
1. Working, Specify_______________ 
2. Doing exercise or sport  
3. Other, 
specify______________________ 
 
112) How many pounds have 
you lost in the last 6 
months?     lbs 
113) What frame time have 
you lost that weight? 
1. ______ days 
2. ______ weeks 
3. ______months 
114) Could you tell me if you 
have seen the aristolochia 
plant or the flower that I 
show in the catalogue)? 
 1.Yes       2.No 
115) If it is yes, where have 
you seen it grow? ____________________ 
116) Does it grow in 
sugarcane fields?     1.Yes       2.No       9.Do not know      
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Have you experienced any of the following symptoms in the last 6 
months? 
Symptoms  How often (check with a circle) 
1) Extremely dry 
mouth 
 1.Yes 
 
Today?  Yes ___    No___ 
 
  2.No      
1. Almost every day or every day 
2. At least once a week 
3. Several times a month 
4. Once during these months 
2) Burning sensation 
while urinating or 
Chistata  
 1.Yes 
 
Today?  Yes ___    No___ 
 
  2.No      
1. Almost every day or every day 
2. At least once a week 
3. Several times a month 
4. Once during these months 
3) Very little urine  
 1.Yes 
 
Today?  Yes ___    No___ 
 
  2.No      
1. Almost every day or every day 
2. At least once a week 
3. Several times a month 
4. Once during these months 
 
4) Very dark urine 
 1.Yes 
 
Today?  Yes ___    No___ 
 
  2.No      
1. Almost every day or every day 
2. At least once a week 
3. Several times a month 
4. Once during these months 
5) Cramps 
 1.Yes 
 
Today?  Yes ___    No___ 
 
  2.No      
1. Almost every day or every day 
2. At least once a week 
3. Several times a month 
4. Once during these months 
6) Headache  
 1.Yes 
 
Today?  Yes __    No___ 
 
  2.No      
1. Almost every day or every day 
2. At least once a week 
3. Several times a month 
4. Once during these months 
7) Palpitations 
(feeling your heart 
is beating very 
fast) 
 1.Yes 
 
Today?  Yes ___    No___ 
 
  2.No      
1. Almost every day or every day 
2. At least once a week 
3. Several times a month 
4. Once during these months 
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Symptoms  How often (check with a circle) 
8) Fever 
 1.Yes 
 
Today?  Yes ___    No___ 
 
  2.No      
1. Almost every day or every day 
2. At least once a week 
3. Several times a month 
4. Once during these months 
9) Muscle weakness  
 1.Yes 
 
Today?  Yes ___    No___ 
 
  2.No      
1. Almost every day or every day 
2. At least once a week 
3. Several times a month 
4. Once during these months 
10) Inflammation of 
hands or feet 
 1.Yes 
 
Today?  Yes ___    No___ 
 
  2.No      
1. Almost every day or every day 
2. At least once a week 
3. Several times a month 
4. Once during these months 
11) Nausea 
 1.Yes 
 
Today?  Yes ___    No___ 
 
  2.No      
1. Almost every day or every day 
2. At least once a week 
3. Several times a month 
4. Once during these months 
12) Rapid breathing or 
difficulty breathing 
 1.Yes 
 
Today?  Yes ___    No___ 
 
  2.No      
1. Almost every day or every day 
2. At least once a week 
3. Several times a month 
4. Once during these months 
13) Dizziness 
 1.Yes 
 
Today?  Yes ___    No___ 
 
  2.No      
1. Almost every day or every day 
2. At least once a week 
3. Several times a month 
4. Once during these months 
14) Fainting, passing 
out 
 1.Yes 
 
Today?  Yes ___    No___ 
 
  2.No      
1. Almost every day or every day 
2. At least once a week 
3. Several times a month 
4. Once during these months 
15) Diarrhoea  1.Yes 
 
Today?  Yes ___    No___ 
1. Almost every day or every day 
2. At least once a week 
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Symptoms  How often (check with a circle) 
 
  2.No      
3. Several times a month 
4. Once during these months 
16) Vomiting 
 1.Yes 
 
Today?  Yes ___    No___ 
 
  2.No      
1. Almost every day or every day 
2. At least once a week 
3. Several times a month 
4. Once during these months 
17) Nose bleed 
 1.Yes 
 
Today?  Yes ___    No___ 
 
  2.No      
1. Almost every day or every day 
2. At least once a week 
3. Several times a month 
4. Once during these months 
18) Stomach ache 
 1.Yes 
 
Today?  Yes ___    No___ 
 
  2.No      
1. Almost every day or every day 
2. At least once a week 
3. Several times a month 
4. Once during these months 
19) Ear ache 
 1.Yes 
 
Today?  Yes ___    No___ 
 
  2.No      
1. Almost every day or every day 
2. At least once a week 
3. Several times a month 
4. Once during these months 
20. Extremely tired 
(much more than 
normal tiredness) 
 1.Yes 
 
Today?  Yes ___    No___ 
 
  2.No      
1. Almost every day or every day 
2. At least once a week 
3. Several times a month 
4. Once during these months 
21. Confusion    
 1.Yes 
 
Today?  Yes ___    No___ 
 
  2.No      
1. Almost every day or every day 
2. At least once a week 
3. Several times a month 
4. Once during these months 
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MATRIX FOR LIQUID CONSUMPTION 
USUAL 24 HOURS LIQUID INTAKE 
Liquids 
consumed 
Sugar 
added 
At home 
before 
work Litres 
or CC  
Litres or CC brought 
from home to work 
and consumed 
Litres or CC obtained or 
supplied at work 
Litters or 
CC 
ingested 
after work 
Observations  
brought Consumed Obtained/supplied Consumed 
Water         
Natural fruit 
drinks  
None 
Little 
A lot 
       
Sodas         
Energy drinks         
Isotonic drink 
or bolis 
        
Coffee/ta None 
Little 
A lot 
       
Milk None 
Little 
A lot 
       
Other liquids:  
Soup 
 
 
        
Thank you!
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Research paper cover sheet  
 
RESEARCH PAPER COVER SHEET 
PLEASE NOTE THAT A COVER SHEET MUST BE COMPLETED FOR EACH RESEARCH 
PAPER INCLUDED IN A THESIS. 
 
SECTION A – Student Details 
Student  Marvin Gonzalez-Quiroz  
Principal Supervisor  Dorothea Nitsch  
Thesis Title Occupational kidney disease among young populations in northwest Nicaragua     
 
If the Research Paper has previously been published please complete Section B, if not 
please move to Section C 
 
SECTION B – Paper already published 
Where was the work published?         
When was the work published?         
If the work was published prior 
to registration for your research 
degree, give a brief rationale for 
its inclusion 
      
Have you retained the copyright 
for the work?* 
Choose an 
item. 
Was the work 
subject to academic 
peer review? 
Choose an 
item. 
 
*If yes, please attach evidence of retention. If no, or if the work is being included in its published 
format, please attach evidence of permission from the copyright holder (publisher or other 
author) to include this work. 
 
SECTION C – Prepared for publication, but not to date published 
Where is the work intended to 
be published?  British Medical Journal (BMJ Open)  
Please list the paper’s authors 
in the intended authorship 
order: 
Marvin Gonzalez-Quiroz, Dorothea Nitsch, Sophie 
Hamilton, Cristina O´Callaghan-Gordo, Ben Caplin, Neil 
Pearce, on behalf of the DEGREE Study Steering 
Committee   
 218 
Stage of publication Not yet submitted 
 
SECTION D – Multi-authored work 
 
For multi-authored work, give full 
details of your role in the research 
included in the paper and in the 
preparation of the paper. (Attach a 
further sheet if necessary) 
I developed this generic protocol based on the 
Nicaragua community-based cohort study with 
advice and supervision from Dorothea Nitsch, Ben 
Caplin and Neil Pearce. Sophie Hamilton and 
O´Callaghan-Gordo provided me support to 
develop the environmental section of baseline and 
follow-up questionnaire. The DEGREE study 
Steering Committee has reviewed the manuscript 
and gave me recommendations to improve it.  
 
After dealing with a political issue with the 
DEGREE study Steering Committee. I will send it 
to BMJ.  
 
Student Signature:      Date:  October 7/2018  
 
  
 
Supervisor Signature:  Date:  October 7/2018  
 
Evidence of copyright retention  
British Medical Journal is an Open Access journal.  
 
 
 
 
 
 
 
 
 
 
 219 
 
Rationale and community-based prospective cohort protocol for the 
Disadvantaged Populations at Risk of Decline in eGFR (CO-DEGREE) 
 
Marvin Gonzalez-Quiroz, Dorothea Nitsch, Sophie Hamilton, Cristina 
O´Callaghan-Gordo, Ben Caplin, Neil Pearce, on behalf of the DEGREE Study 
Steering Committee 
 
Marvin González-Quiroz, MSc. Research Centre on Health, Work and 
Environment (CISTA), National Autonomous University of Nicaragua at León 
(UNAN-León), León, Nicaragua. Department of Non-Communicable Disease 
Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. 
Centre for Nephrology, University College London, London, UK. 
Marvin.Gonzalez@lshtm.ac.uk or marvin99_00@yahoo.es 
Dorothea Nitsch, Dr.med. Department of Non-Communicable Disease 
Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. 
Dorothea.Nitsch@lshtm.ac.uk  
Sophie Hamilton, MSc. School of Public Health, Faculty of Medicine at 
Imperial College London, London, UK. s.hamilton16@ic.ac.uk 
Cristina O´Callaghan-Gordo, PhD. Barcelona Institute for Global Health, 
Barcelona, Spain. cristina.ocallaghan@isglobal.org 
Ben Caplin*, PhD. Centre for Nephrology, University College London Medical 
School, London, UK. b.caplin@ucl.ac.uk  
 220 
Neil Pearce*, PhD. Department of Medical Statistics and Non-Communicable 
Disease Epidemiology, London School of Hygiene and Tropical Medicine, 
London, UK, Centre for Global NCDs, London School of Hygiene and Tropical 
Medicine, London, UK. Neil.Pearce@lshtm.ac.uk  
on behalf of the DEGREE Study Steering Committee 
 
*Equal contribution 
Corresponding author: Marvin Gonzalez-Quiroz 
Research Centre on Health, Work and Environment (CISTA), National 
Autonomous University of Nicaragua at León (UNAN-León), León, Nicaragua  
Address: Campus Médico, Facultad de Ciencias Médica, edificio C, León, 
Nicaragua  
Tel: +505 89368376 
Email: Marvin.Gonzalez@lshtm.ac.uk or marvin99_00@yahoo.es 
 
This original article has been seen and approved by all authors listed above 
and is not under consideration for publication elsewhere. 
 
Word count for Abstract: 315 
Word count for text: 4159 
Total word count including tables and figures: 3 
 
 221 
Abstract 
Introduction 
A recently recognised form of chronic kidney disease of unknown origin (CKDu) 
is afflicting communities in rural areas in several regions of the world. 
Prevalence studies are currently being conducted in a number of countries, 
using a standardised protocol, to estimate the distribution of glomerular filtration 
rate (GFR), and thus to identify communities where there is a high prevalence 
of reduced GFR. In many of these communities, cohort studies are now being 
planned to investigate the natural history of, and risk factors for, decline in 
kidney function over time. In this paper, we propose a standardised minimum 
protocol for such cohort studies in high risk communities. 
 
Methods and analysis 
This generic cohort protocol provides the information to establish a prospective 
community-based cohort study in low-income settings with high prevalence of 
CKDu. This involves a baseline survey that included key elements from the 
DEGREE survey methodology (e.g. using the previously published DEGREE 
methodology) of a population-representative sample, and subsequent follow-up 
visits in young adults (without known kidney disease (eGFR<60 mL/min/1.73 
m2) at baseline) over several years. Each visit involves a core questionnaire, 
and collection and storage of biological samples. Local capacity to measure 
serum creatinine (Scr) will be required so that immediate feedback on kidney 
function can be provided to participants. At the follow-up assessments repeat 
renal biomarkers should be measured in a central laboratory, using traceable to 
isotope dilution mass spectrometry (IDMS) traceable quality control to quantify 
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the main outcome of decline in kidney function over-time. A secondary aim of 
these studies is to investigate the possible risk factors for eGFR decline by 
quantifying exposures to potential causes of CKDu (by questionnaire or 
biosampling). 
 
Ethics and dissemination 
Ethical approval will be obtained by local researchers, and participants will 
provide informed consent before the study commences. All participants will 
receive feedback and advice on their laboratory results, and referral to a local 
health system where appropriate.  
 
Trial registration number: Not applicable 
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Strengths and limitations of this study 
• We propose a prospective community-based generic cohort protocol for 
communities affected by CKDu in which the sampling frame consists of 
the entire at-risk population. 
• Serial eGFR measurements in an apparently healthy population will allow 
the description of the natural history of disease and reduce problems 
associated with recall bias and reverse causation when assessing 
potential risk factors.  
• Samples will be analysed in a single batch at local or international level 
at the end of the study to minimize time-dependent measurement errors. 
• A biobank is expected to be created in each centre to store biological 
samples for future analyses 
• The use of a standardised protocol will allow for regional and 
international comparisons 
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Introduction  
A recently recognised form of chronic kidney disease of unknown origin (CKDu) 
is afflicting rural communities in several regions of the world.(1-10) Several 
definitions for CKDu exist;  the criteria typically include demonstration of renal 
damage using biomarkers in the absence of diabetes, severe hypertension or 
evidence of alternative renal diagnoses.(11-14) This disease has caused 
thousands of deaths and reduced the life expectancy among young adults in 
Mesoamerica, South Asia, and possibly in other tropical/subtropical regions of 
the world.(7, 15-19) The cause(s) of CKDu are not yet established, but proposed 
causes include recurrent dehydration from heat stress, pesticides, infections, 
and water contamination/heavy metals.(1, 20-22) 
 
Although a broad range of cross-sectional studies of the prevalence of CKDu 
have been conducted in Mesoamerica, South Asia, and other regions of the 
world,(1-7, 9, 17) these have generally not use standardised methodology, and 
therefore do not allow for valid international comparisons. A recently published 
standardised protocol (the Disadvantaged Populations eGFR Epidemiology 
Study (DEGREE) protocol) for estimating the population distribution of 
glomerular filtration rate (eGFR), has addressed this concern, and its use will 
help to identify communities where there is a high prevalence of reduced eGFR. 
The DEGREE protocol makes it possible to undertake comparisons 
internationally, by mandating a population-representative sample and 
standardised collection of information on sociodemographic factors, 
occupational and environmental exposures, body composition and kidney 
function.(23) To date, studies using the DEGREE methodology have been 
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conducted in four countries (Peru, Sri Lanka, India, Malawi), with a number of 
further projects in preparation or in progress.(17)  
 
A recent meta-analysis highlighted the lack of robust studies that have 
considered the natural history of CKDu.(24)  We have therefore established a 
community-based cohort study to investigate the natural history of, and risk 
factors for, decline in kidney function over time.(25) Based on our experience(25, 
26) we propose a generic cohort protocol to estimate the decline in kidney 
function over time and generate evidence of factors for loss of eGFR  among at-
risk populations. Our focus is on conducting such cohort studies in communities 
which are at high risk for CKDu that have been classified previously by cross-
sectional study in high, medium or low prevalence based on a single or two 
GFR measurement. In general, such cohort studies would follow on from a 
cross-sectional survey using the DEGREE protocol, and hence we will use the 
term ‘CO-DEGREE’ (cohorts based on the DEGREE study) for such studies. In 
some situations, a DEGREE survey may form the ‘baseline’, with a subgroup of 
DEGREE survey participants then being selected for follow-up based on a 
single measurement of eGFR >60 mL/min/1.73 m2 and without clinical 
diagnosis or history of hypertension, diabetes mellitus or obesity. However, the 
standardised protocol we propose here can also be used as a ‘stand-alone’ 
study design, without requiring that a DEGREE survey is conducted first.  
 
We are already conducting such a cohort study in Nicaragua,(25, 26) and have 
had many challenges to address, including: (i) community engagement, 
awareness of conditions, political unrest and ethics; (ii) follow-up over time 
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(frequency and minimising loss to follow-up); (iii) fieldwork and laboratory 
standards to ensure decline is detected; and (iv) regular feedback information 
on study progress. We will draw on our experience in Nicaragua in presenting 
both the generic CO-DEGREE protocol, as well as observations on the practical 
issues involved in conducting such studies in a particular community.  
 
Objectives 
Studies using this generic cohort protocol, and contributing to the wider 
DEGREE collaboration, will aim to: 
1. investigate the natural history of kidney function decline over time among 
populations at risk of CKDu  
2. identify risk factors for kidney function decline in these populations, to 
better inform further in-depth aetiological studies and direct future 
preventative strategies 
3. compare the natural history, and risk factors for kidney function decline, 
in different communities and regions at risk of CKDu 
4. establish a framework for international collaboration and promote a 
network for future work on the causality of CKDu 
 
Rationale for a community cohort study of decline in eGFR 
A representative sample of those at-risk 
Community-based cohort studies have several advantages:(27) Firstly this type 
of study allows the recruitment of a representative sample of the at-risk 
population, e.g. it will include workers from a variety of occupations (including 
not economically active) at the community level. Assuming that the study 
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sample is randomly selected from the entire at-risk population, and there are no 
substantial problems with non-response, these studies are unlikely to be 
affected by significant selection bias. This is in contrast to occupationally-based 
studies where the healthy worker effect can be a major problem, particularly if 
workers are screened for kidney disease prior to starting employment because 
it unlikely to observe the effect in this group due to a small number/null of cases 
during the study period.(28) One general disadvantage of community-based 
studies is that this approach typically requires large sample sizes and long-term 
follow-up if disease is not highly prevalent. However, the focus of CO-DEGREE 
is on conducting studies in communities with a high prevalence of CKDu (see 
below).(26, 27)  
 
Handling reverse causation and recall bias 
Reverse causality in cross-sectional studies arises when participants at risk 
modify their lifestyle, behavioural or working exposures due to the outcome of 
interest (e.g. renal dysfunction). For example, someone with impaired kidney 
function may leave employment (or may be screened and then denied 
continued employment), in which case their exposures (e.g. to heat stress or 
pesticides) will change. This problem can be avoided, or minimised, in a cohort 
study by excluding people with pre-existing disease, and then following the 
remaining ‘healthy’ participants over time. Similarly, cross-sectional studies may 
be prone to recall bias regarding previous exposures. 
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Measuring kidney function  
Quantification of kidney function is most easily undertaken by determining the 
serum creatinine (Scr) concentration, which is relatively easy and cheap to 
measure, and then calculating the eGFR.  A case of CKDu is typically defined 
by an eGFR <60 mL/min/1.73 m2 (sustained for at least 3 months where 
chronicity is confirmed) in the absence of known causes of kidney disease. 
However, this dichotomous definition of CKDu has weaknesses in studies 
exploring the causation of CKDu, as it is well established that substantial 
damage may have already occurred at the histological level before serum 
biomarkers of renal dysfunction become definitively abnormal (and other 
markers such as proteinuria are often absent in this disease). Furthermore, Scr 
levels are modified by multiple non-renal factors such as: high animal protein-
intake, strenuous exercise, changes in plasma volume, body mass index (BMI), 
sex, age, ethnicity, and some drugs;(29) thus, cross-sectional studies examining 
associations with reduced eGFR based on a single Scr measurement may be 
prone to a significant degree of misclassification. In addition, the CKD-EPI or 
MDRD equation used to calculate eGFR from serum creatinine,(29) have not 
been validated in many populations reported to be suffering CKDu,(30) 
potentially further increasing misclassification bias in cross-sectional studies. 
 
Alternative approaches based on serial eGFR measurements in the same 
person over time render between-person variation less problematic. If estimated 
across a period of time using multiple measures, this will also reduce the 
influence of the within-person factors that are not directly related to kidney 
damage. The successful measurements of eGFR over time can admit a dropout 
 229 
less than 30% of the original sample size. In summary, an approach utilising 
serial eGFR measures substantially increases the potential utility to identify 
risk/causal factors for CKDu as well as allowing the description of the natural 
history of disease. 
 
Core protocol 
Study design 
This is a prospective cohort study protocol for studying decline in kidney 
function over time in populations with high reported prevalence of CKDu, 
primarily in low- and middle- income countries (LMICs). We consider the 
following study design issues: (i) population sampling strategy, and follow-up 
interval (ii) questionnaire development and delivery, (iii) clinical measurements 
and biosampling, and (iv) data management and reporting.(26) (See figure 1) In 
addition, we discuss: (a) sample size and follow-up duration; and (b) ethical 
considerations. 
 
Population, sampling strategy and follow-up interval 
In Mesoamerica, CKDu typically affects young men on the Pacific Coast. This 
population is dying often younger or in their 40s from end stage renal 
disease.(15, 31) The disease appears to occur at a later age in South Asia, with 
few cases occurring in men in their 20s.(7, 32) Nevertheless, one might expect 
preliminary changes in GFR to occur early in adulthood. In general, the study 
population should include participants who are old enough to experience an 
identifiable decline in kidney function, but not older age-groups (> 50 year-old) 
where the prevalence of CKD is already high in almost all populations globally 
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(e.g. greater than 10%). Thus, inclusion criteria should be tailored to the local 
disease profile, but the default approach should be to recruit participants aged 
18-40 years-old (though 18-30 might be more appropriate in Central America, 
and 18-50 may be more appropriate in areas such as Sri Lanka where age of 
onset appears older). A community-census should be conducted to identify all 
potential participants in the appropriate age range and either the entire 
population recruited, or a random sample selected. In either case, response 
rates by age and sex, should be reported.  
 
The focus is on studying participants who are ‘at risk’ of CKDu, i.e. they do not 
already have CKD or factors which would exclude a CKDu diagnosis (e.g. 
diabetes mellitus, hypertension) and pregnancy. Thus, the sample size 
estimates (see below) are based on following a cohort in which those where a 
pre-existing diagnosis of CKD, diabetes or hypertension have been excluded.(26) 
For practical, ethical or scientific reasons, one may wish to study an entire 
community (including those with pre-existing clinical diagnosis of CKD, diabetes 
mellitus (fasting serum glucose: >105 mg/dL) and hypertension (blood pressure 
>140/90 mmHg)), but in that case it is important to ensure that there are 
sufficient ‘disease free’ participants to meet the sample size requirements.  
Although the disease is generally more common in men, women with CKDu are 
of strong scientific interest in that they may suggest alternative risk factors, or 
help to rule out some that have been previously proposed. Hence recruitment 
should in general involve equal numbers of males and females.  
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The baseline study visit will require the administration of the core-questionnaire, 
clinical measurements and biological samples.  Subsequent to the baseline 
visit, follow-up visits should be conducted at least annually for a minimum 
follow-up of two-years to evaluate the study outcome and keep close contact 
with the participants and update their contact information. This will help 
minimize the loss to follow-up at each study point. Substantial seasonal 
variation in eGFR has been reported in a number of settings (both CKDu related 
and unrelated). Therefore, the conduct of additional study visits at a 6-monthly 
interval (at beginning and end of summer season) might be useful in explaining 
within-person eGFR variation as well as providing important information for the 
wider population on the significance of kidney function testing at different time 
point in the year (perhaps for a subset of participants or a proportion of the 
follow-up period). 
 
Questionnaires 
The purpose of the baseline core-questionnaire is to obtain a minimum dataset 
to explore associations with decline kidney function and make comparisons 
within and between persons. The baseline core-questionnaire (supplementary 
file 1) is based on the questionnaire used in our study in Nicaragua, and has 
been further developed by combining questionnaires that have been used in 
DEGREE-related studies in a number of settings.  The baseline core-
questionnaire represents a minimum data set, and local research teams may 
decide to add data items of specific interest to the core dataset. The as well 
have the responsibility to translate, validate, and to make any local contextual 
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changes. Additional modules are under development by the DEGREE study 
collaboration (e.g. an environmental exposure questionnaire).  
 
Researchers will return annually for in-person follow-up visits. All participants 
have to respond a follow-up questionnaire (supplementary file 2) and update 
their contact information. 
 
Clinical measurements 
Blood pressure should be measured after 5 minutes rest in the sitting position 
using an automated sphygmomanometer and the average of three readings 
recorded. Subjects height and weight (in centimetres and kilograms) should be 
measured (without shoes) using a stadiometer and digital calibrated scales.  
 
Biosamples 
Blood and urine samples will be collected at each study visit and stored in the 
field into dry ice or liquid nitrogen after collection or in a worse scenario store in 
coolers with icebox (4ºC) no more than 3 hours.  
Dipstick urinalysis should be performed by using electronic readers (urine 
chemistry analyzer) where possible to use it or if not possible at least 10% of 
urine dipstick analysed by a lab technician should be re-analysed by other 
reader. The minimum of parameters that should be reported are: specific 
urinary gravity, pH, protein, blood, leucocytes, and glucose. 
Samples for serum analysis should be centrifuged at 3500 rpm for 10 minutes 
within 3 hours of collection, and subsequently separated into four aliquots of 1-2 
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mL each one and stored at -80ºC (or -20ºC if not possible). One aliquot should 
be used for contemporary local serum creatinine measurements e.g. by using 
the modified Jaffe assay (traceable to isotope dilution mass spectrometry 
[IDMS] reference standards if possible). At baseline and during each study visit 
a cross-checking of local lab quality control is highly recommended to ensure 
that Scr determinations are comparable. Also, lab results will guide clinical care 
for participants during the follow-up period. 
 
A further aliquot should be stored for batch measurement of serum creatinine at 
the end of follow-up using a method traceable to an IDMS reference material. 
The CO-DEGREE group suggest the storage of at least three 1-2mL aliquots of 
serum and a similar amount of urine in addition to those described above. 
Additional samples and analyses should be pursued depending on the priorities 
of the local research team. All samples for future analysis should be stored at -
20ºC or ideally at -80ºC in a local or international biobank. This biobank needs 
to secure an uninterruptible power supply to protect the samples because loss 
of electricity for even a few days will ruin the samples.  
 
Investigators should assess and obtain consent from participants for future use 
of samples for further analyses both locally and internationally (e.g. through the 
DEGREE collaboration) as well as ensure that storage capacity is available.  
 
Data management and reporting 
Questionnaires and samples will be labelled using a unique bar-code to keep 
the participants confidentiality. Electronic data capture systems such as Open 
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Data Kit Software(33) may be the most resource efficient method to capture 
questionnaire data but where hard-copies are used double data-entry should be 
undertaken to minimise the transcription errors. 
The CO-DEGREE protocols are openly available to interested research teams. 
Each centre will be owner of their data and expected to publish the results of 
their study independently. However, where a study is registered as part of the 
DEGREE collaboration the group will request a digital copy of anonymized 
individual-level data, with a guideline for basic contextual information of local 
setting and a description of the population characteristics should be elaborated, 
for the DEGREE data centre to conduct international comparisons.  
 
Sample size and follow-up duration 
The overall scale of the cohort will be largely dependent on the proportion of the 
‘healthy’ population which is expected to experience a ‘substantial’ decline in 
eGFR over time in the community as a result of CKDu. As discussed above, 
demonstrating that reduced renal function without diabetes, hypertension or 
known kidney diseases is prevalent on a cross-sectional basis is a necessary 
first step before pursuing this work. If for example this study protocol was to be 
conducted in a general population sample in Europe or the USA with similar 
exclusion criteria, then CKDu would be virtually non-existent, and there would 
also be very little or no decline of kidney function. In contrast, in our Nicaragua 
study of apparently healthy adults aged 18-30 years,(25, 26) there was a clearly 
distinct subgroup which experienced a marked decline in kidney function over 
time, whereas the eGFR in the other study participants was relatively stable. 
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Given this distribution of eGFR trajectories in the population we would expect 
the analysis to be conducted using a prospective case-control approach. 
 
Therefore, the sample size requirements to detect an association with an 
exposure at any given power will be determined by the following factors: 
1. Proportion of the population that experience ‘substantial’ decline  
In turn the power to detect ‘substantial’ decline will depend 
on: 
a) The rate of eGFR decline in those affected 
b) The duration of follow-up 
c) The number of eGFR measures 
2. Proportion of general population exposed to any exposure of interest 
3. Effect size of any exposure 
4. The study retention rate 
Taking a simplistic approach, the duration of the study should be designed so 
that those affected have sustained a clinically important loss of kidney function, 
e.g. in our Nicaragua study this was 30% over two-years.(34) Therefore, if CKDu 
in the study population is predicted, from a normal baseline, to lead to a loss of 
eGFR of a magnitude of 5% each year (~7mL/min/1.73 m2/year) the study 
duration should be 4 years. If alternatively, loss is predicted to 10% each year 
study duration could be as short as 2 years. Additional eGFR measures, over 
and above the suggested annual frequency will reduce error associated with 
determining trajectory (and might be performed for the reasons discussed 
above) but either way a minimum follow-up of 2 years is recommended. 
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After basing the study duration on the expected rate of eGFR decline among 
those affected, the sample size can then be calculated on the basis of the 
expected frequency of ‘substantial’ decline amongst the population and the 
effect size of any proposed exposure that it is desirable to detect. A number of 
scenarios are outlined in Table 2. A further (10-20%, depending on local 
circumstances) increase in target recruitment is advised to allow for loss to 
follow-up. 
 
Finally, these initial sample size estimates will need further adjustment for 
exclusions following the detection of previously unknown CKD (based on 
eGFR/albuminuria tests), or newly detected diabetes or hypertension at 
baseline (unless these data are available from a previously conducted cross-
sectional study). It is worth considering whether people who may have CKDu 
(eGFR <60 mL/min/1.73 m2) will be aware of it, as this will affect how many 
people need to be tested prior to recruitment into the cohort. If there is 
screening for kidney problems (as for example in Nicaraguan Sugarcane mills), 
then potential cohort participants may be aware of their kidney function status 
and can be excluded from the cohort prior to the baseline visit. This occurred for 
example for 5% of the target population in the community studied in Nicaragua. 
Nevertheless, there was an additional 10% who had undiagnosed impaired 
kidney function at baseline assessment based on their laboratory records, 
highlighting the importance of choosing an age-group where CKDu is not 
already highly prevalent so as to easily satisfy a key inclusion criterion (absence 
of CKD at baseline).  
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Ethics/regulatory issues and dissemination 
Local research teams will ensure these studies are conducted in accordance 
with the Declaration of Helsinki Principles and be responsible for assuring that 
the work is approved by the local institutional review board (IRBs). Written 
informed consent will be obtained from all participants before taking part in the 
study. Information should be transparent in terms of using the data and stored 
biosamples stored for future research. A key aspect of the ethical review of any 
protocol is ensuring the adequate provision of feedback and advice to 
participants when abnormal results become available. Furthermore, 
mechanisms will need to be developed in partnership with local health 
providers/healthcare systems to handle participants needing referral for medical 
care.  Findings from these studies should be disseminated widely by publication 
in peer-reviewed journals and presentations/representations to relevant local 
stake holders. 
 
Experience with the CO-DEGREE protocol in Nicaragua 
The protocol presented here is, by necessity, very generic. The approaches and 
challenges of implementing the protocol will vary widely in different communities 
and regions of the world. However, since we have already implemented this 
protocol in a study in Nicaragua,(25, 26) we will make some observations on the 
practicalities, and challenges, or implementing the protocol in this context. 
 
The Nicaragua study involved community-based follow-up in Leon and 
Chinandega departments. (26)  A number of strategies were used to maximise 
response and retention rates. As the workday starts very early in the morning 
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and finishes late in the afternoon attempts were made to conduct data collection 
during economically less active (e.g. each side of the main harvest) periods of 
the year, so as to still capture participants who were employed at the time. 
Additionally, participants receive their kidney test results within a fortnight of the 
study visits, and receive reimbursement of expenses and any lost income they 
have incurred to attend the study visit. Although study visits have been 
timetabled to occur outside of the harvest season, employees still express the 
concern that their employment opportunities might be affected by taking part in 
the study. In an attempt to mitigate against these types of consequences, the 
study team have corresponded with local employers explaining the content and 
extent of this study in order to reduce any concerns about workers’ participation. 
In addition, the study team takes particular precautions to maintain participant’s 
confidentiality during the study and beyond. 
 
Conducting a follow up study in a rural area remains a major challenge. 
Alongside the logistical challenges of reaching geographically isolated 
neighbourhoods along poor quality roads, a significant obstacle has been 
internal and external migration due to lack of employment source or social 
unrest. Rural communities have a tradition of working with seasonal crops and 
sugarcane workers often leave their communities at the end of each harvest 
season, to go abroad or to other regions within the country in search of 
temporary employment. At the end of each harvest, up to 30% of the study 
population left their communities in search of alternative employment during the 
non-harvest period in our study. Despite these problems our team achieved 
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92% for follow-up at two years.(25, 26) but this has required the investment of 
significant time and resources.  
 
Finally, continuing community engagement and the maintenance of good 
relationships between researchers, community leaders, participants and 
communication with local health care system have been key. E.g., It is very 
important to develop a reference flowchart and communication with local health 
posts/primary hospital or hospital for persons with health problems detected 
during the study. 
Discussion 
The CO-DEGREE protocol was developed in response to the highly prevalent 
form of CKD of unknown cause that is affecting Mesoamerica and other 
countries around the globe. To date, the existing epidemiological studies of 
CKDu have provided an incomplete understanding of the natural history of and 
risk factors for disease. This CO-DEGREE protocol aims to provide a 
framework to address this. 
 
This CO-DEGREE protocol is designed to capture the entire at-risk population 
by aiming to recruit men and women, and those that work across a variety of 
different occupations. The main outcome measure of within-person loss of 
eGFR over time means it is not only possible to describe the natural history of 
disease but also to capture the earliest disease stages of disease, making 
associations with possible exposures less prone to reverse causation and recall 
bias. 
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We do not underestimate the challenges posed by the lack of standardized 
exposure questionnaires in this area. This protocol uses a questionnaire that 
combines questions from a number of sites (Nicaragua, and various DEGREE 
sites) aimed at capturing a variety of exposures, including sociodemographic 
data, occupational and environmental exposures, lifestyle factors, heat-related 
symptoms, etc. both in agricultural and non-agricultural settings. However, in 
the absence of globally generalisable instruments, short or long-term 
environmental measurements and/or novel biomarkers that capture exposure to 
heat, agrichemicals, and/or infection in either the community or workplace are 
likely to be valuable additions to this type of study but are beyond the scope of 
this basic protocol.  
 
Finally, it should be emphasized that this protocol is not suitable for studying 
progression of CKD in general, due to the specific constraints introduced by 
excluding those with hypertension, diabetes and CKD (i.e. those with proteinuria 
and/or with reduced eGFR) at baseline. In settings where there is no a high 
prevalence of CKDu, a cohort comprised of people without traditional risk 
factors for CKD or with CKD would be unlikely to identify any detectable kidney 
function loss over time in the target population. For studies outside the CKDu 
arena, investigators are advised to use alternative methodologies using 
established protocols, for example, the CRIC study.(35)  
 
In conclusion, we have designed a CO-DEGREE protocol that can be used in 
the different settings around the globe to investigate the natural history of CKDu 
and associated risk factors for decline in kidney function. These studies should 
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provide important information on the rate of decline of kidney function across 
different affected areas as well as key insight into the cause(s) of disease.   
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Figure 1: Flow chart and study procedures of CO-DEGREE protocol. 
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Table 1. Details and procedures of the baseline study visit and subsequence 
follow-up 
Items Baseline visit 
(0 month) 
Follow-up period 
(variable) 
12 
months 
24 
months 
36 
months 
48 
months 
At 
completion 
Community 
census X - - - - - 
Participants 
enrolment X - - - - - 
Informed consent X      
Update personnel 
contact 
information 
X X X X X  
Anthropometric 
measurements X X X X X  
Biological 
samples X X X X X  
Baseline core-
questionnaire X - - - -  
Follow-up 
questionnaire  X X X X  
Local serum 
creatinine 
measurement 
X X X X X  
Results feedback X X X X X  
Biobank X X X X X  
Batch testing of 
serum creatinine      X 
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Table 2: Sample Size Calculations  
Parameters Scenario 
1 
Scenario 
2 
Scenario 
3 
Scenario 
4 
Scenario 
5 
Scenario 
6 
Scenario 
7 
Scenario 
8 
Population frequency 
of eGFR decline 
0.04 0.06 0.08 0.10 0.04 0.06 0.08 0.10 
Proportion population 
exposed 
0.5 
Odds ratio associated 
with exposure 
2 3 
P 
(oucome|unexposed) 
0.027 0.04 0.053 0.066 0.02 0.03 0.04 0.05 
P (oucome|exposed) 0.054 0.08 0.106 0.132 0.06 0.09 0.12 0.15 
Group size 993 686 405 436 463 317 243 200 
Sample size 1986 1372 810 872 926 634 486 400 
Abbreviations, eGFR, estimated glomerular filtration rate; P: probability. Assumes 1-!=0.80;  
=0.05; Calculations based on equal proportion of the population exposed/unexposed for 
simplicity.  No adjustments made for loss to follow-up or multiple testing. 
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